<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Dev Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Dev Biol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32850836</article-id>
<article-id pub-id-type="pmc">7419626</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2020.00717</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>USP7 Is a Master Regulator of Genome Stability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Valles</surname>
<given-names>Gabrielle J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/978064/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bezsonova</surname>
<given-names>Irina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Woodgate</surname>
<given-names>Roger</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/974693/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashton</surname>
<given-names>Nicholas W.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/863837/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Molecular Biology and Biophysics, UConn Health</institution>, <addr-line>Farmington, CT</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Julia Kate Pagan, The University of Queensland, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Kaushlendra Tripathi, University of Alabama at Birmingham, United States; Román González-Prieto, Leiden University Medical Center, Netherlands</p>
</fn>
<corresp id="c001">*Correspondence: Roger Woodgate, <email>woodgate@nih.gov</email></corresp>
<corresp id="c002">Nicholas W. Ashton, <email>nicholas.ashton@nih.gov</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>8</volume>
<elocation-id>717</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Valles, Bezsonova, Woodgate and Ashton.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Valles, Bezsonova, Woodgate and Ashton</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Genetic alterations, including DNA mutations and chromosomal abnormalities, are primary drivers of tumor formation and cancer progression. These alterations can endow cells with a selective growth advantage, enabling cancers to evade cell death, proliferation limits, and immune checkpoints, to metastasize throughout the body. Genetic alterations occur due to failures of the genome stability pathways. In many cancers, the rate of alteration is further accelerated by the deregulation of these processes. The deubiquitinating enzyme ubiquitin specific protease 7 (USP7) has recently emerged as a key regulator of ubiquitination in the genome stability pathways. USP7 is also deregulated in many cancer types, where deviances in USP7 protein levels are correlated with cancer progression. In this work, we review the increasingly evident role of USP7 in maintaining genome stability, the links between USP7 deregulation and cancer progression, as well as the rationale of targeting USP7 in cancer therapy.</p>
</abstract>
<kwd-group>
<kwd>ubiquitin</kwd>
<kwd>mutagenesis</kwd>
<kwd>genomic integrity</kwd>
<kwd>replication</kwd>
<kwd>DNA repair</kwd>
<kwd>tumor suppressor protein p53</kwd>
<kwd>cancer</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn001">R35 GM128864</award-id>
<award-id rid="cn001">P41 GM111135</award-id>
<award-id rid="cn001">R01 GM123249</award-id>
</award-group>
<award-group>
<funding-source id="cn002">National Science Foundation<named-content content-type="fundref-id">10.13039/100000001</named-content></funding-source>
<award-id rid="cn002">1616184</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="272"></ref-count>
<page-count count="24"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Maintaining the genomic integrity of cells is vital, as alterations to the genetic code can result in deregulation of cellular function, malignant transformation or cell death. This can lead to a variety of disorders including neurological degeneration, premature aging, developmental defects and cancer (<xref ref-type="bibr" rid="B108">Khanna and Jackson, 2001</xref>). To prevent genetic alterations, cells employ a range of genome stability pathways, which allow for the accurate metabolism of the DNA, as well as for any DNA errors or damage to be rapidly repaired (<xref ref-type="bibr" rid="B85">Hoeijmakers, 2001</xref>). Post-translational modifications play an essential role in the signaling, activation and coordination of the genome stability pathways (<xref ref-type="bibr" rid="B181">Polo and Jackson, 2011</xref>). The reversable ubiquitination of proteins is one such essential modification that regulates numerous key factors involved in genome stability. Known as the “ubiquitin code”, this versatile pattern of mono- or polyubiquitin moieties dynamically regulates the activity, interactions, localization and stability of substrate proteins (<xref ref-type="bibr" rid="B114">Komander and Rape, 2012</xref>). For example, ubiquitination promotes initiation of DNA replication (<xref ref-type="bibr" rid="B82">Hernandez-Carralero et al., 2018</xref>), regulates all DNA damage tolerance and repair pathways and activates cell cycle regulatory components (<xref ref-type="bibr" rid="B149">Mocciaro and Rape, 2012</xref>). Dynamic ubiquitination is therefore essential to prevent genome instability.</p>
<p>Ubiquitination is mediated by a cascade of E1, E2 and E3 ubiquitin enzymes, which covalently attach the 8.5 kDa ubiquitin protein onto a substrate molecule, while deubiquitinating enzymes (DUBs) can edit or remove ubiquitin modifications (<xref ref-type="bibr" rid="B180">Pickart and Eddins, 2004</xref>). The human genome encodes close to 100 DUBs, which can be structurally grouped into seven distinct protein families: ubiquitin specific proteases (USPs), ovarian tumor proteases (OUTs), JAB1/MPN/MOV24 metalloproteases (JAMMs), ubiquitin c-terminal hydrolases (UCHs), Macho-Joseph disease protein domain proteases (MHDs), motif interacting with ubiquitin (MIU)-containing novel deubiquitinases (MINDYs) and ZUP1 (<xref ref-type="bibr" rid="B196">Ruan et al., 2020</xref>). Of these, the ubiquitin specific proteases (USPs) represent the largest DUB family, with 57 members (<xref ref-type="bibr" rid="B113">Komander et al., 2009</xref>). Many USPs have been found to function within the genome stability pathways (<xref ref-type="bibr" rid="B94">Jacq et al., 2013</xref>). USP1, for instance, regulates the monoubiquitination of FANCD2 (<xref ref-type="bibr" rid="B167">Oestergaard et al., 2007</xref>; <xref ref-type="bibr" rid="B129">Liang et al., 2019</xref>) and PCNA (<xref ref-type="bibr" rid="B90">Huang et al., 2006</xref>), thereby influencing the pathways of interstrand crosslink repair and translesion synthesis, respectively. By contrast, USP47 deubiquitinates and stabilizes polyubiquitinated DNA polymerase β, ensuring availability of the latter to participate in base excision repair (<xref ref-type="bibr" rid="B175">Parsons et al., 2011</xref>). While many USPs play essential roles in ensuring genome stability, they are often dysregulated in cancers where they promote tumorigenesis (<xref ref-type="bibr" rid="B257">Young et al., 2019</xref>). The prospect of targeting USPs has thus been increasingly considered as an attractive approach for cancer therapies (<xref ref-type="bibr" rid="B258">Yuan et al., 2018</xref>).</p>
<p>Ubiquitin specific protease 7 (USP7), also known as Herpesvirus associated protease (HAUSP), is an ∼128 kDa cysteine protease and member of the USP DUB family. USP7 was first identified as an interacting partner of herpes simplex virus type 1 (HSV-1) regulatory protein infected cell polypeptide 0 (ICP0) (<xref ref-type="bibr" rid="B49">Everett et al., 1997</xref>). Since its discovery, mounting evidence has demonstrated the extensive roles and interaction network of USP7 in several cellular pathways. This includes its significant role in genome stability, where USP7 regulates the well-characterized p53/Mdm2 signaling axis (<xref ref-type="bibr" rid="B126">Li et al., 2004</xref>), along with many other factors that will be addressed in detail in this review. USP7 is an essential enzyme; its homozygous knockout in mice results is early embryonic lethality (<xref ref-type="bibr" rid="B115">Kon et al., 2010</xref>) and no human individuals have been identified who are USP7 homozygous-null (<xref ref-type="bibr" rid="B59">Fountain et al., 2019</xref>). Heterozygous loss-of-function USP7 mutations have, however, been identified in 23 individuals, all of whom have experienced neurodevelopmental disorders – characterized by developmental delay/intellectual disability (DD/ID), speech delay, behavioral anomalies and autism spectrum disorder – as well as physical characteristics that include dysmorphic facial features (<xref ref-type="bibr" rid="B76">Hao et al., 2015</xref>; <xref ref-type="bibr" rid="B59">Fountain et al., 2019</xref>). While diseases caused by pathogenic somatic mutations of USP7 are rare, the aberrant expression of USP7 is much more frequent, resulting in deregulation of numerous pathways and contributing to disease states that include non-small cell lung cancer (<xref ref-type="bibr" rid="B144">Masuya et al., 2006</xref>) and prostate cancer (<xref ref-type="bibr" rid="B216">Song et al., 2008a</xref>). In this review, we will discuss the many roles USP7 plays in maintaining genome stability and its links with cancer.</p>
</sec>
<sec id="S2">
<title>Overview of USP7 Structure</title>
<p>All USPs share a conserved catalytic core, while their unique substrate specificity is determined by a variety of accessory substrate-binding domains (<xref ref-type="bibr" rid="B161">Nijman et al., 2005</xref>). From its N- to C-terminus, USP7 contains a tumor necrosis factor receptor associated factor-like (TRAF-like) domain, a catalytic domain and five ubiquitin-like (UBL) domains (<xref ref-type="fig" rid="F1">Figure 1</xref>). Although a full-length structure of USP7 is yet to be determined, structural information is known for each individual USP7 domain (<xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>; <xref ref-type="bibr" rid="B203">Saridakis et al., 2005</xref>; <xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Overview of USP7 domain structure. <bold>(A)</bold> USP7 model based on superposition of PDBs 2f1z, 5fwi and 4z97, with ubiquitin (black) (PDB ID:1nbf). Red spheres on the TRAF-like domain indicate the residues D164 and W165 responsible for substrate binding. Green spheres on catalytic domain represent catalytic triad active site residues C223, H464, and D481. Blue spheres on UBL2 indicate substrate-binding residues D758, E759, and D764. Red dashed lines indicate the characteristic papain-like fold “thumb, palm, fingers” sub-domain architecture of the USP7 catalytic domain. <bold>(B)</bold> Schematic of USP7 indicating the amino acid location of each domain, as well as of each substrate-binding region. Lists below the schematic indicate protein substrates known to bind each substrate-binding site.</p>
</caption>
<graphic xlink:href="fcell-08-00717-g001"></graphic>
</fig>
<sec id="S2.SS1">
<title>Substrate Recognition by TRAF-Like Domain</title>
<p>At its very N-terminus, USP7 contains an intrinsically disordered ∼50 amino acid sequence with a polyglutamine region, followed by its TRAF-like domain (residues 52–205). The USP7 TRAF-like domain has been extensively characterized as one of two major substrate-binding sites within USP7. Of the USP family of enzymes, USP7 is the sole member with a TRAF-like domain. This endows USP7 with unique substrate recognition and specificity that sets it apart from other USPs (<xref ref-type="bibr" rid="B161">Nijman et al., 2005</xref>).</p>
<p>USP7 is primarily nuclear and the N-terminus of the enzyme is largely responsible for its nuclear localization. Thus, truncation of amino acids 1–207 abolishes its ability to enter the nucleus. As this region of the protein does not contain a nuclear localization signal, it has been speculated that binding to USP7 substrates – which are primarily nuclear – may mediate translocation of USP7 into the nucleus (<xref ref-type="bibr" rid="B259">Zapata et al., 2001</xref>; <xref ref-type="bibr" rid="B58">Fernandez-Montalvan et al., 2007</xref>).</p>
<p>The majority of known USP7 substrate interactions occur within the TRAF-like domain. This wide range of substrates includes several factors that are involved in genome stability. The interactions between the USP7 TRAF-like domain and its substrates has been extensively characterized structurally. The TRAF-like domain assumes an eight stranded antiparallel β- sandwich fold, with residues D164 and W165 forming essential contacts with P/A/ExxS motifs shared by all TRAF-like domain-binding substrates. These substrates include the tumor suppressor p53 (<xref ref-type="bibr" rid="B88">Hu et al., 2006</xref>; <xref ref-type="bibr" rid="B212">Sheng et al., 2006</xref>), the Mdm2 E3 ubiquitin ligase (<xref ref-type="bibr" rid="B88">Hu et al., 2006</xref>; <xref ref-type="bibr" rid="B212">Sheng et al., 2006</xref>; <xref ref-type="bibr" rid="B204">Sarkari et al., 2010</xref>), the Mdm2 homolog Mdm4 (<xref ref-type="bibr" rid="B204">Sarkari et al., 2010</xref>) and mini-chromosome maintenance binding-protein MCM-BP (<xref ref-type="bibr" rid="B95">Jagannathan et al., 2014</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>List of USP7 substrates involved in genome stability and maintenance with available structural information.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>USP7 substrate</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>USP7 interaction domain</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>K<sub>d</sub> (μM)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>PDB ID</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">p53</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAF</td>
<td align="center" colspan="1" rowspan="1" valign="top">18 ± 1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">2foo, 2foj, 2f1x</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mdm2</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAF</td>
<td align="center" colspan="1" rowspan="1" valign="top">8 ± 0.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">2fop, 2f1y, 3mqs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mdm4</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAF</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">3mqr</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MCM-BP</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAF</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">4kg9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">UHRF1</td>
<td align="left" colspan="1" rowspan="1" valign="top">UBL1-2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">5c6d</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DNMT1</td>
<td align="left" colspan="1" rowspan="1" valign="top">UBL 1-2</td>
<td align="center" colspan="1" rowspan="1" valign="top"> 0.6 ± 0.05</td>
<td align="left" colspan="1" rowspan="1" valign="top">4yoc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RNF169</td>
<td align="left" colspan="1" rowspan="1" valign="top">UBL 1-2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.5 ± 1.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">5gg4</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>As all USP7 TRAF-like substrate interactions occur on an identical interface, these interactions occur in a mutually exclusive manner. This regulation of TRAF-like-mediated interactions is important for fine-tuning ubiquitination of USP7 substrates (as is described in the “<bold><italic>p53-Dependent Transcription”</italic></bold> section below).</p>
</sec>
<sec id="S2.SS2">
<title>USP7 Catalytic Domain</title>
<p>Following the TRAF-like domain and central to USP7 is its catalytic domain (residues 207–560). The catalytic domains of USPs contain a highly conserved Cysteine-Histidine box, which in USP7 is formed by residues C223, H464 and D481 (<xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>).</p>
<p>Despite differences in size, the catalytic domains of all USPs possess a characteristic papain-like fold with a “thumb, palm, fingers” sub-domain architecture (<xref ref-type="bibr" rid="B191">Reyes-Turcu et al., 2009</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). The fingers “hold” ubiquitin and is the primary interaction interface between the enzyme and ubiquitin. The active site catalytic triad resides in a cleft between the “palm” and “thumb” of the enzyme. The C-terminal tail of ubiquitin conjugated to a lysine residue of the substrate enters this cleft, allowing for hydrolysis of the isopeptide bond between ubiquitin and the substrate (<xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>; <xref ref-type="bibr" rid="B183">Pozhidaeva et al., 2017</xref>). Once cleaved, the low affinity between free ubiquitin and the catalytic domain results in subsequent release of the product (<xref ref-type="bibr" rid="B52">Faesen et al., 2011b</xref>; <xref ref-type="bibr" rid="B183">Pozhidaeva et al., 2017</xref>; <xref ref-type="bibr" rid="B109">Kim et al., 2019</xref>). Accordingly, mutations that enhance ubiquitin affinity to USPs result in inhibition of the enzyme (<xref ref-type="bibr" rid="B150">Morrow et al., 2018</xref>)</p>
<p>Crystal structures of the USP7 catalytic domain apo-enzyme (PDB ID: 1nb8) and the USP7 catalytic domain in complex with ubiquitin-aldehyde (PBD ID: 1nbf), reveal that for the most part, ubiquitin-binding does not result in broad conformational changes to the catalytic domain. However, major structural deviations do occur for the active site catalytic triad residues (C223, H464, D481), which undergo drastic conformational movement upon ubiquitin binding. In the apo-enzyme or “inactive” catalytic domain structure, active site residues are too far apart to perform enzymatic functions, while these same residues move towards each other in the “active” ubiquitin-bound structure. The “switching loop,” a loop that is proximal to the active site, undergoes even larger rearrangement and becomes more structured upon ubiquitin-binding (<xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>; <xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>). The existence of these two distinct conformations assumed by the USP7 catalytic domain may be a mechanism employed by the enzyme to regulate its activity (<xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>; <xref ref-type="bibr" rid="B171">Ozen et al., 2018</xref>).</p>
</sec>
<sec id="S2.SS3">
<title>C-Terminal UBL Domains Regulate Activation and Specificity of USP7</title>
<p>A long and potentially flexible α-helix connects the USP7 catalytic domain to its 64 kDa C-terminal ubiquitin-like domains (UBL 1–5) (<xref ref-type="bibr" rid="B111">Kim et al., 2016</xref>). Of the USPs, USP7 has the greatest number of UBLs (<xref ref-type="bibr" rid="B113">Komander et al., 2009</xref>). Despite low sequence homology to each other and to ubiquitin, these UBLs all structurally resemble the classic β-grasp ubiquitin fold (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>, <xref ref-type="bibr" rid="B53">2012</xref>).</p>
<p>USP7 UBLs function as di-UBL units in a 2-1-2 domain architecture: UBL 1-2, UBL 3, and UBL 4-5 (<xref ref-type="bibr" rid="B110">Kim and Sixma, 2017</xref>). These units are separated by flexible linkers, which allow for the C-terminus to assume an extended or compact conformation. This conformational flexibility and allosteric regulation is required for enzymatic activity (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>, <xref ref-type="bibr" rid="B53">2012</xref>; <xref ref-type="bibr" rid="B179">Pfoh et al., 2015</xref>; <xref ref-type="bibr" rid="B111">Kim et al., 2016</xref>; <xref ref-type="bibr" rid="B195">Rouge et al., 2016</xref>). While the catalytic domain is essential for enzymatic activity of USP7, the isolated catalytic domain has poor catalytic activity compared to the full-length enzyme (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>). Interestingly, efficient enzymatic activity of USP7 requires its UBL 4-5 domains (amino acids 894–1102). Studies have shown that following ubiquitin binding to the catalytic domain, the USP7 C-terminal domains assume a conformation that allows its disordered tail (residues 1084–1102) to bind to the “switching loop.” This conformational switch promotes an “active” state, increasing USP7 enzymatic activity. Without UBL 4–5, the catalytic activity of USP7 is severely compromised. Therefore, a functional full-length USP7 is required for its proper activity (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>; <xref ref-type="bibr" rid="B195">Rouge et al., 2016</xref>; <xref ref-type="bibr" rid="B109">Kim et al., 2019</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>UBL Domains Also Function as Additional Platform for Substrate-Binding</title>
<p>Outside of the TRAF-like domain, the UBL 1–2 domains contain the second major substrate recognition site for USP7 substrates. These interactions largely occur through an acidic patch on the interface of UBL 2 (<xref ref-type="fig" rid="F1">Figure 1</xref>). This acidic interface interacts with a highly basic motif (R/KxKxxxK) within USP7 substrates that include UHRF1 (<xref ref-type="bibr" rid="B266">Zhang et al., 2015</xref>), DNMT1 (<xref ref-type="bibr" rid="B29">Cheng et al., 2015</xref>) and RNF169 (<xref ref-type="bibr" rid="B4">An et al., 2017</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>UBL 4–5 has also been speculated to contain a secondary binding site outside of the TRAF-like domain for binding to p53 and Mdm2, although further validation of this site is still needed (<xref ref-type="bibr" rid="B137">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="B109">Kim et al., 2019</xref>).</p>
</sec>
</sec>
<sec id="S3">
<title>USP7 Cleaves Mono- and Polyubiquitin Chains From Substrate Proteins</title>
<p>The “ubiquitin code,” or pattern of ubiquitin modifications that occurs on a substrate, serves to regulate tagged substrates (<xref ref-type="bibr" rid="B114">Komander and Rape, 2012</xref>). Proteins may be monoubiquitinated, where a single ubiquitin moiety is covalently attached to a lysine residue of a substrate, or polyubiquitinated, where the initial ubiquitin group is further ubiquitinated. Successive ubiquitination can occur at one of the seven lysine residues within ubiquitin – K6, K11, K27, K29, K33, K48, and K63 – to form polyubiquitin chains of specific linkage types. Besides lysine residues, the N-terminal methionine of ubiquitin can also be ubiquitinated (<xref ref-type="bibr" rid="B220">Spit et al., 2019</xref>). USP7 specifically cleaves ubiquitin and is unable to cleave other ubiquitin-like modifiers including SUMO and Nedd8 (<xref ref-type="bibr" rid="B58">Fernandez-Montalvan et al., 2007</xref>).</p>
<p>The pattern of ubiquitin linkage on a substrate can have several effects, including targeting the substrate for proteasomal or lysosomal degradation, influencing substrate localization, regulating protein-protein interactions, and altering substrate activity (<xref ref-type="bibr" rid="B114">Komander and Rape, 2012</xref>). To date, the most common and well-characterized ubiquitin modifications include K11 and K48 polyubiquitin chains, which are best known for targeting substrates for proteasomal degradation and K63 polyubiquitin chains, which can signal proteins for lysosomal targeting and NF-KB activation (<xref ref-type="bibr" rid="B114">Komander and Rape, 2012</xref>). K63 polyubiquitination, as well as monoubiquitination, can also generate binding-platforms to mediate specific protein-protein interactions. The USP7 substrate PCNA, for instance, can be modified by both mono- and K63 polyubiquitination, which mediates interactions with translesion DNA polymerases (<xref ref-type="bibr" rid="B16">Bienko et al., 2005</xref>) and ZRANB3 (<xref ref-type="bibr" rid="B240">Vujanovic et al., 2017</xref>), respectively (discussed further in the <bold><italic>DNA Damage Bypass</italic></bold> section below).</p>
<p>Although USP7 substrate-specificity has been extensively characterized, its ubiquitin chain specificity for its specific substrates is still being elucidated. Like other USPs, USP7 is unable to cleave methionine-linked linear ubiquitin chains (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>). USP7 can, however, cleave K6, K11, K33, K48, and K63-linked modifications and does so with similar efficiencies (<xref ref-type="bibr" rid="B51">Faesen et al., 2011a</xref>; <xref ref-type="bibr" rid="B206">Schaefer and Morgan, 2011</xref>; <xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>; <xref ref-type="bibr" rid="B143">Masuda et al., 2019</xref>). As a means of regulating substrate-specificity, USP7 is inefficient in recycling and converting free-floating polyubiquitin chains to monoubiquitin if the chain is not attached to a substrate (<xref ref-type="bibr" rid="B206">Schaefer and Morgan, 2011</xref>; <xref ref-type="bibr" rid="B143">Masuda et al., 2019</xref>). USP7 can, however, cleave ubiquitin chains that are attached to the small ubiquitin-like modifier, SUMO, regardless of whether SUMO is itself attached to another substrate or otherwise free-floating (<xref ref-type="bibr" rid="B122">Lecona et al., 2016</xref>).</p>
<p>K63 and K48 polyubiquitin chains are the best-characterized ubiquitin linkages cleaved by USP7. USP7 indiscriminately cleaves K63 polyubiquitin linkages throughout the chain. This includes cleavage between ubiquitin and the substrate (base cleavage), between two ubiquitin molecules within the chain (endo-cleavage) or at the distal end of the chain, working inwards (exo-cleavage) (<xref ref-type="fig" rid="F2">Figure 2</xref>). One study suggests that K48-polyubiquitin linkages are not favored by USP7 and that the enzyme prefers ubiquitin modifications with a free K48 side chain. Because of this, USP7 preferentially exo-cleaves K48 polyubiquitin linkages, rather than endo-or base cleavage. This preference may act as an intrinsic negative regulator of USP7, helping to ensure that proteins destined for proteasomal degradation are in fact degraded (<xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>). USP7 activity is also influenced by the length of the polyubiquitin chain, as long polyubiquitin chains (&gt;4 ubiquitin) seem to be “resistant” to cleavage compared to shorter chains. This chain specificity is speculated to be an additional mechanism regulating USP7 activity, by serving as a threshold for proteasome-targeting polyubiquitination (<xref ref-type="bibr" rid="B206">Schaefer and Morgan, 2011</xref>; <xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>USP7 can cleave monoubiquitin moieties, as well as K48 and K63-linked polyubiquitin chains, from substrate proteins. K48 polyubiquitin chains are cleaved from the distal end of the chain, working inwards, while linkages between K63 polyubiquitin chains can be cleaved indiscriminately.</p>
</caption>
<graphic xlink:href="fcell-08-00717-g002"></graphic>
</fig>
<p>Despite the limitations above, stabilizing proteins by removal of proteasome-targeting K48 polyubiquitin chains is a common mechanism by which USP7 regulates many of its characterized substrates. Remarkably, these USP7 substrates include a high number of E3 ubiquitin ligases and their target substrates (<xref ref-type="bibr" rid="B110">Kim and Sixma, 2017</xref>). This results in an interesting dichotomy, where USP7 can deubiquitinate and stabilize: 1) the E3 ubiquitin ligase, allowing it to mediate K48 ubiquitination of its substrates; or 2) the substrate targeted by the E3 ubiquitin ligase. Most intriguing is the frequent observation for this pattern to occur as part of a negative feedback system, where USP7 contributes to both stabilizing and degrading both substrates. This arrangement allows USP7 to fine-tune substrate protein levels and dynamically regulate its target pathways.</p>
</sec>
<sec id="S4">
<title>USP7 Is a Master Regulator of Genomic Integrity Pathways</title>
<p>In this section, we will discuss the intricate manner through which USP7 regulates the genome stability pathways. We will firstly discuss the roles of USP7 in maintaining genome stability during normal cellular metabolism, by regulating the cell cycle, replication, mitosis and telomere stability. We will then review roles of USP7 following the induction of DNA damage, in regulating p53-dependent transcription and the pathways of nucleotide excision repair, double-strand DNA break repair and DNA damage bypass. Finally, we will consider roles of USP7 in the ‘last resort’ pathway of apoptosis.</p>
<sec id="S4.SS1">
<title>Cell Cycle Regulation</title>
<p>For a proliferating cell to give rise to identical daughter cells, genomic DNA must be duplicated and equally distributed into two new nuclei. These events occur in the S and M phases of the cell cycle; DNA is replicated during S phase, and then separated into distinct nuclei via mitosis in M phase. Towards the end of M phase, these two nuclei are partitioned into separate daughter cells in the process of cytokinesis. Interspersing S phase and M phase are two growth phases – G<sub>1</sub> and G<sub>2</sub> – during which the cell synthesizes new mRNA and protein for the subsequent phase. Progression through the cell cycle – G<sub>1</sub>, S, G<sub>2</sub>, M – is tightly regulated by proteins referred to as cyclins, which activate cyclin-dependent kinases (CDKs) to phosphorylate key proteins that initiate each cell cycle phase (<xref ref-type="bibr" rid="B141">Malumbres and Barbacid, 2009</xref>).</p>
<p>Numerous reports have demonstrated that the inhibition or depletion of USP7 in cells causes defects in cell cycle progression and a resulting decrease in cell proliferation (<xref ref-type="bibr" rid="B190">Reverdy et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>; <xref ref-type="bibr" rid="B95">Jagannathan et al., 2014</xref>; <xref ref-type="bibr" rid="B256">Yi et al., 2016</xref>). While these phenotypes are multi-factorial – resulting from disruptions to DNA replication, mitosis, and DNA repair – mounting evidence suggests they are also the result of disrupted cell cycle regulation. This includes recent findings regarding a role of USP7 in regulating the expression of cyclin A2, one of the major regulators of S phase initiation and the subsequent transition to G2 (<xref ref-type="fig" rid="F3">Figure 3A</xref>; <xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>USP7 functions in numerous genome stability pathways. Schematics indicate roles of USP7 in: <bold>(A)</bold> cell cycle regulation, <bold>(B)</bold> replication, <bold>(C)</bold> mitosis, <bold>(D)</bold> telomere regulation, <bold>(E)</bold> p53-dependent transcription, <bold>(F)</bold> nucleotide excision repair, <bold>(G)</bold> double-strand DNA break repair, <bold>(H)</bold> DNA damage bypass, and <bold>(I)</bold> apoptosis. Curved arrows towards a substrate indicate ubiquitination events, while curved arrows away from a substrate indicate deubiquitination; enzymes adjacent to the arrow catalyze the reaction. Color coding throughout the figure is indicated by the Key at the bottom of the figure.</p>
</caption>
<graphic xlink:href="fcell-08-00717-g003"></graphic>
</fig>
<p>USP7 regulates cyclin A2 indirectly, by stabilizing the PHF8 demethylase (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>). PHF8 activates transcription start sites by demethylating the histone substrates H3K9me<sup>1/2</sup>, H3K27me<sup>2</sup>, and H4K20me<sup>1</sup>. PHF8 also has an integral role in the upregulation of gene targets involved in cell cycle progression, including cyclin A2 (<xref ref-type="bibr" rid="B134">Liu et al., 2010</xref>). Protein levels of PHF8 are themselves cell cyclically regulated, with levels peaking in G2 due to USP7-mediated deubiquitination, before being degraded in M and G1 due to polyubiquitination by the anaphase-promoting complex (APC/C) (<xref ref-type="bibr" rid="B131">Lim et al., 2013</xref>; <xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>).</p>
<p>Another means through which USP7 regulates cell cycle progression is via stabilization of the Ki-67 antigen (<xref ref-type="bibr" rid="B261">Zhang et al., 2016</xref>). Ki-67 is a nuclear protein often used as biomarker of cell proliferation in immunohistochemical analysis of malignant tissues (<xref ref-type="bibr" rid="B200">Sales Gil and Vagnarelli, 2018</xref>). This is due to the near-exclusive expression of Ki-67 in the active cell cycle phases (G<sub>1</sub>, S, G<sub>2</sub>, M), as opposed to in the quiescent ‘G<sub>0</sub>’ state of non-dividing cells. Although Ki-67 expression has been used as a proliferation marker for many decades, roles for this protein remain poorly described. Recent findings, however, suggest that Ki-67 contributes to cell cycle regulation, heterochromatin maintenance and mitosis (<xref ref-type="bibr" rid="B226">Sun and Kaufman, 2018</xref>).</p>
</sec>
<sec id="S4.SS2">
<title>Replication</title>
<p>In addition to broad cell cycle regulation, USP7 also has more direct roles in regulating DNA replication (<xref ref-type="fig" rid="F3">Figure 3B</xref>). One of the earliest steps in this process is the so-called ‘licensing’ of origins of replication (<xref ref-type="bibr" rid="B11">Bell, 2017</xref>). This process occurs in late M phase/G1 and involves recruiting mini-chromosome maintenance 2–7 (MCM 2–7) replicative helicases to thousands of potential replication start sites, ready for use during S phase. Replication licensing is mediated by the licensing factors Cdc6 and Cdt1, which help to load the MCM proteins onto DNA (<xref ref-type="bibr" rid="B50">Evrin et al., 2009</xref>; <xref ref-type="bibr" rid="B189">Remus et al., 2009</xref>). To ensure that origins of replication can only be fired once per cell cycle, licensing is strictly inhibited once the cell enters S phase. This is essential to prevent DNA being replicated more than once per cell cycle, an undesirable outcome which can cause genome instability and tumorigenesis as a result of gene amplification (<xref ref-type="bibr" rid="B233">Truong and Wu, 2011</xref>).</p>
<p>USP7 has a role in preventing DNA re-replication by stabilizing Geminin, a negative regulator of replication (<xref ref-type="bibr" rid="B83">Hernández-Pérez et al., 2017</xref>). Geminin interacts directly with Cdt1, preventing Cdt1from loading MCM proteins onto origins of replication (<xref ref-type="bibr" rid="B250">Wohlschlegel et al., 2000</xref>). Analogous to the regulation of PHF8, Geminin protein levels are cyclically regulated to increase in S and G2 due to USP7-mediated deubiquitination, prior to degradation in M phase and G1 as a result of APC/C-mediated polyubiquitination (<xref ref-type="bibr" rid="B146">McGarry and Kirschner, 1998</xref>). By deubiquitinating Geminin in S and G2, USP7 helps to ensure its availability to suppress aberrant origin licensing (<xref ref-type="bibr" rid="B83">Hernández-Pérez et al., 2017</xref>).</p>
<p>The firing of replication origins occurs once the MCM2-7 proteins associate with Cdc45 and the GINS protein complex, to form an active replicative helicase (<xref ref-type="bibr" rid="B63">Gambus et al., 2006</xref>; <xref ref-type="bibr" rid="B152">Moyer et al., 2006</xref>; <xref ref-type="bibr" rid="B92">Ilves et al., 2010</xref>). This complex then begins the process of unwinding the DNA, allowing the recruitment of ‘replisome’ proteins, while exposing single-stranded DNA for use as a template for new DNA synthesis by replicative DNA polymerases (<xref ref-type="bibr" rid="B123">Leman and Noguchi, 2013</xref>). A recent study has indicated that USP7 associates at sites of replication and is important for origin firing and replication fork progression (<xref ref-type="bibr" rid="B122">Lecona et al., 2016</xref>). Here, USP7 deubiquitinates replication fork proteins, with an apparent preference for substrates that are also SUMOylated. This role allows USP7 to maintain a high local ratio of SUMOylated to ubiquitinated proteins, a distinguishing feature of replication fork-adjacent chromatin (<xref ref-type="bibr" rid="B136">Lopez-Contreras et al., 2013</xref>). An explanation for this role is that by deubiquitinating replication proteins, USP7 is able to prevent their recognition by the valosin-containing protein (VCP) [also known as the p97 segregase (<xref ref-type="bibr" rid="B122">Lecona et al., 2016</xref>)]. VCP recognizes and extracts chromatin-bound ubiquitinated proteins, allowing for their proteasomal degradation (<xref ref-type="bibr" rid="B38">Dantuma and Hoppe, 2012</xref>). By deubiquitinating SUMOylated proteins at the replication fork, USP7 may therefore help to maintain protein levels required for new DNA synthesis. A precise catalog of SUMOylated proteins targeted by USP7, will, however, require further exploration.</p>
<p>USP7 also contributes to maintaining the methylation status of newly synthesized DNA through multi-level regulation of DNA (cytosine-5)-methyltransferase 1 (DNMT1) (<xref ref-type="bibr" rid="B57">Felle et al., 2011</xref>; <xref ref-type="bibr" rid="B185">Qin et al., 2011</xref>). DNMT1 catalyzes the methylation of cytosine bases at cytosine-phosphate-guanine (CpG) dinucleoside sites and as such is an important mediator of epigenetic gene silencing (<xref ref-type="bibr" rid="B99">Jones et al., 1998</xref>; <xref ref-type="bibr" rid="B41">Dhe-Paganon et al., 2011</xref>). Unlike related DNA methyltransferases of the DNMT3 family, which have a higher affinity for non-methylated DNA, DNMT1 instead preferences the methylation of hemi-methylated CpG sites (<xref ref-type="bibr" rid="B81">Hermann et al., 2004</xref>). This preference allows DNMT1 to specifically modify newly synthesized DNA by copying the methylation pattern of the template strand. Although an association with the replication fork is not strictly necessary for the post-replicative activity of DNMT1, DNMT1 does interact directly with the PCNA sliding clamp. This interaction is thought to increase the catalytic efficiency of DNMT1 (<xref ref-type="bibr" rid="B34">Chuang et al., 1997</xref>; <xref ref-type="bibr" rid="B209">Schermelleh et al., 2007</xref>; <xref ref-type="bibr" rid="B219">Spada et al., 2007</xref>).</p>
<p>USP7 has been found to interact directly with DNMT1 and was initially suggested to stabilize the latter by opposing its polyubiquitination by the E3 ubiquitin ligase UHRF1 (<xref ref-type="bibr" rid="B57">Felle et al., 2011</xref>; <xref ref-type="bibr" rid="B185">Qin et al., 2011</xref>). Acetylation of DNMT1 by Kat5 (also known as Tip60) at the end of S phase was further proposed to disrupt the USP7-DNMT1 interaction and target the latter for degradation (<xref ref-type="bibr" rid="B45">Du et al., 2010</xref>; <xref ref-type="bibr" rid="B29">Cheng et al., 2015</xref>). Some doubt has, however, recently arisen as to the extent to which USP7 contributes to DNMT1 stability (<xref ref-type="bibr" rid="B255">Yarychkivska et al., 2018</xref>). Indeed, in this report, DNMT1 protein levels were found to be unaffected by USP7-depletion or to decrease at the end of S phase. Reconciling these findings will require further study.</p>
<p>While the role of USP7 in regulating DNMT1 protein levels remains unclear, numerous reports have indicated that USP7 also regulates DNMT1 chromatin localization via indirect means. This includes USP7-mediated stabilization of UHRF1 (<xref ref-type="bibr" rid="B97">Jenkins et al., 2005</xref>; <xref ref-type="bibr" rid="B57">Felle et al., 2011</xref>). In addition to its role in polyubiquitinating DNMT1, UHRF1 is also a critical factor in localizing DNMT1 to chromatin (<xref ref-type="bibr" rid="B20">Bostick et al., 2007</xref>; <xref ref-type="bibr" rid="B1">Achour et al., 2008</xref>; <xref ref-type="bibr" rid="B22">Bronner et al., 2019</xref>). UHRFI has been suggested to guide DNMT1 towards hemi-methylated DNA, by cooperative binding to both hemi-methylated DNA and lysine 9 methylated histone H3 (H3K9me<sup>3</sup>) (<xref ref-type="bibr" rid="B135">Liu et al., 2013</xref>). USP7 has been suggested to have an additional role in this step, where its binding to UHRF1 seems to promote a conformational change in UHRF1, allowing for efficient H3K9me<sup>3</sup>-binding (<xref ref-type="bibr" rid="B64">Gao et al., 2018</xref>). These rearrangements presumably contribute to the subsequent channeling of DNMT1 to these histone marks. In addition, UHRF1 seems to promote DNMT1 chromatin binding by monoubiquitinating histone H3 at three different lysine residues, K14, K18, and K23, which generates a platform for DNMT1-binding (<xref ref-type="bibr" rid="B163">Nishiyama et al., 2013</xref>; <xref ref-type="bibr" rid="B78">Harrison et al., 2016</xref>; <xref ref-type="bibr" rid="B93">Ishiyama et al., 2017</xref>). Interesting, USP7 seems to play a role in negatively regulating this interaction by deubiquitinating H3 (<xref ref-type="bibr" rid="B253">Yamaguchi et al., 2017</xref>); this may allow USP7 to fine-tune DNMT1 recruitment.</p>
<p>USP7 also has a likely role in the final stages of replication, in the unloading of MCM complexes. This was first suggested by the delayed progression of USP7-depleted cells through late S and G2 of the cell cycle, which corresponds with a defect in the dissociation of MCM proteins from chromatin (<xref ref-type="bibr" rid="B95">Jagannathan et al., 2014</xref>). Furthermore, USP7 was found to interact with MCM-binding protein (MCM-BP) – a protein that mediates MCM disassembly and dissociation from DNA following the completion of replication (<xref ref-type="bibr" rid="B162">Nishiyama et al., 2011</xref>; <xref ref-type="bibr" rid="B159">Nguyen et al., 2012</xref>). Although a precise mechanism remains unclear, these observations suggest USP7 has a direct role in the disassembly of replication forks, presumably involving an interaction with MCM-BP.</p>
</sec>
<sec id="S4.SS3">
<title>Mitosis</title>
<p>While the accurate replication of DNA is essential to prevent the accumulation of DNA mutations, the precise division of this DNA during mitosis is equally important for the generation of genetically identical daughter cells. Indeed, failures during this process can result in aneuploidy – the production of daughter cells with too many or too few chromosomes – as well as other chromosomal rearrangements (<xref ref-type="bibr" rid="B125">Levine and Holland, 2018</xref>). The consequence of these errors is highlighted by the structural alterations and copy number changes of chromosomes found in the vast majority of tumors (<xref ref-type="bibr" rid="B46">Duijf et al., 2013</xref>). A number of studies have suggested that USP7 functions in the regulation of mitosis (<xref ref-type="bibr" rid="B168">Oh et al., 2007</xref>; <xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>, <xref ref-type="bibr" rid="B69">2014</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>; <xref ref-type="fig" rid="F3">Figure 3C</xref>). Here, cells depleted of USP7 exhibit increases in chromosomal abnormalities and aneuploidy, as well as an accumulation of micronuclei (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>, <xref ref-type="bibr" rid="B69">2014</xref>).</p>
<p>Mitosis occurs as a series of five distinct phases: prophase, prometaphase, metaphase, anaphase, telophase (<xref ref-type="bibr" rid="B147">McIntosh, 2016</xref>). In prophase, the duplicated and entangled chromosomes are condensed into two distinct sister chromatids, joined together by a centromere (<xref ref-type="bibr" rid="B12">Belmont, 2006</xref>). Disk-shaped protein structures called kinetochores then assemble on the centromere in prometaphase, which are bound by microtubules originating from centrosomes found at either end of the cell (<xref ref-type="bibr" rid="B138">Magidson et al., 2011</xref>). The chromosomal centromeres are then aligned at equal distances from the centrosomes in metaphase, along the so-call metaphase plate (<xref ref-type="bibr" rid="B96">Jaqaman et al., 2010</xref>). In anaphase, the sister chromatids are then separated and move to opposite ends of the cell, prior to formation of distinct nuclear membranes around each identical set of chromatids in telophase (<xref ref-type="bibr" rid="B147">McIntosh, 2016</xref>).</p>
<p>One of the major ways USP7 contributes to mitosis, is by regulating the stability of polo-like kinase 1 (PLK1) (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). PLK1 is one of the foremost M phase kinases, which functions in almost every stage of mitosis, including progression through the G2/M boundary, the alignment of chromatids on the metaphase plate and sister chromatid segregation (<xref ref-type="bibr" rid="B36">Combes et al., 2017</xref>). USP7 both positively and negatively influences PLK1 proteins levels by deubiquitinating and stabilizing both PLK1 and its E3 ubiquitin ligase, CHFR (<xref ref-type="bibr" rid="B168">Oh et al., 2007</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). CHFR triggers the degradation of PLK1 in response to mitotic stress, which prevents activation of mitosis-promoting factor and progression into M phase (<xref ref-type="bibr" rid="B102">Kang et al., 2002</xref>). By stabilizing both PLK1 and CHFR, USP7 thereby helps to regulate mitotic entry; indeed, cells depleted of USP7 exhibit G2/M cell cycle arrest and delayed mitotic progression (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). How the cell balances these opposing functions of USP7 will, however, require further study.</p>
<p>In addition to mitotic entry, USP7-mediated stabilization of PLK1 also contributes to the PLK1 regulation of chromatid alignment and segregation. Indeed, cells depleted of PLK1 or USP7 exhibit increased rates of chromosomal misalignment and segregation during metaphase and anaphase, respectively (<xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). PLK1 exerts these functions by localizing to the chromatid kinetochores in prometaphase, where it promotes microtubule attachments (<xref ref-type="bibr" rid="B133">Liu et al., 2012</xref>).</p>
<p>Aside from PLK1-mediated regulation, USP7 also influences proper chromatid alignment and segregation by deubiquitinating Bub3 during M phase (<xref ref-type="bibr" rid="B69">Giovinazzi et al., 2014</xref>). Bub3 is a key component of the Spindle Assembly Checkpoint (SAC), where it functions with other members of the Mitotic Checkpoint Complex (MCC) (<xref ref-type="bibr" rid="B156">Musacchio, 2015</xref>). The SAC regulates the metaphase-to-anaphase transition, by ensuring that all sister chromatids are aligned on the metaphase plate and properly connected to centrosomal microtubules – a process regulated by PLK1 (<xref ref-type="bibr" rid="B36">Combes et al., 2017</xref>) – prior to chromatid segregation during anaphase. The SAC delays this transition by inhibiting the anaphase-promoting complex (APC/C) and preventing it from degrading cyclin B and securin (<xref ref-type="bibr" rid="B156">Musacchio, 2015</xref>). Securin, in turn, inhibits the protease separase, which is responsible for cleaving the cohesin rings that hold sister chromatids together to initiate anaphase (<xref ref-type="bibr" rid="B194">Ross and Cohen-Fix, 2002</xref>). By stabilizing both PLK1 and Bub3, USP7 therefore regulates chromosomal segregation in two ways: 1) by regulating the proper attachment of microtubules to the kinetochores, and 2) by ensuring a proper checkpoint response can be initiated, in the event of any errors.</p>
</sec>
<sec id="S4.SS4">
<title>Telomere Maintenance</title>
<p>Another means by which USP7 influences genome stability, is through the maintenance of telomere ends (<xref ref-type="fig" rid="F3">Figure 3D</xref>; <xref ref-type="bibr" rid="B260">Zemp and Lingner, 2014</xref>; <xref ref-type="bibr" rid="B47">Episkopou et al., 2019</xref>). Telomeres are protein-nucleotide structures at the termini of each eukaryotic chromosome, which in humans contain 10 to 15 kb of a repeating hexanucleotide sequence (<xref ref-type="bibr" rid="B116">Kong et al., 2013</xref>). While the vast majority of the telomeric DNA is double-stranded, the termini of each telomere is characterized by a 3’ overhang of 50–300 bp of single-stranded DNA (ssDNA). These overhangs result from the so called “end-replication problem,” where the cell is unable to replicate the 3’ termini of chromosomes due to the strict requirement of a primed template from which replication can proceed (<xref ref-type="bibr" rid="B77">Harley et al., 1990</xref>). These overhangs represent a challenge for the cell, as exposed ssDNA is vulnerable to both chemical and enzymatic degradation. Furthermore, as telomere ends resemble broken chromosomes, they must be protected to prevent triggering a double-strand DNA break response and the fusion of adjacent chromosomes (<xref ref-type="bibr" rid="B170">O’Sullivan and Karlseder, 2010</xref>).</p>
<p>One of the ways cells sequester telomere overhangs is through the formation of so called “t-loops”. These structures form when the telomeric ssDNA overhang invades an upstream region of the telomere duplex and stably binds via complementarity of the hexanucleotide sequence (<xref ref-type="bibr" rid="B72">Griffith et al., 1999</xref>). Although this protects the telomere overhang, it does so at the expense of displacing a section of ssDNA from the upstream DNA duplex. This displaced section is, however, rapidly bound by proteins of the shelterin complex – comprised of TRF1, TRF2, POT1, TPP1, TIN2, and Rap1 – which bind both directly to the ssDNA section, as well as the adjacent dsDNA (<xref ref-type="bibr" rid="B40">de Lange, 2005</xref>). In germ cells and the vast majority of cancer cells, the shelterin complex also contributes to regulating telomere lengthening, either via telomerase-mediated DNA synthesis (active in 85 – 90% of cancers) or recombination-based alternative lengthening of telomeres (ALT; active in 10 – 15% of cancers) (<xref ref-type="bibr" rid="B24">Cesare and Reddel, 2010</xref>).</p>
<p>USP7 contributes to telomere maintenance by interacting with and deubiquitinating the shelterin component, TPP1 (<xref ref-type="bibr" rid="B260">Zemp and Lingner, 2014</xref>). TPP1 binds to telomeric ssDNA as a heterodimer with POT1, which helps to protect the telomere from degradation. In addition, TPP1 interacts directly with telomerase and is a processivity factor for telomerase-mediated telomere lengthening (<xref ref-type="bibr" rid="B241">Wang et al., 2007</xref>; <xref ref-type="bibr" rid="B252">Xu et al., 2019</xref>). Unlike murine TPP1, whose ubiquitination promotes telomere localization (<xref ref-type="bibr" rid="B187">Rai et al., 2011</xref>), the ubiquitination of human TPP1 signals the protein for proteasomal degradation. USP7, however, stabilizes human TPP1, likely in conjunction with other DUBs (<xref ref-type="bibr" rid="B260">Zemp and Lingner, 2014</xref>). Although a precise functional outcome of USP7-mediated TPP1 stabilization remains unclear, by limiting TPP1 degradation, USP7 presumably contributes to the integrity of telomere cap as well as regulation of telomerase-mediated end lengthening.</p>
<p>USP7 localizes to telomere ends in both telomerase<sup>+</sup> and ALT<sup>+</sup> human cell lines, however, its roles at either seem to differ. Indeed, while USP7 has an apparent protective role in telomerase<sup>+</sup> cells – via TPP1 stabilization – USP7 seems to promote POT1 degradation in ALT<sup>+</sup> cells (<xref ref-type="bibr" rid="B47">Episkopou et al., 2019</xref>). Although a precise explanation for this difference remains unclear, it seems to involve the specific localization of ALT<sup>+</sup> telomeres within promyelocytic leukemia (PML) nuclear bodies. These ALT-associated PML bodies have an essential role in telomere-lengthening in ALT<sup>+</sup> cells, by bringing chromosome ends together with the recombination proteins that mediate their lengthening (<xref ref-type="bibr" rid="B44">Draskovic et al., 2009</xref>; <xref ref-type="bibr" rid="B169">Osterwald et al., 2015</xref>). USP7 also associates with PML bodies (<xref ref-type="bibr" rid="B205">Sarkari et al., 2011</xref>) and PML proteins are essential for USP7 to degrade POT1 (<xref ref-type="bibr" rid="B47">Episkopou et al., 2019</xref>). Here, USP7 is thought to contribute to POT1 degradation by stabilizing one of the many E3 ubiquitin ligases known to accumulate within PML bodies (<xref ref-type="bibr" rid="B31">Cheng and Kao, 2013</xref>; <xref ref-type="bibr" rid="B47">Episkopou et al., 2019</xref>). Although USP7-regulated degradation of POT1 is likely required for proper ALT regulation, this process is strictly regulated by the USP7 inhibitor protein, TSPYL5 (testis-specific Y-encoded-like protein 5). TSPYL5 competitively binds to the USP7 TRAF-like domain, limiting USP7 substrate-binding (<xref ref-type="bibr" rid="B48">Epping et al., 2011</xref>). Regulation of USP7 by TSPYL5 is of particular importance in ALT<sup>+</sup> cells, as unlike in telomerase<sup>+</sup> cells, TSPYL5 depletion causes cell death due to unrestricted POT1 degradation (<xref ref-type="bibr" rid="B47">Episkopou et al., 2019</xref>).</p>
</sec>
<sec id="S4.SS5">
<title>p53-Dependent Transcription</title>
<p>Regulating the p53 pathway is one of the most well-studied and well-characterized aspects of USP7 function (<xref ref-type="bibr" rid="B127">Li et al., 2002</xref>; <xref ref-type="fig" rid="F3">Figure 3E</xref>). Colloquially referred to as the ‘guardian of the genome’, tumor suppressor protein p53 is an essential transcription factor that stimulates the expression of hundreds of target genes in response to genomic stress. Depending on the type and extent of the damage that occurs, these target genes encode proteins that function in cell cycle arrest, DNA damage repair and apoptosis (<xref ref-type="bibr" rid="B75">Hafner et al., 2019</xref>).</p>
<p>In undamaged cells, p53 protein levels are maintained at minimal levels due to prompt proteasome-targeting polyubiquitination by the Mdm2 E3 ubiquitin ligase (<xref ref-type="bibr" rid="B79">Haupt et al., 1997</xref>; <xref ref-type="bibr" rid="B86">Honda et al., 1997</xref>; <xref ref-type="bibr" rid="B118">Kubbutat et al., 1997</xref>). While Mdm2 is also targeted for proteasomal degradation due its auto-polyubiquitination (<xref ref-type="bibr" rid="B55">Fang et al., 2000</xref>), USP7 is able to stabilize Mdm2 by rapidly removing these ubiquitin chains (<xref ref-type="bibr" rid="B37">Cummins et al., 2004</xref>; <xref ref-type="bibr" rid="B126">Li et al., 2004</xref>). Furthermore, USP7 deubiquitinates and stabilizes the Mdm2 interacting partner – and substrate (<xref ref-type="bibr" rid="B106">Kawai et al., 2003</xref>; <xref ref-type="bibr" rid="B173">Pan and Chen, 2003</xref>) – Mdm4 (also known as Mdmx) (<xref ref-type="bibr" rid="B148">Meulmeester et al., 2005</xref>). Mdm4 further contributes to Mdm2 stability by disrupting self-ubiquitination of the latter (<xref ref-type="bibr" rid="B221">Stad et al., 2001</xref>), while also stimulating Mdm2-mediated polyubiquitination of p53 (<xref ref-type="bibr" rid="B132">Linares et al., 2003</xref>). Further, Mdm4 directly interacts with p53 to disrupts its DNA-binding and transcriptional activation (<xref ref-type="bibr" rid="B61">Francoz et al., 2006</xref>; <xref ref-type="bibr" rid="B247">Wei et al., 2016</xref>). The interaction between USP7 and Mdm2 is also enhanced by DAXX, which simultaneously binds both proteins and enhances the E3 ubiquitin ligase activity of Mdm2 towards p53 (<xref ref-type="bibr" rid="B230">Tang J. et al., 2006</xref>).</p>
<p>The SUV39H1 methyltransferase (also known as KMT1A) is another Mdm2 substrate that is deubiquitinated and stabilized by USP7 in undamaged cells (<xref ref-type="bibr" rid="B19">Bosch-Presegué et al., 2011</xref>; <xref ref-type="bibr" rid="B154">Mungamuri et al., 2016</xref>). As with Mdm4, SUV39H1 negatively regulates the transcriptional activation of p53. It does so by co-localizing with p53 at the promoters of target genes, where it trimethylates lysine 9 of histone H3 (H3K9me3) to promote formation of transcriptionally inactive higher-order heterochromatin (<xref ref-type="bibr" rid="B153">Mungamuri et al., 2012</xref>). SUV39H1 function is also modulated by the SIRT1 deacetylase, which regulates SUV39H1 in two separate ways: (1) by deacetylating SUV39H1 lysine residue 266 (K266) (<xref ref-type="bibr" rid="B238">Vaquero et al., 2007</xref>) and (2) by deacetylating lysine 9 of histone H3 (H3K9Ac) to allow SUV39H1 methylation (<xref ref-type="bibr" rid="B239">Vaquero et al., 2004</xref>, <xref ref-type="bibr" rid="B238">2007</xref>). As SIRT1 was recently found to be deubiquitinated and stabilized by USP7, these findings suggest another way through which USP7 can regulate SUV39H1 activity and p53 transcription (<xref ref-type="bibr" rid="B218">Song et al., 2020</xref>).</p>
<p>The above interactions demonstrate the critical roles USP7 plays in suppressing p53 activation in undamaged cells. USP7 is, however, also important for mounting a strong p53 response following DNA damage. Fundamental to this response is a switch from USP7 deubiquitinating Mdm2 to preferentially deubiquitinating p53 (<xref ref-type="bibr" rid="B126">Li et al., 2004</xref>). An obstacle to this switch is that while USP7 binds both Mdm2 and p53 via its TRAF-like domain, Mdm2 makes more extensive contacts and thus binds the TRAF-like domain with a higher affinity (<xref ref-type="bibr" rid="B88">Hu et al., 2006</xref>; <xref ref-type="bibr" rid="B212">Sheng et al., 2006</xref>). A contributor to this switch is the DNA damage-induced phosphorylation of p53, Mdm2, Mdm4, and DAXX by the Ataxia telangiectasia mutated (ATM) kinase and its downstream effector kinase, Chk2 (<xref ref-type="bibr" rid="B30">Cheng and Chen, 2010</xref>; <xref ref-type="bibr" rid="B142">Maréchal and Zou, 2013</xref>). These phosphorylation events contribute to disrupting the p53-Mdm2 (<xref ref-type="bibr" rid="B26">Chehab et al., 2000</xref>; <xref ref-type="bibr" rid="B213">Shieh et al., 2000</xref>), and Mdm2-DAXX (<xref ref-type="bibr" rid="B229">Tang et al., 2013</xref>) interactions, as well as to the degradation of Mdm2 and Mdm4 (<xref ref-type="bibr" rid="B223">Stommel and Wahl, 2004</xref>; <xref ref-type="bibr" rid="B28">Chen et al., 2005</xref>; <xref ref-type="bibr" rid="B178">Pereg et al., 2005</xref>, <xref ref-type="bibr" rid="B177">2006</xref>; <xref ref-type="bibr" rid="B121">LeBron et al., 2006</xref>). Deacetylation of Mdm2 by Sirt1 also contributes to the Mdm2/p53 switch, by disrupting the association between Mdm2 and USP7, leading to Mdm2 auto-ubiquitination (<xref ref-type="bibr" rid="B160">Nihira et al., 2017</xref>).</p>
<p>Various regulatory proteins also influence the transition of USP7 between Mdm2- and p53-binding. The RASSF1A tumor suppressor is one such protein, which disrupts the Mdm2-DAXX-USP7 interaction in response to DNA damage by simultaneously binding to both Mdm2 and DAXX. RASSF1A thereby destabilizes Mdm2, allowing for a p53-dependent delay in G1-S cell cycle progression (<xref ref-type="bibr" rid="B217">Song et al., 2008b</xref>). ABRO1 (also known as FAM175B) also contributes to the p53 response by stabilizing the p53-USP7 interaction and promoting USP7-mediated p53 deubiquitination (<xref ref-type="bibr" rid="B262">Zhang J. et al., 2014</xref>). The p53-USP7 interaction is also negatively regulated by the TSPYL5 inhibitor protein (<xref ref-type="bibr" rid="B48">Epping et al., 2011</xref>). As mentioned in the ‘<bold><italic>Telomere Maintenance</italic></bold>’ section above, TSPYL5 binds to the USP7 TRAF-like domain, competitively inhibiting USP7 substrate binding. TSPYL5 disrupts the p53-USP7 interaction, leading to increased polyubiquitination and degradation of p53. Unlike RASSF1A and ABRO, which stimulates p53-activation, TSPYL5 therefore seems to contribute to a more measured p53 response.</p>
</sec>
<sec id="S4.SS6">
<title>Nucleotide Excision Repair</title>
<p>Aside from activating p53, multiple studies have suggested that USP7 also has a direct role in the DNA damage response via regulation of the nucleotide excision repair (NER) pathway (<xref ref-type="bibr" rid="B202">Sarasin, 2012</xref>; <xref ref-type="bibr" rid="B210">Schwertman et al., 2012</xref>; <xref ref-type="bibr" rid="B80">He et al., 2014</xref>; <xref ref-type="bibr" rid="B84">Higa et al., 2016</xref>; <xref ref-type="bibr" rid="B269">Zhu et al., 2020</xref>; <xref ref-type="fig" rid="F3">Figure 3F</xref>). NER is a central pathway through which cells remove a range of bulky DNA lesions, caused by numerous environmental mutagens and metabolic byproducts. While such lesions are structurally diverse and are caused by a range of DNA-damaging agents, UV radiation-induced lesions are a primary substrate (<xref ref-type="bibr" rid="B207">Schärer, 2013</xref>). Indeed, cells depleted of USP7 are deficient in the repair of UV-induced cylobutane pyrimidine dimers and 6-4 photoproducts (<xref ref-type="bibr" rid="B80">He et al., 2014</xref>).</p>
<p>The detection of DNA lesions and the initiation of NER, occurs through two sub-pathways: global genome NER (GG-NER) and transcription-coupled NER (TC-NER). In GG-NER, lesions are detected throughout the genome by the XPC-Rad23B and DDB1-XPE protein complexes, which recognize helical distortions caused by the DNA adduct. By contrast, TC-NER is activated by the stalling of RNA polymerase II at lesions in the transcribed strand of active genes, as well by accumulation of the TC-NER proteins ERCC8 (CSA), ERCC6 (CSB), and XAB2 at sites of damage. In both GG- and TC-NER, lesion recognition is followed by unwinding of the DNA by TFIIH helicase, excision of the lesion, and the synthesis and ligation of a new DNA patch (<xref ref-type="bibr" rid="B119">Kusakabe et al., 2019</xref>).</p>
<p>USP7 has apparent functions in the initiation steps of both GG- and TC-NER pathways. In the former, USP7 has been found to interact with and deubiquitinate the lesion sensing factor, XPC (<xref ref-type="bibr" rid="B80">He et al., 2014</xref>). XPC is polyubiquitinated in cells in response to UV-induced DNA damage by a complex containing the DDB1-XPE proteins and the Cul4A E3 ubiquitin ligase (<xref ref-type="bibr" rid="B225">Sugasawa et al., 2005</xref>; <xref ref-type="bibr" rid="B244">Wang et al., 2005</xref>). Although ubiquitination of XPC is functionally important for enhancing binding to damaged DNA, it does so at the expense of exposing XPC to valosin-containing protein (VCP/p97)-mediated proteolysis. Deubiquitination of XPC by USP7, however, stabilizes XPC and prevents its premature degradation (<xref ref-type="bibr" rid="B80">He et al., 2014</xref>).</p>
<p>In the early stages of TC-NER, USP7 interacts with and is recruited to lesions by the UVSSA scaffolding protein. This interaction is important for USP7 to localize and subsequently stabilize the adjacent protein, ERCC6 (<xref ref-type="bibr" rid="B210">Schwertman et al., 2012</xref>). Indeed, ERCC6 protein levels are substantially reduced in cells depleted of USP7 or UVSSA (<xref ref-type="bibr" rid="B265">Zhang et al., 2012</xref>). Furthermore, while ERCC6 is degraded in cells following UV irradiation (<xref ref-type="bibr" rid="B73">Groisman et al., 2006</xref>; <xref ref-type="bibr" rid="B246">Wei et al., 2011</xref>), this degradation is more rapid in the absence of either protein. Although ERCC6 degradation is necessary for the resumption of transcription following NER, it has been suggested that USP7 helps to delay this process until the proper completion of ERCC6 function (<xref ref-type="bibr" rid="B210">Schwertman et al., 2012</xref>).</p>
</sec>
<sec id="S4.SS7">
<title>Double-Strand DNA Break Repair</title>
<p>USP7 also has important regulatory roles in the repair of double-strand DNA breaks (DSBs) (<xref ref-type="fig" rid="F3">Figure 3G</xref>). DSBs are an especially toxic form of DNA lesion, as their incorrect repair can lead to chromosomal fragmentation and/or rearrangement (<xref ref-type="bibr" rid="B214">So et al., 2017</xref>). Two major DNA repair pathways are employed for the repair of double-strand DNA breaks in cells: non-homologous end-joining (NHEJ) and homologous recombination (HR). NHEJ is a comparatively simple DSB repair pathway, in which either end of a DSB are bound by the Ku70/80 heterodimer, aligned and then re-ligated by DNA ligase IV. If necessary, this process may involve a small degree of end-processing (either gap-filling or ssDNA-trimming) to create compatible DNA ends (<xref ref-type="bibr" rid="B130">Lieber, 2010</xref>). By contrast, the initial stages of HR involve the large-scale resection of the 5’-terminating DNA strand to generate 3’-ssDNA tracts of up to 3.5 kb in length (<xref ref-type="bibr" rid="B268">Zhou et al., 2014</xref>). Resection of the break is catalyzed by the Mre11-Rad50-Nbs1 (MRN), DNA2, and Exonuclease 1 (Exo1) nucleases, in concert with the BLM helicase (BLM). These tracts are then used to invade a sister chromatid, where they are extended past the break and then reanneal with the second end of the DSB (<xref ref-type="bibr" rid="B21">Brandsma and van Gent, 2012</xref>). While NHEJ may be used at any stage during the cell cycle, HR is only available during the S and G2 cell cycle phases, where a sister chromatid is available (<xref ref-type="bibr" rid="B108">Khanna and Jackson, 2001</xref>). HR is also the dominant pathway used in the repair of “single-ended DSBs” caused by the collapse of replication forks (<xref ref-type="bibr" rid="B249">Whelan et al., 2018</xref>).</p>
<p>The depletion of USP7 from cells has been found to greatly compromise the repair of DSBs by either NHEJ or HR (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B4">An et al., 2017</xref>). This is due to a key role of USP7 in the early recruitment of DNA repair proteins to sites of DSB lesions. One such protein is the histone demethyltransferase, PHF8. As discussed in our “<bold><italic>Cell Cycle Regulation</italic></bold>” section above, PHF8 is an interactor of USP7, which the latter stabilizes via deubiquitination. In addition to the transcriptional regulation of cyclin A2, PHF8 interacts with Ku70 and the BLM helicase to facilitate their localization to sites of DSBs. Indeed, the recruitment of either protein is impaired in cells following PHF8 or USP7 depletion (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>). As Ku70 and BLM are essential factors in NHEJ and HR, respectively, USP7 is thus able to influence both pathways.</p>
<p>USP7 also regulates the protein stability of mediator of DNA damage checkpoint 1 (MDC1) (<xref ref-type="bibr" rid="B224">Su et al., 2018</xref>). MDC1 is a binding partner of the MRN nuclease complex (<xref ref-type="bibr" rid="B70">Goldberg et al., 2003</xref>) and functions in the initial detection and signaling of DSBs (<xref ref-type="bibr" rid="B222">Stewart et al., 2003</xref>). This is demonstrated by the failed recruitment of the downstream DNA repair proteins 53BP1 and BRCA1 in MDC1-depleted cells following DNA damage; this defect is mimicked in cells depleted of USP7 (<xref ref-type="bibr" rid="B224">Su et al., 2018</xref>). MDC1 promotes DSB signaling by binding to histone H2AX following its phosphorylation by the repair kinase, ataxia-telangiectasia mutated (ATM) (<xref ref-type="bibr" rid="B222">Stewart et al., 2003</xref>). In addition, MDC1 is itself phosphorylated by ATM, which creates a binding site for the RNF8 E3 ubiquitin ligase (<xref ref-type="bibr" rid="B112">Kolas et al., 2007</xref>; <xref ref-type="bibr" rid="B139">Mailand et al., 2007</xref>). The accumulation of RNF8 subsequently triggers the recruitment of another E3 ubiquitin ligase, RNF168 (<xref ref-type="bibr" rid="B165">Nowsheen et al., 2018</xref>), which catalyzes the K63-linked polyubiquitination of histones H2A and H2AX (<xref ref-type="bibr" rid="B145">Mattiroli et al., 2012</xref>). These ubiquitin chains are in-turn bound by the ubiquitin-binding domains of 53BP1, and the BRCA1-interacting protein, Rap80 (<xref ref-type="bibr" rid="B215">Sobhian et al., 2007</xref>; <xref ref-type="bibr" rid="B60">Fradet-Turcotte et al., 2013</xref>).</p>
<p>In addition to stabilizing MDC1 – and thus promoting RNF168 accumulation – USP7 also directly deubiquitinates and stabilizes RNF168 (<xref ref-type="bibr" rid="B270">Zhu et al., 2015</xref>), as well as its paralog, RNF169 (<xref ref-type="bibr" rid="B4">An et al., 2017</xref>). While RNF168 promotes 53BP1 and BCRA1 localization to sites of DSBs, RNF169 is a direct inhibitor of this binding. This is because, once RNF168 synthesizes H2A/H2AX ubiquitin chains, RNF169 competes with 53BP1 and BRCA1 for ubiquitin binding (<xref ref-type="bibr" rid="B27">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="B174">Panier et al., 2012</xref>; <xref ref-type="bibr" rid="B182">Poulsen et al., 2012</xref>). Although it seems counterintuitive for USP7 to both promote and limit 53BP1 and BRCA1 accumulation at sites of DSBs, an explanation may come from the finding that while 53BP1 and BRCA1 promote DSB signaling, 53BP1 subsequently prevent DSB resection during HR (<xref ref-type="bibr" rid="B23">Bunting et al., 2010</xref>; <xref ref-type="bibr" rid="B35">Coleman and Greenberg, 2011</xref>). USP7 might therefore have an important role in balancing these activities, to allow for both HR activation as well as subsequent DSB resection.</p>
<p>USP7 also influences DSB repair by regulating checkpoint kinase 1 (Chk1) (<xref ref-type="bibr" rid="B56">Faustrup et al., 2009</xref>; <xref ref-type="bibr" rid="B3">Alonso-de Vega et al., 2014</xref>; <xref ref-type="bibr" rid="B263">Zhang P. et al., 2014</xref>). Chk1 is activated during HR following the resection of DSBs and the exposure of single-stranded DNA. This elicits activation of the ATR kinase, which stimulates Chk1 activity via phosphorylation (<xref ref-type="bibr" rid="B33">Choi et al., 2007</xref>). Chk1 then phosphorylates numerous downstream targets, including the Cdc25A phosphatase (<xref ref-type="bibr" rid="B236">Uto et al., 2004</xref>), which prompts Cdc25A proteasomal degradation (<xref ref-type="bibr" rid="B140">Mailand et al., 2000</xref>; <xref ref-type="bibr" rid="B251">Xiao et al., 2003</xref>). Cdc25A is a dual-specific phosphatase, which promotes cell cycle progression by removing inhibitory phosphate modifications from cyclin dependent kinases. The degradation of Cdc25A during HR thus prevents cell cycle progression, triggering S and G2 cell cycle arrest (<xref ref-type="bibr" rid="B43">Donzelli and Draetta, 2003</xref>).</p>
<p>USP7 controls Chk1 signaling by deubiquitinating and stabilizing both Chk1 and its activator protein, Claspin (<xref ref-type="bibr" rid="B56">Faustrup et al., 2009</xref>; <xref ref-type="bibr" rid="B3">Alonso-de Vega et al., 2014</xref>; <xref ref-type="bibr" rid="B263">Zhang P. et al., 2014</xref>). Here, the interaction between USP7 and Chk1 is enhanced by ZEB1, which is itself phosphorylated and stabilized by the ATM kinase, in response to DNA damage (<xref ref-type="bibr" rid="B263">Zhang P. et al., 2014</xref>). Interestingly, USP7 also negatively regulates Chk1-mediated cell cycle arrest, by deubiquitinating and stabilizing Cdc25A in response to DNA damage. Here, USP7 is recruited via an interaction with the Cdc25A-interactor, BRE (<xref ref-type="bibr" rid="B17">Biswas et al., 2018</xref>). Although the precise purpose of this opposing regulation is not fully understood, one explanation might be that by maintaining a small pool of Cdc25A, USP7 might play a role in cell cycle re-entry, following DSB repair. Such a model will, however, require further investigation.</p>
</sec>
<sec id="S4.SS8">
<title>DNA Damage Bypass</title>
<p>Another way USP7 regulates the cellular response to DNA damage is via the specialized replication pathways of DNA damage bypass (<xref ref-type="bibr" rid="B272">Zlatanou and Stewart, 2015</xref>; <xref ref-type="fig" rid="F3">Figure 3H</xref>). Unlike the NER and DSB repair pathways, DNA damage bypass does not mediate the repair of damaged DNA, but rather allows the cell to avoid DNA lesions encountered during replication, so they may be repaired at a later time (<xref ref-type="bibr" rid="B198">Sale, 2012</xref>). These lesions include bulky DNA adducts such as those repaired by NER.</p>
<p>The synthesis of DNA during normal replication is facilitated by the three “replicative” DNA polymerases: Pol α, Pol δ and Pol ε (<xref ref-type="bibr" rid="B98">Johansson and Dixon, 2013</xref>). In this process, high accuracy is essential to prevent the inadvertent accumulation of DNA mutations. A major contributor to this accuracy is the intrinsic high-fidelity of the replicative polymerases (<xref ref-type="bibr" rid="B9">Bębenek and Ziuzia-Graczyk, 2018</xref>). This is largely ensured by the tight active site of these polymerases, which geometrically accommodates the template DNA and only those dNTPs that can form a correct base pair (<xref ref-type="bibr" rid="B8">Beard and Wilson, 2003</xref>). However, while the active site of the replicative polymerase is suited to replicating undamaged DNA, it is unaccommodating if the polymerase encounters a DNA lesion on the template strand. In such cases, DNA damage becomes a replication barrier, which must be overcome to ensure the DNA is completely duplicated prior to cell division. Furthermore, in the absence of a timely restart of replication, stalled replication forks can collapse to generate toxic DSBs, which pose further risk to the cell (<xref ref-type="bibr" rid="B197">Saintigny et al., 2001</xref>).</p>
<p>To overcome replication lesions, the cell employs one of two pathways of DNA damage bypass: translesion synthesis (TLS) and template switching (<xref ref-type="bibr" rid="B198">Sale, 2012</xref>). In the former, replicative polymerases that have stalled due to a bulky DNA lesion are replaced by specialized TLS polymerases, which are able to bypass the damaged residues (<xref ref-type="bibr" rid="B199">Sale et al., 2012</xref>). Such bypass is facilitated by the comparatively more open active sites of TLS polymerases, which can accommodate alterations to the template strand (<xref ref-type="bibr" rid="B254">Yang, 2003</xref>). TLS, however, comes at the expense of potential misincorporation of incorrect dNTPs, due to the intrinsic lower fidelity of the translesion polymerase active sites (<xref ref-type="bibr" rid="B7">Beard et al., 2002</xref>). By contrast, template switching is considered a more accurate form of DNA damage tolerance. Here, the stalled replicative polymerase makes use of the undamaged, newly synthesized strand on the sister chromatid. This reaction occurs via a strand invasion mechanism, similar to that employed during HR (<xref ref-type="bibr" rid="B67">Giannattasio et al., 2014</xref>).</p>
<p>Recent reports have suggested that USP7 has a role in the initial stages of both translesion synthesis and template switching. Indeed, following UV exposure, cells depleted of USP7 are defective at elongating nascent DNA strands (<xref ref-type="bibr" rid="B271">Zlatanou et al., 2016</xref>). This defect seems due to a role of USP7 in regulating ubiquitination of the PCNA sliding clamp (<xref ref-type="bibr" rid="B104">Kashiwaba et al., 2015</xref>; <xref ref-type="bibr" rid="B184">Qian et al., 2015</xref>; <xref ref-type="bibr" rid="B143">Masuda et al., 2019</xref>). During translesion synthesis, the PCNA sliding clamp is monoubiquitinated at lysine residue 164 (K164) by the E3 ubiquitin ligase, Rad18 (<xref ref-type="bibr" rid="B245">Watanabe et al., 2004</xref>). This modification stimulates recruitment of translesion synthesis polymerases, which bind the PCNA ubiquitin group via their ubiquitin-binding domains (<xref ref-type="bibr" rid="B103">Kannouche et al., 2004</xref>; <xref ref-type="bibr" rid="B16">Bienko et al., 2005</xref>). In template switching, the monoubiquitin moiety added to K164 of PCNA is instead further ubiquitinated by the HLTF E3 ubiquitin ligase, to form a K63-linked ubiquitin chain (<xref ref-type="bibr" rid="B151">Motegi et al., 2008</xref>; <xref ref-type="bibr" rid="B235">Unk et al., 2008</xref>). Recently, K63-linked polyubiquitination of PCNA was found to stimulate template switching by creating a binding platform for the DNA translocase, ZRANB3 (<xref ref-type="bibr" rid="B240">Vujanovic et al., 2017</xref>).</p>
<p>Research over the past decade has suggested an intricate manner through which USP7 fine-tunes PCNA ubiquitination. Most directly, USP7 has been reported to deubiquitinate PCNA during interphase of the cell cycle, to suppress PCNA monoubiquitination in response to oxidative – and to a lesser extent, UV-induced – DNA damage (<xref ref-type="bibr" rid="B104">Kashiwaba et al., 2015</xref>). Although it is yet to be demonstrated in cells, biochemical assays have suggested USP7 might also be able to deubiquitinate PCNA modified by the addition of K63-linked ubiquitin chains (<xref ref-type="bibr" rid="B143">Masuda et al., 2019</xref>). These observations suggest that USP7 might deubiquitinate PCNA to negatively regulate both the translesion synthesis and template switching pathways.</p>
<p>In addition, USP7 has been suggested to indirectly influence PCNA mono-ubiqutination, by regulating the stability of the Rad18 and HLTF E3 ubiquitin ligases (<xref ref-type="bibr" rid="B186">Qing et al., 2011</xref>; <xref ref-type="bibr" rid="B271">Zlatanou et al., 2016</xref>). Indeed, depleting USP7 from cells was found to decrease the protein levels of Rad18 and HLTF, suppress PCNA mono and polyubiquitination, as well as reduce Pol η foci formation in UV irradiated cells. These findings are, however, complicated by the finding that, in addition to stabilizing HLTF, USP7 also deubiquitinates the HLTF E3 ubiquitin ligase, CHFR (<xref ref-type="bibr" rid="B168">Oh et al., 2007</xref>). USP7 may therefore act to balance the level of HLTF in the cell, by promoting both polyubiquitination (via CHFR) and deubiquitination of the protein. These reports further demonstrate the intricacies through which USP7 influences PCNA ubiquitination.</p>
<p>USP7 has also been proposed to regulate the stability of the TLS polymerase, DNA polymerase eta (Pol η) (<xref ref-type="bibr" rid="B184">Qian et al., 2015</xref>). Here, USP7 seems to regulate Pol η transcriptionally – via p53 (<xref ref-type="bibr" rid="B124">Lerner et al., 2017</xref>) – as well as through protein stabilization by directly removing K48-linked polyubiquitin chains. Furthermore, as Pol η is polyubiquitinated by Mdm2 (<xref ref-type="bibr" rid="B101">Jung et al., 2012</xref>), which is itself a substrate of USP7 (<xref ref-type="bibr" rid="B126">Li et al., 2004</xref>), these observations suggest that USP7 regulates Pol η protein levels both positively (by direct deubiquitination) and negatively (by stabilizing Mdm2). Indeed, as evidence of this complexity, both the depletion and over-expression of USP7 in cells were reported to enhance Pol η protein levels (<xref ref-type="bibr" rid="B184">Qian et al., 2015</xref>). It should be noted, however, that despite the attractive elegance of this proposed model, these claims have been contradicted by a subsequent publication, where Pol η protein levels appeared unchanged following siRNA-mediated depletion of USP7 (<xref ref-type="bibr" rid="B271">Zlatanou et al., 2016</xref>). Further work will, therefore, be required to unravel these apparent inconsistencies.</p>
</sec>
<sec id="S4.SS9">
<title>Apoptosis</title>
<p>The final genome stability pathway we will discuss is that of apoptosis (<xref ref-type="fig" rid="F3">Figure 3I</xref>). Unlike the pathways above, which are important for preventing cells from developing DNA mutations, apoptosis is essential for removing cells which have suffered irreparable genomic damage (<xref ref-type="bibr" rid="B267">Zhivotovsky and Kroemer, 2004</xref>; <xref ref-type="bibr" rid="B18">Borges et al., 2008</xref>). Apoptosis is thereby essential to prevent the propagation of cells whose genomic integrity has been compromised (<xref ref-type="bibr" rid="B267">Zhivotovsky and Kroemer, 2004</xref>).</p>
<p>As discussed in previous sections, USP7 has a central role in stabilizing p53 protein levels in response to genomic stress (<xref ref-type="bibr" rid="B212">Sheng et al., 2006</xref>). This allows p53 to participate in the DNA damage response, by transcriptionally activating genes involved in cell cycle arrest and DNA damage repair. Beyond a certain level of DNA damage, however, p53 switches to a pro-apoptotic function, where it transcriptionally activates a distinct set of gene targets (<xref ref-type="bibr" rid="B62">Fridman and Lowe, 2003</xref>). This includes pro-apoptotic members of the Bcl-2 family (e.g., PUMA, Bax), which mediate mitochondrial outer membrane permeabilization and subsequent caspase activation, to dismantle the cell (<xref ref-type="bibr" rid="B158">Nakano and Vousden, 2001</xref>; <xref ref-type="bibr" rid="B32">Chipuk et al., 2004</xref>; <xref ref-type="bibr" rid="B5">Aubrey et al., 2018</xref>).</p>
<p>The switch between cell cycle arrest and apoptosis in response to DNA damage, is largely dictated by the cell reaching threshold p53 protein levels (<xref ref-type="bibr" rid="B117">Kracikova et al., 2013</xref>; <xref ref-type="bibr" rid="B172">Paek et al., 2016</xref>). This is driven by aspects of USP7 function we have considered in previous sections. In addition, however, the apoptotic function of p53 is activated by a series of post-translational modifications. This includes acetylation of lysine residue 120 (K120) by the Kat5 histone acetyltransferase (also known as Tip60). K120 resides within the p53 DNA-binding domain and its acetylation increases its binding affinity for the <italic>Bax</italic> and <italic>PUMA</italic> gene promoters, while simultaneously preventing binding to the promoter of p21 (<xref ref-type="bibr" rid="B228">Sykes et al., 2006</xref>; <xref ref-type="bibr" rid="B231">Tang Y. et al., 2006</xref>; <xref ref-type="bibr" rid="B188">Reed and Quelle, 2014</xref>). In addition to stabilizing p53 protein levels, USP7 contributes to p53-dependent apoptosis through interacting with and de-ubiquitinating Kat5. Further, USP7 was found to promote p53 K120 acetylation, as well as <italic>PUMA</italic> expression and apoptosis following DNA damage (<xref ref-type="bibr" rid="B39">Dar et al., 2013</xref>).</p>
</sec>
</sec>
<sec id="S5">
<title>USP7: Links With Cancer</title>
<p>In the above sections we have discussed the numerous and intricate manners through which USP7 regulates genome stability. In the following section, we will now discuss links between USP7 deregulation and carcinogenesis, as well as strategies for targeting USP7 in anti-cancer therapy.</p>
<sec id="S5.SS1">
<title>USP7 Has Context-Dependent Tumor Suppressor and Oncogenic Roles in Cancer Progression</title>
<p>USP7 was initially described as a having a tumor suppressive role, following its identification as a p53 deubiquitinating enzyme (<xref ref-type="bibr" rid="B127">Li et al., 2002</xref>; <xref ref-type="bibr" rid="B13">Bhattacharya et al., 2018</xref>). Consistent with this assessment, USP7 gene expression has been found to be frequently downregulated in non-small cell lung adenocarcinomas, where low USP7 mRNA expression correlated with reduced p53 immunostaining (<xref ref-type="bibr" rid="B144">Masuya et al., 2006</xref>). These clinical findings reflect observations in cell lines, where partially – although not completely – depleting USP7 causes a reduction in p53 protein levels (<xref ref-type="bibr" rid="B126">Li et al., 2004</xref>). Furthermore, low USP7 expression levels were found to be an indicator of poor patient prognosis, supporting a role for USP7 in suppressing cancer progression by maintaining genome stability (<xref ref-type="bibr" rid="B144">Masuya et al., 2006</xref>).</p>
<p>While the tumor suppressive role of USP7 has been largely attributed to regulating p53, USP7 evidently also prevents genetic alterations through an assortment of p53-independent means, given its intricate roles in maintaining genomic stability. For instance, USP7 mRNA expression levels were found to correlate with genomic instability across the NCI-60 panel of cancer cell lines (<xref ref-type="bibr" rid="B69">Giovinazzi et al., 2014</xref>). Here, genomic instability was detected based on karyotypic complexity (<xref ref-type="bibr" rid="B193">Roschke et al., 2003</xref>). Although p53 status was not a reported parameter in these analyses, similar chromosomal abnormalities were detected in both p53 positive and null cell lines following USP7 depletion, suggesting this phenotype might be caused by means other than p53 deregulation (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>, <xref ref-type="bibr" rid="B69">2014</xref>). A complete understanding of how each individual USP7 function contributes to tumor suppression, however, remains unclear and will require further investigation.</p>
<p>In addition to tumor suppressive roles, USP7 also seems to have context-dependent oncogenic functions (<xref ref-type="bibr" rid="B13">Bhattacharya et al., 2018</xref>). Indeed, in one study, a non-monotonic relationship was observed between USP7 expression and breast cancer survival, where both low and high levels of USP7 were associated with poor outcome (<xref ref-type="bibr" rid="B83">Hernández-Pérez et al., 2017</xref>). In this study, USP7 and Geminin protein levels were strongly correlated in a cohort of invasive breast cancers. High Geminin protein levels are prognostic of poor clinical outcome and are associated with genome instability, DNA replication errors and aneuploidy (<xref ref-type="bibr" rid="B227">Sundara Rajan et al., 2014</xref>). As Geminin is a substrate of USP7, these findings suggest USP7 over-expression contributes to breast cancer progression by stabilizing Geminin (<xref ref-type="bibr" rid="B83">Hernández-Pérez et al., 2017</xref>).</p>
<p>A strong correlation has also been observed between USP7 and the cell cycle regulatory protein PHF8 (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>). This correlation was observed in clinical breast cancer samples and increased with histological grade. As we discussed in the <bold><italic>Cell Cycle Regulation</italic></bold> section, USP7 deubiquitinates and stabilizes PHF8, allowing the latter to upregulate gene targets involved in cell cycle progression, including cyclin A2 (<xref ref-type="bibr" rid="B134">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>). Indeed, USP7, PHF8 and cyclin A2 were all found to be upregulated in several breast cancers, as well as in colon and rectum cancers, compared to adjacent tissues (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>). As cyclin A2 deregulation is associated with aberrant cell proliferation (<xref ref-type="bibr" rid="B71">Gopinathan et al., 2014</xref>), these findings suggest another way in which USP7 upregulation may promote oncogenesis.</p>
<p>USP7 might also contribute to oncogenesis by deubiquitinating and stabilizing Ki-67 (<xref ref-type="bibr" rid="B261">Zhang et al., 2016</xref>). As with Cyclin A2, Ki-67 is highly expressed in malignant tissues and promotes cell division (<xref ref-type="bibr" rid="B200">Sales Gil and Vagnarelli, 2018</xref>; <xref ref-type="bibr" rid="B87">Horie et al., 2019</xref>). This interaction may be particular disease-relevant in non-small cell lung cancer cells, where a strong positive correlation between the two proteins has been observed (<xref ref-type="bibr" rid="B261">Zhang et al., 2016</xref>).</p>
<p>Although outside the scope of this review, USP7 likely also contributes to carcinogenesis by regulating a number of tumor suppressors and oncogenes with roles outside of direct genome stability maintenance (<xref ref-type="bibr" rid="B13">Bhattacharya et al., 2018</xref>). These include the tumor suppressors PTEN (<xref ref-type="bibr" rid="B216">Song et al., 2008a</xref>), NOTCH1 (<xref ref-type="bibr" rid="B211">Shan et al., 2018</xref>), the Foxo proteins (<xref ref-type="bibr" rid="B237">van der Horst et al., 2006</xref>) and the retinoblastoma protein (<xref ref-type="bibr" rid="B14">Bhattacharya and Ghosh, 2014</xref>), as well the oncoproteins c-Myc (<xref ref-type="bibr" rid="B15">Bhattacharya and Ghosh, 2015</xref>), the REST transcription factor (<xref ref-type="bibr" rid="B91">Huang et al., 2011</xref>) and β-catenin (<xref ref-type="bibr" rid="B164">Novellasdemunt et al., 2017</xref>). Together, these data demonstrate that USP7 has context-dependent tumor suppressor and oncogenic roles and that up- or down-regulation can contribute to carcinogenesis.</p>
</sec>
<sec id="S5.SS2">
<title>Targeting USP7 in Cancer Therapy</title>
<p>The frequent up-regulation of USP7 in many cancer types and the apparent contributions of this upregulation to carcinogenesis, has led to speculation that USP7 could be an effective target in anti-cancer therapies. Enthusiasm for this approach is demonstrated by the dozens of small molecule USP7 inhibitors developed in the past few years. While human trials of USP7 inhibitors have yet to be conducted, many of these compounds have been found to inhibit cancer cell growth <italic>in vitro</italic>, as well as in animal xenograft models (<xref ref-type="bibr" rid="B54">Fan et al., 2013</xref>; <xref ref-type="bibr" rid="B2">Agathanggelou et al., 2017</xref>; <xref ref-type="bibr" rid="B234">Turnbull et al., 2017</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>; <xref ref-type="bibr" rid="B264">Zhang et al., 2020</xref>). The molecular basis of the interaction between several inhibitors and USP7 has been determined, revealing that these small molecules largely target the USP7 catalytic domain [<xref ref-type="fig" rid="F4">Figure 4</xref> and <xref ref-type="table" rid="T2">Table 2</xref>; for a recent and extensive review, see <xref ref-type="bibr" rid="B128">Li and Liu (2020)</xref>].</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Numerous inhibitors of USP7 have been developed. The structure represents the USP7 catalytic domain. Green spheres on the USP7 catalytic domain represent catalytic triad active site residues C223, H464, and D481. USP7 inhibitors indicated with a purple background target the catalytic cleft, those with an orange background bind near the catalytic cleft and those with a blue background bind outside the catalytic cleft. The binding region for each group of inhibitors is demonstrated by the correspondingly colored surfaces of the USP7 catalytic domain.</p>
</caption>
<graphic xlink:href="fcell-08-00717-g004"></graphic>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Available structures and strength of interactions of select USP7 inhibitors.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>USP7 inhibitor</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Strength of interaction with USP7 catalytic domain</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>PDB ID</bold>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">XL188</td>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>d</sub> = 90 nM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5vs6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Compound 46</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 0.09 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">6f5h</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Compound 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 0.3 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5n9r</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Compound 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 22.0 nM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5n9t</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FT671</td>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>d</sub> = 65 nM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5nge</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FT827</td>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>d</sub> = 7.8 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5ngf</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">5091</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> 4.2 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">217564</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 3 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GNE-6776</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 0.61 ± 0.15 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5uqx</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GNE-6640</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 0.43 ± 0.07 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5uqv</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inhibitor 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50</sub> = 79 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">5whc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GNE Compound 11</td>
<td align="left" colspan="1" rowspan="1" valign="top">IC<sub>50 =</sub> 4.2 μM</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The quinazolin-based compound XL188 is one such inhibitor that was developed by a structure-guided approach. XL188 non-covalently binds the USP7 catalytic domain near the active site cleft. The inhibitor in complex with the USP7 catalytic domain reveals that binding occurs about 5 Å from the catalytic triad (<xref ref-type="bibr" rid="B120">Lamberto et al., 2017</xref>). Similarly, the non-covalent pyrimidine-based USP7 inhibitor Compound 46 binds a few angstroms from the active site residues (<xref ref-type="bibr" rid="B166">O’Dowd et al., 2018</xref>).</p>
<p>High-throughput screening led to the development of non-covalent pyrimidone-based inhibitors, including Compounds 2 and 5. These compounds both bind over 5 Å away from C223 (<xref ref-type="bibr" rid="B66">Gavory et al., 2018</xref>).</p>
<p>Interestingly, USP7 pyrimidine-based FT class inhibitors target different sites of the USP7 catalytic domain. The non-covalent inhibitor FT671 in complex with the catalytic domain reveals this inhibitor is several angstroms from C223, similar to XL188. Inhibitor FT827 in complex with the catalytic domain reveals that this inhibitor enters the active site cleft and covalently modifies C223. This covalent modification of C223 prevents it from acting as a nucleophile and hydrolyzing isopeptide bonds (<xref ref-type="bibr" rid="B234">Turnbull et al., 2017</xref>). Despite differences in binding, both USP7-FT inhibitor complexes reveal a misaligned catalytic triad and the switching loop being in an unproductive conformation.</p>
<p>Like the covalent FT827 inhibitor, several other USP7 inhibitors also covalently modify the catalytic cysteine to inactivate USP7. USP7 nitrothiophene-based inhibitor 5091 proved to be a promising therapeutic for treatment of multiple myeloma (<xref ref-type="bibr" rid="B25">Chauhan et al., 2012</xref>), and its second generation inhibitor, 217564, was determined to covalently modify C223 to inhibit USP7 activity (<xref ref-type="bibr" rid="B242">Wang et al., 2017</xref>). P22077 and P50429, also derivatives of 5091, both irreversibly modify C223. Here, mutation of C223 to an alanine prevents inhibitor binding to USP7, revealing specificity for the catalytic cysteine (<xref ref-type="bibr" rid="B183">Pozhidaeva et al., 2017</xref>). While the USP7 IC<sub>50</sub> for P50429 and P22077 are in the low micromolar range, these inhibitors are not specific to USP7 as they also target the USP7 homolog USP47 (<xref ref-type="bibr" rid="B232">Tian et al., 2011</xref>; <xref ref-type="bibr" rid="B248">Weinstock et al., 2012</xref>). USP7 inhibitor HBX 19,818 also specifically and covalently targets C223 with low micromolar affinity (<xref ref-type="bibr" rid="B190">Reverdy et al., 2012</xref>).</p>
<p>Interestingly, some USP7 inhibitors work in an allosteric manner, by binding distally to the active site to inhibit USP7 activity. USP7 catalytic domain in complex with aminopyridine-based inhibitors GNE-6776 and GNE-6640 reveals these interactions occur 12 Å from the active site cleft. Rather than interfering with the active site residues, this class of inhibitors disrupts USP7-ubiquitin binding. With IC<sub>50</sub> values for the catalytic domain in the low micromolar range, these GNE class inhibitors are unfortunately not specific to USP7, as other USPs are inhibited by these small molecules (<xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>). USP7 Inhibitor 2, which was part of the GNE-inhibitor screen, also binds distal to the catalytic site (<xref ref-type="bibr" rid="B42">Di Lello et al., 2017</xref>).</p>
<p>Recently, a new class of GNE cyanopyrrolidine-based inhibitors has been described. These inhibitors, including GNE Compound 11, specifically target C223. Interestingly, these novel inhibitors cause desulfhydration of the active-site cysteine of USP7, converting it to dehydroalanine (DHA). Therefore, the ability of C223 to act as a nucleophile for bond hydrolysis is eliminated (<xref ref-type="bibr" rid="B6">Bashore et al., 2020</xref>).</p>
<p>USP7 inhibitors predominantly kill cancer cells by inducing p53-dependent apoptosis (<xref ref-type="bibr" rid="B208">Schauer et al., 2020</xref>). One way through which this occurs is via the stabilization of p53, resulting from the degradation of Mdm2 in the absence of its USP7-mediated deubiquitination (<xref ref-type="bibr" rid="B127">Li et al., 2002</xref>, <xref ref-type="bibr" rid="B126">2004</xref>; <xref ref-type="bibr" rid="B37">Cummins et al., 2004</xref>; <xref ref-type="bibr" rid="B10">Becker et al., 2008</xref>; <xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>). In addition, USP7 inhibitors simultaneously promote p53 activation via the induction of genomic instability (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>, <xref ref-type="bibr" rid="B69">2014</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). For instance, as we discussed in the <bold><italic>Mitosis</italic></bold> section above, USP7 inhibition causes mitotic stress as a result of Plk1 depletion, driving cells towards apoptotic cell-death (<xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). Interestingly, while some studies have reported a strict dependency on p53 for USP7 inhibitor-induced cell death (<xref ref-type="bibr" rid="B54">Fan et al., 2013</xref>; <xref ref-type="bibr" rid="B208">Schauer et al., 2020</xref>), others have suggested the inhibition of USP7 may cause cell death even in the absence of functional p53, possibly due to deregulation of other essential cellular pathways (<xref ref-type="bibr" rid="B25">Chauhan et al., 2012</xref>; <xref ref-type="bibr" rid="B39">Dar et al., 2013</xref>; <xref ref-type="bibr" rid="B105">Kategaya et al., 2017</xref>).</p>
<p>Aside from monotherapy-type approaches, several publications in the past decade have indicated USP7 inhibitors might also be effective in cancer treatment, in combination with other chemotherapeutic agents. For instance, P22077 has been found to significantly enhance the efficacy of the DNA damaging compounds doxorubicin and etoposide to kill cultured neuroblastoma cells (<xref ref-type="bibr" rid="B54">Fan et al., 2013</xref>). While sensitization by P22077 was, in this study, found to be dependent on a functional USP7-HDM2-p53 axis, others have found USP7 inhibition may sensitize cancer cells to DNA damaging agents, even in p53 defective tumors. USP7 inhibition with the compound HBX19, 818, for example, was shown to sensitize chronic lymphoblastic leukemia cells to the chemotherapeutic agents cyclophosphamide and mitomycin C in cells with defects in p53 or the ATM kinase (<xref ref-type="bibr" rid="B2">Agathanggelou et al., 2017</xref>; <xref ref-type="bibr" rid="B201">Sampath, 2017</xref>). Such co-treatment may be particularly effective in cancers that overexpress USP7. For instance, USP7 has been found to be upregulated in many cervical carcinomas, where its expression positively correlates with that of MDC1, as well as with histological tumor grade. Inhibition of USP7 with the compounds GNE-6640 or GNE-6776, however, destabilizes MDC1, as well as sensitizes cervical cancer cells to ionizing radiation-induced genotoxic insult (<xref ref-type="bibr" rid="B224">Su et al., 2018</xref>). USP7 has also been suggested as a potential target for sensitization in breast cancer treatment, where USP7 is frequently upregulated and confers resistance to genotoxic insult, by stabilizing PHF8 (<xref ref-type="bibr" rid="B243">Wang et al., 2016</xref>).</p>
<p>Another proposed use for USP7 inhibitors is in sensitizing taxane-resistant tumors to taxane therapies (<xref ref-type="bibr" rid="B68">Giovinazzi et al., 2013</xref>; <xref ref-type="bibr" rid="B261">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). Taxanes, such as paclitaxel and docetaxel, kill cancer cells by binding to and stabilizing β-tubulin on the inner surface of microtubules, increasing their polymerization (<xref ref-type="bibr" rid="B100">Jordan et al., 1993</xref>). This binding prevents proper mitotic cell division, as although chromosomes can be attached to taxane-stabilized microtubules, the disruption to microtubule dynamics precludes proper tension being established across sister chromatids (<xref ref-type="bibr" rid="B107">Kelling et al., 2003</xref>). Taxanes, in this way, prevent proper chromosome orientation on the metaphase plate, leading to activation of the spindle-assembly checkpoint and stalling cells at the metaphase to anaphase transition (<xref ref-type="bibr" rid="B157">Musacchio and Salmon, 2007</xref>; <xref ref-type="bibr" rid="B65">Gascoigne and Taylor, 2009</xref>). Prolonged stalling at this boundary leads to eventual cell death (<xref ref-type="bibr" rid="B192">Rieder and Maiato, 2004</xref>). While paclitaxel and docetaxel are front-line chemotherapeutics for treating breast, prostate and nasopharyngeal carcinomas, resistance to these compounds often develops (<xref ref-type="bibr" rid="B155">Murray et al., 2012</xref>). USP7 may contribute to such resistance via its roles in stabilizing PLK1. Indeed, USP7 and PLK1 were found to correlate in tissue sections of primary breast cancer and to be highly expressed in taxane-resistant tumors (<xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). Here, PLK1 over-expression likely contributes to taxane resistance by regulating microtuble dynamics and microtubule-kinetochore attachment (<xref ref-type="bibr" rid="B74">Gutteridge et al., 2016</xref>). By inducing PLK1 degradation, USP7 inhibition with P5091 was, however, found to sensitize taxane-resistant cancer cells to paclitaxel and docetaxel and to trigger apoptotic cell death (<xref ref-type="bibr" rid="B176">Peng et al., 2019</xref>). These findings suggest another prospective use for USP7 inhibitors in cancer treatment.</p>
</sec>
</sec>
<sec id="S6">
<title>Conclusion</title>
<p>In this review article, we have discussed the extensive roles of USP7 in maintaining the integrity of the genome. Improper activity of USP7 leads to destabilization of its many substrates, resulting in genetic alterations that may drive tumorigenesis. Recently, USP7 has become an attractive pharmacological target for inducing apoptotic cell death in cancer cells. This appreciation has skyrocketed the development of small-molecule compounds targeting USP7. With relentless high-throughput screens and optimizations being pursued, human trials of USP7 inhibitors may be on the horizon.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>GV and NA wrote the first draft of the manuscript, prepared the figures, and established the scope of the review. IB and RW assisted with structuring the manuscript and editing the final text. All authors read and approved the final version prior to submission.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by funds from the National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) Intramural Research Program (to RW), as well by NIH grants (R35 GM128864, P41 GM111135, and R01 GM123249 to IB), and funding from the National Science Foundation (NSF 1616184 to IB). Funding for open access charge: NICHD/NIH Intramural Research Program.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achour</surname><given-names>M.</given-names></name><name><surname>Jacq</surname><given-names>X.</given-names></name><name><surname>Rondé</surname><given-names>P.</given-names></name><name><surname>Alhosin</surname><given-names>M.</given-names></name><name><surname>Charlot</surname><given-names>C.</given-names></name><name><surname>Chataigneau</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.</article-title>
<source/><italic>Oncogene</italic>
<volume>27</volume>
<fpage>2187</fpage>–<lpage>2197</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1210855</pub-id>
<pub-id pub-id-type="pmid">17934516</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agathanggelou</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>E.</given-names></name><name><surname>Davies</surname><given-names>N. J.</given-names></name><name><surname>Kwok</surname><given-names>M.</given-names></name><name><surname>Zlatanou</surname><given-names>A.</given-names></name><name><surname>Oldreive</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.</article-title>
<source/><italic>Blood</italic>
<volume>130</volume>
<fpage>156</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2016-12-758219</pub-id>
<pub-id pub-id-type="pmid">28495793</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso-de Vega</surname><given-names>I.</given-names></name><name><surname>Martín</surname><given-names>Y.</given-names></name><name><surname>Smits</surname><given-names>V. A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>USP7 controls Chk1 protein stability by direct deubiquitination.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>13</volume>
<fpage>3921</fpage>–<lpage>3926</lpage>. <pub-id pub-id-type="doi">10.4161/15384101.2014.973324</pub-id>
<pub-id pub-id-type="pmid">25483066</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Ng</surname><given-names>H. H. W.</given-names></name><name><surname>Man</surname><given-names>E. P. S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Khoo</surname><given-names>U.-S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Dual-utility NLS drives RNF169-dependent DNA damage responses.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>114</volume>
<fpage>E2872</fpage>–<lpage>E2881</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1616602114</pub-id>
<pub-id pub-id-type="pmid">28325877</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aubrey</surname><given-names>B. J.</given-names></name><name><surname>Kelly</surname><given-names>G. L.</given-names></name><name><surname>Janic</surname><given-names>A.</given-names></name><name><surname>Herold</surname><given-names>M. J.</given-names></name><name><surname>Strasser</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>25</volume>
<fpage>104</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2017.169</pub-id>
<pub-id pub-id-type="pmid">29149101</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashore</surname><given-names>C.</given-names></name><name><surname>Jaishankar</surname><given-names>P.</given-names></name><name><surname>Skelton</surname><given-names>N. J.</given-names></name><name><surname>Fuhrmann</surname><given-names>J.</given-names></name><name><surname>Hearn</surname><given-names>B. R.</given-names></name><name><surname>Liu</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Cyanopyrrolidine inhibitors of ubiquitin specific protease 7 mediate desulfhydration of the active-site cysteine.</article-title>
<source/><italic>ACS Chem. Biol.</italic>
<volume>15</volume>
<fpage>1392</fpage>–<lpage>1400</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.0c00031</pub-id>
<pub-id pub-id-type="pmid">32302100</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>W. A.</given-names></name><name><surname>Shock</surname><given-names>D. D.</given-names></name><name><surname>Vande Berg</surname><given-names>B. J.</given-names></name><name><surname>Wilson</surname><given-names>S. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Efficiency of correct nucleotide insertion governs DNA polymerase fidelity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>277</volume>
<fpage>47393</fpage>–<lpage>47398</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M210036200</pub-id>
<pub-id pub-id-type="pmid">12370169</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>W. A.</given-names></name><name><surname>Wilson</surname><given-names>S. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Structural insights into the origins of DNA polymerase fidelity.</article-title>
<source/><italic>Structure</italic>
<volume>11</volume>
<fpage>489</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-2126(03)00051-0</pub-id><pub-id pub-id-type="pmid">12737815</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bębenek</surname><given-names>A.</given-names></name><name><surname>Ziuzia-Graczyk</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Fidelity of DNA replication—a matter of proofreading.</article-title>
<source/><italic>Curr. Genet.</italic>
<volume>64</volume>
<fpage>985</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1007/s00294-018-0820-1</pub-id>
<pub-id pub-id-type="pmid">29500597</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>Marchenko</surname><given-names>N. D.</given-names></name><name><surname>Palacios</surname><given-names>G.</given-names></name><name><surname>Moll</surname><given-names>U. M.</given-names></name></person-group> (<year>2008</year>). <article-title>A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>7</volume>
<fpage>1205</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.4161/cc.7.9.5756</pub-id>
<pub-id pub-id-type="pmid">18418047</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>S. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Rethinking origin licensing.</article-title>
<source/><italic>eLife</italic>
<volume>6</volume>:<issue>e24052</issue>. <pub-id pub-id-type="doi">10.7554/eLife.24052</pub-id>
<pub-id pub-id-type="pmid">28102819</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmont</surname><given-names>A. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitotic chromosome structure and condensation.</article-title>
<source/><italic>Curr. Opin. Cell Biol</italic>
<volume>18</volume>
<fpage>632</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2006.09.007</pub-id>
<pub-id pub-id-type="pmid">17046228</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Chakraborty</surname><given-names>D.</given-names></name><name><surname>Basu</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>M. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.</article-title>
<source/><italic>Signal Transduct. Target. Ther.</italic>
<volume>3</volume>:<issue>17</issue>. <pub-id pub-id-type="doi">10.1038/s41392-018-0012-y</pub-id>
<pub-id pub-id-type="pmid">29967688</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>M. K.</given-names></name></person-group> (<year>2014</year>). <article-title>HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.</article-title>
<source/><italic>FEBS J.</italic>
<volume>281</volume>
<fpage>3061</fpage>–<lpage>3078</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12843</pub-id>
<pub-id pub-id-type="pmid">24823443</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>M. K.</given-names></name></person-group> (<year>2015</year>). <article-title>HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.</article-title>
<source/><italic>Cell. Oncol.</italic>
<volume>38</volume>
<fpage>265</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1007/s13402-015-0228-6</pub-id>
<pub-id pub-id-type="pmid">25925205</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bienko</surname><given-names>M.</given-names></name><name><surname>Green</surname><given-names>C. M.</given-names></name><name><surname>Crosetto</surname><given-names>N.</given-names></name><name><surname>Rudolf</surname><given-names>F.</given-names></name><name><surname>Zapart</surname><given-names>G.</given-names></name><name><surname>Coull</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis.</article-title>
<source/><italic>Science</italic>
<volume>310</volume>
<fpage>1821</fpage>–<lpage>1824</lpage>. <pub-id pub-id-type="doi">10.1126/science.1120615</pub-id>
<pub-id pub-id-type="pmid">16357261</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>K.</given-names></name><name><surname>Philip</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>B. K.</given-names></name><name><surname>Burkett</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>537</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-03020-6</pub-id>
<pub-id pub-id-type="pmid">29416040</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>H. L.</given-names></name><name><surname>Linden</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J. Y. J.</given-names></name></person-group> (<year>2008</year>). <article-title>DNA damage-induced cell death: lessons from the central nervous system.</article-title>
<source/><italic>Cell Res.</italic>
<volume>18</volume>
<fpage>17</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2007.110</pub-id>
<pub-id pub-id-type="pmid">18087290</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch-Presegué</surname><given-names>L.</given-names></name><name><surname>Raurell-Vila</surname><given-names>H.</given-names></name><name><surname>Marazuela-Duque</surname><given-names>A.</given-names></name><name><surname>Kane-Goldsmith</surname><given-names>N.</given-names></name><name><surname>Valle</surname><given-names>A.</given-names></name><name><surname>Oliver</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>42</volume>
<fpage>210</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.02.034</pub-id>
<pub-id pub-id-type="pmid">21504832</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostick</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Estève</surname><given-names>P. O.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name><name><surname>Pradhan</surname><given-names>S.</given-names></name><name><surname>Jacobsen</surname><given-names>S. E.</given-names></name></person-group> (<year>2007</year>). <article-title>UHRF1 plays a role in maintaining DNA methylation in mammalian cells.</article-title>
<source/><italic>Science</italic>
<volume>317</volume>
<fpage>1760</fpage>–<lpage>1764</lpage>. <pub-id pub-id-type="doi">10.1126/science.1147939</pub-id>
<pub-id pub-id-type="pmid">17673620</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandsma</surname><given-names>I.</given-names></name><name><surname>van Gent</surname><given-names>D. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Pathway choice in DNA double strand break repair: observations of a balancing act.</article-title>
<source/><italic>Genome Integr.</italic>
<volume>3</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1186/2041-9414-3-9</pub-id>
<pub-id pub-id-type="pmid">23181949</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronner</surname><given-names>C.</given-names></name><name><surname>Alhosin</surname><given-names>M.</given-names></name><name><surname>Hamiche</surname><given-names>A.</given-names></name><name><surname>Mousli</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Coordinated dialogue between UHRF1 and DNMT1 to ensure faithful inheritance of methylated DNA patterns.</article-title>
<source/><italic>Genes</italic>
<volume>10</volume>:<issue>65</issue>. <pub-id pub-id-type="doi">10.3390/genes10010065</pub-id>
<pub-id pub-id-type="pmid">30669400</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunting</surname><given-names>S. F.</given-names></name><name><surname>Callén</surname><given-names>E.</given-names></name><name><surname>Wong</surname><given-names>N.</given-names></name><name><surname>Chen</surname><given-names>H. T.</given-names></name><name><surname>Polato</surname><given-names>F.</given-names></name><name><surname>Gunn</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.</article-title>
<source/><italic>Cell</italic>
<volume>141</volume>
<fpage>243</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.012</pub-id>
<pub-id pub-id-type="pmid">20362325</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesare</surname><given-names>A. J.</given-names></name><name><surname>Reddel</surname><given-names>R. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Alternative lengthening of telomeres: models, mechanisms and implications.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>11</volume>
<fpage>319</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2763</pub-id>
<pub-id pub-id-type="pmid">20351727</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>D.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Nicholson</surname><given-names>B.</given-names></name><name><surname>Kumar</surname><given-names>K. G.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Carrasco</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.</article-title>
<source/><italic>Cancer Cell</italic>
<volume>22</volume>
<fpage>345</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2012.08.007</pub-id>
<pub-id pub-id-type="pmid">22975377</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chehab</surname><given-names>N. H.</given-names></name><name><surname>Malikzay</surname><given-names>A.</given-names></name><name><surname>Appel</surname><given-names>M.</given-names></name><name><surname>Halazonetis</surname><given-names>T. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>14</volume>
<fpage>278</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1101/gad.14.3.278</pub-id><pub-id pub-id-type="pmid">10673500</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Huen</surname><given-names>M. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Ring finger protein RNF169 antagonizes the ubiquitin-dependent signaling cascade at sites of DNA damage.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>27715</fpage>–<lpage>27722</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.373530</pub-id>
<pub-id pub-id-type="pmid">22733822</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Gilkes</surname><given-names>D. M.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Lane</surname><given-names>W. S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.</article-title>
<source/><italic>EMBO J.</italic>
<volume>24</volume>
<fpage>3411</fpage>–<lpage>3422</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600812</pub-id>
<pub-id pub-id-type="pmid">16163388</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Gong</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>6</volume>:<issue>7023</issue>. <pub-id pub-id-type="doi">10.1038/ncomms8023</pub-id>
<pub-id pub-id-type="pmid">25960197</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Mechanism of p53 stabilization by ATM after DNA damage.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>9</volume>
<fpage>472</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.4161/cc.9.3.10556</pub-id>
<pub-id pub-id-type="pmid">20081365</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Kao</surname><given-names>H.-Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Post-translational modifications of PML: consequences and implications.</article-title>
<source/><italic>Front. Oncol.</italic>
<volume>2</volume>:<issue>210</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2012.00210</pub-id>
<pub-id pub-id-type="pmid">23316480</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chipuk</surname><given-names>J. E.</given-names></name><name><surname>Kuwana</surname><given-names>T.</given-names></name><name><surname>Bouchier-Hayes</surname><given-names>L.</given-names></name><name><surname>Droin</surname><given-names>N. M.</given-names></name><name><surname>Newmeyer</surname><given-names>D. D.</given-names></name><name><surname>Schuler</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.</article-title>
<source/><italic>Science</italic>
<volume>303</volume>
<fpage>1010</fpage>–<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1126/science.1092734</pub-id>
<pub-id pub-id-type="pmid">14963330</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.-H.</given-names></name><name><surname>Lindsey-Boltz</surname><given-names>L. A.</given-names></name><name><surname>Sancar</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Reconstitution of a human ATR-mediated checkpoint response to damaged DNA.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>13301</fpage>–<lpage>13306</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706013104</pub-id>
<pub-id pub-id-type="pmid">17686975</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>L. S.</given-names></name><name><surname>Ian</surname><given-names>H. I.</given-names></name><name><surname>Koh</surname><given-names>T. W.</given-names></name><name><surname>Ng</surname><given-names>H. H.</given-names></name><name><surname>Xu</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>B. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.</article-title>
<source/><italic>Science</italic>
<volume>277</volume>
<fpage>1996</fpage>–<lpage>2000</lpage>. <pub-id pub-id-type="doi">10.1126/science.277.5334.1996</pub-id>
<pub-id pub-id-type="pmid">9302295</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>K. A.</given-names></name><name><surname>Greenberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>13669</fpage>–<lpage>13680</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.213728</pub-id>
<pub-id pub-id-type="pmid">21335604</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname><given-names>G.</given-names></name><name><surname>Alharbi</surname><given-names>I.</given-names></name><name><surname>Braga</surname><given-names>L. G.</given-names></name><name><surname>Elowe</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Playing polo during mitosis: PLK1 takes the lead.</article-title>
<source/><italic>Oncogene</italic>
<volume>36</volume>
<fpage>4819</fpage>–<lpage>4827</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.113</pub-id>
<pub-id pub-id-type="pmid">28436952</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummins</surname><given-names>J. M.</given-names></name><name><surname>Rago</surname><given-names>C.</given-names></name><name><surname>Kohli</surname><given-names>M.</given-names></name><name><surname>Kinzler</surname><given-names>K. W.</given-names></name><name><surname>Lengauer</surname><given-names>C.</given-names></name><name><surname>Vogelstein</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Disruption of HAUSP gene stabilizes p53.</article-title>
<source/><italic>Nature</italic>
<volume>428</volume>
<fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1038/nature02501</pub-id>
<pub-id pub-id-type="pmid">15058298</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantuma</surname><given-names>N. P.</given-names></name><name><surname>Hoppe</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>22</volume>
<fpage>483</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2012.06.003</pub-id>
<pub-id pub-id-type="pmid">22818974</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname><given-names>A.</given-names></name><name><surname>Shibata</surname><given-names>E.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>33</volume>
<fpage>3309</fpage>–<lpage>3320</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00358-13</pub-id>
<pub-id pub-id-type="pmid">23775119</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lange</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Shelterin: the protein complex that shapes and safeguards human telomeres.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>19</volume>
<fpage>2100</fpage>–<lpage>2110</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1346005</pub-id>
<pub-id pub-id-type="pmid">16166375</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhe-Paganon</surname><given-names>S.</given-names></name><name><surname>Syeda</surname><given-names>F.</given-names></name><name><surname>Park</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.</article-title>
<source/><italic>Int. J. Biochem. Mol. Biol.</italic>
<volume>2</volume>
<fpage>58</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">21969122</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Lello</surname><given-names>P.</given-names></name><name><surname>Pastor</surname><given-names>R.</given-names></name><name><surname>Murray</surname><given-names>J. M.</given-names></name><name><surname>Blake</surname><given-names>R. A.</given-names></name><name><surname>Cohen</surname><given-names>F.</given-names></name><name><surname>Crawford</surname><given-names>T. D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Discovery of small-molecule inhibitors of ubiquitin specific protease 7 (USP7) using integrated NMR and in silico techniques</article-title>. <source/><italic>J. Med. Chem.</italic>
<volume>60</volume>, <fpage>10056</fpage>–<lpage>10070</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b01293</pub-id>
<pub-id pub-id-type="pmid">29166018</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donzelli</surname><given-names>M.</given-names></name><name><surname>Draetta</surname><given-names>G. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Regulating mammalian checkpoints through Cdc25 inactivation.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>4</volume>
<fpage>671</fpage>–<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.embor887</pub-id>
<pub-id pub-id-type="pmid">12835754</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draskovic</surname><given-names>I.</given-names></name><name><surname>Arnoult</surname><given-names>N.</given-names></name><name><surname>Steiner</surname><given-names>V.</given-names></name><name><surname>Bacchetti</surname><given-names>S.</given-names></name><name><surname>Lomonte</surname><given-names>P.</given-names></name><name><surname>Londoño-Vallejo</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>15726</fpage>–<lpage>15731</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0907689106</pub-id>
<pub-id pub-id-type="pmid">19717459</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Guda</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination.</article-title>
<source/><italic>Sci. Signal.</italic>
<volume>3</volume>:<issue>ra80</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.2001462</pub-id>
<pub-id pub-id-type="pmid">21045206</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duijf</surname><given-names>P. H. G.</given-names></name><name><surname>Schultz</surname><given-names>N.</given-names></name><name><surname>Benezra</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Cancer cells preferentially lose small chromosomes.</article-title>
<source/><italic>Int. J. Cancer</italic>
<volume>132</volume>
<fpage>2316</fpage>–<lpage>2326</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.27924</pub-id>
<pub-id pub-id-type="pmid">23124507</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Episkopou</surname><given-names>H.</given-names></name><name><surname>Diman</surname><given-names>A.</given-names></name><name><surname>Claude</surname><given-names>E.</given-names></name><name><surname>Viceconte</surname><given-names>N.</given-names></name><name><surname>Decottignies</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>TSPYL5 depletion induces specific death of ALT cells through USP7-dependent proteasomal degradation of POT1.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>75</volume>
<fpage>469</fpage>–<lpage>482.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2019.05.027</pub-id>
<pub-id pub-id-type="pmid">31278054</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epping</surname><given-names>M. T.</given-names></name><name><surname>Meijer</surname><given-names>L. A. T.</given-names></name><name><surname>Krijgsman</surname><given-names>O.</given-names></name><name><surname>Bos</surname><given-names>J. L.</given-names></name><name><surname>Pandolfi</surname><given-names>P. P.</given-names></name><name><surname>Bernards</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>TSPYL5 suppresses p53 levels and function by physical interaction with USP7.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>13</volume>
<fpage>102</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2142</pub-id>
<pub-id pub-id-type="pmid">21170034</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everett</surname><given-names>R. D.</given-names></name><name><surname>Meredith</surname><given-names>M.</given-names></name><name><surname>Orr</surname><given-names>A.</given-names></name><name><surname>Cross</surname><given-names>A.</given-names></name><name><surname>Kathoria</surname><given-names>M.</given-names></name><name><surname>Parkinson</surname><given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein.</article-title>
<source/><italic>EMBO J.</italic>
<volume>16</volume>
<fpage>1519</fpage>–<lpage>1530</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.7.1519</pub-id>
<pub-id pub-id-type="pmid">9130697</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evrin</surname><given-names>C.</given-names></name><name><surname>Clarke</surname><given-names>P.</given-names></name><name><surname>Zech</surname><given-names>J.</given-names></name><name><surname>Lurz</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Uhle</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>20240</fpage>–<lpage>20245</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0911500106</pub-id>
<pub-id pub-id-type="pmid">19910535</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faesen</surname><given-names>A. C.</given-names></name><name><surname>Dirac</surname><given-names>A. M.</given-names></name><name><surname>Shanmugham</surname><given-names>A.</given-names></name><name><surname>Ovaa</surname><given-names>H.</given-names></name><name><surname>Perrakis</surname><given-names>A.</given-names></name><name><surname>Sixma</surname><given-names>T. K.</given-names></name></person-group> (<year>2011a</year>). <article-title>Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>44</volume>
<fpage>147</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.06.034</pub-id>
<pub-id pub-id-type="pmid">21981925</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faesen</surname><given-names>A. C.</given-names></name><name><surname>Luna-Vargas</surname><given-names>M. P.</given-names></name><name><surname>Geurink</surname><given-names>P. P.</given-names></name><name><surname>Clerici</surname><given-names>M.</given-names></name><name><surname>Merkx</surname><given-names>R.</given-names></name><name><surname>van Dijk</surname><given-names>W. J.</given-names></name><etal></etal></person-group> (<year>2011b</year>). <article-title>The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types.</article-title>
<source/><italic>Chem. Biol.</italic>
<volume>18</volume>
<fpage>1550</fpage>–<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2011.10.017</pub-id>
<pub-id pub-id-type="pmid">22195557</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faesen</surname><given-names>A. C.</given-names></name><name><surname>Luna-Vargas</surname><given-names>M. P.</given-names></name><name><surname>Sixma</surname><given-names>T. K.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of UBL domains in ubiquitin-specific proteases.</article-title>
<source/><italic>Biochem. Soc. Trans.</italic>
<volume>40</volume>
<fpage>539</fpage>–<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1042/BST20120004</pub-id>
<pub-id pub-id-type="pmid">22616864</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y. H.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Vasudevan</surname><given-names>S. A.</given-names></name><name><surname>Dou</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Patel</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>4</volume>:<issue>e867</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2013.400</pub-id>
<pub-id pub-id-type="pmid">24136231</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>S.</given-names></name><name><surname>Jensen</surname><given-names>J. P.</given-names></name><name><surname>Ludwig</surname><given-names>R. L.</given-names></name><name><surname>Vousden</surname><given-names>K. H.</given-names></name><name><surname>Weissman</surname><given-names>A. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>8945</fpage>–<lpage>8951</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.12.8945</pub-id>
<pub-id pub-id-type="pmid">10722742</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faustrup</surname><given-names>H.</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name><name><surname>Mailand</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>184</volume>
<fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200807137</pub-id>
<pub-id pub-id-type="pmid">19124652</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felle</surname><given-names>M.</given-names></name><name><surname>Joppien</surname><given-names>S.</given-names></name><name><surname>Nemeth</surname><given-names>A.</given-names></name><name><surname>Diermeier</surname><given-names>S.</given-names></name><name><surname>Thalhammer</surname><given-names>V.</given-names></name><name><surname>Dobner</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>39</volume>
<fpage>8355</fpage>–<lpage>8365</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr528</pub-id>
<pub-id pub-id-type="pmid">21745816</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Montalvan</surname><given-names>A.</given-names></name><name><surname>Bouwmeester</surname><given-names>T.</given-names></name><name><surname>Joberty</surname><given-names>G.</given-names></name><name><surname>Mader</surname><given-names>R.</given-names></name><name><surname>Mahnke</surname><given-names>M.</given-names></name><name><surname>Pierrat</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.</article-title>
<source/><italic>FEBS J.</italic>
<volume>274</volume>
<fpage>4256</fpage>–<lpage>4270</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2007.05952.x</pub-id>
<pub-id pub-id-type="pmid">17651432</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fountain</surname><given-names>M. D.</given-names></name><name><surname>Oleson</surname><given-names>D. S.</given-names></name><name><surname>Rech</surname><given-names>M. E.</given-names></name><name><surname>Segebrecht</surname><given-names>L.</given-names></name><name><surname>Hunter</surname><given-names>J. V.</given-names></name><name><surname>McCarthy</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>21</volume>
<fpage>1797</fpage>–<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-019-0433-1</pub-id>
<pub-id pub-id-type="pmid">30679821</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fradet-Turcotte</surname><given-names>A.</given-names></name><name><surname>Canny</surname><given-names>M. D.</given-names></name><name><surname>Escribano-Díaz</surname><given-names>C.</given-names></name><name><surname>Orthwein</surname><given-names>A.</given-names></name><name><surname>Leung</surname><given-names>C. C.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.</article-title>
<source/><italic>Nature</italic>
<volume>499</volume>
<fpage>50</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/nature12318</pub-id>
<pub-id pub-id-type="pmid">23760478</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francoz</surname><given-names>S.</given-names></name><name><surname>Froment</surname><given-names>P.</given-names></name><name><surname>Bogaerts</surname><given-names>S.</given-names></name><name><surname>De Clercq</surname><given-names>S.</given-names></name><name><surname>Maetens</surname><given-names>M.</given-names></name><name><surname>Doumont</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>3232</fpage>–<lpage>3237</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0508476103</pub-id>
<pub-id pub-id-type="pmid">16492744</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridman</surname><given-names>J. S.</given-names></name><name><surname>Lowe</surname><given-names>S. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Control of apoptosis by p53.</article-title>
<source/><italic>Oncogene</italic>
<volume>22</volume>
<fpage>9030</fpage>–<lpage>9040</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207116</pub-id>
<pub-id pub-id-type="pmid">14663481</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambus</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>R. C.</given-names></name><name><surname>Sanchez-Diaz</surname><given-names>A.</given-names></name><name><surname>Kanemaki</surname><given-names>M.</given-names></name><name><surname>van Deursen</surname><given-names>F.</given-names></name><name><surname>Edmondson</surname><given-names>R. D.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>8</volume>
<fpage>358</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1382</pub-id>
<pub-id pub-id-type="pmid">16531994</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>X. F.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Z. M.</given-names></name><name><surname>Ai</surname><given-names>H. W.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>An intramolecular interaction of UHRF1 reveals dual control for its histone association.</article-title>
<source/><italic>Structure</italic>
<volume>26</volume>
<fpage>304</fpage>–<lpage>311.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2017.12.016</pub-id>
<pub-id pub-id-type="pmid">29395786</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gascoigne</surname><given-names>K. E.</given-names></name><name><surname>Taylor</surname><given-names>S. S.</given-names></name></person-group> (<year>2009</year>). <article-title>How do anti-mitotic drugs kill cancer cells?</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>122</volume>(<issue>Pt 15</issue>), <fpage>2579</fpage>–<lpage>2585</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.039719</pub-id>
<pub-id pub-id-type="pmid">19625502</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavory</surname><given-names>G.</given-names></name><name><surname>O’Dowd</surname><given-names>C. R.</given-names></name><name><surname>Helm</surname><given-names>M. D.</given-names></name><name><surname>Flasz</surname><given-names>J.</given-names></name><name><surname>Arkoudis</surname><given-names>E.</given-names></name><name><surname>Dossang</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Discovery and characterization of highly potent and selective allosteric USP7 inhibitors</article-title>. <source/><italic>Nat. Chem. Biol.</italic>
<volume>14</volume>, <fpage>118</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2528</pub-id>
<pub-id pub-id-type="pmid">29200206</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannattasio</surname><given-names>M.</given-names></name><name><surname>Zwicky</surname><given-names>K.</given-names></name><name><surname>Follonier</surname><given-names>C.</given-names></name><name><surname>Foiani</surname><given-names>M.</given-names></name><name><surname>Lopes</surname><given-names>M.</given-names></name><name><surname>Branzei</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Visualization of recombination-mediated damage bypass by template switching.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>21</volume>
<fpage>884</fpage>–<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2888</pub-id>
<pub-id pub-id-type="pmid">25195051</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovinazzi</surname><given-names>S.</given-names></name><name><surname>Morozov</surname><given-names>V. M.</given-names></name><name><surname>Summers</surname><given-names>M. K.</given-names></name><name><surname>Reinhold</surname><given-names>W. C.</given-names></name><name><surname>Ishov</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>20</volume>
<fpage>721</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2012.169</pub-id>
<pub-id pub-id-type="pmid">23348568</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovinazzi</surname><given-names>S.</given-names></name><name><surname>Sirleto</surname><given-names>P.</given-names></name><name><surname>Aksenova</surname><given-names>V.</given-names></name><name><surname>Morozov</surname><given-names>V. M.</given-names></name><name><surname>Zori</surname><given-names>R.</given-names></name><name><surname>Reinhold</surname><given-names>W. C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>USP7 protects genomic stability by regulating Bub3.</article-title>
<source/><italic>Oncotarget</italic>
<volume>5</volume>
<fpage>3728</fpage>–<lpage>3742</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.1989</pub-id>
<pub-id pub-id-type="pmid">25003721</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>M.</given-names></name><name><surname>Stucki</surname><given-names>M.</given-names></name><name><surname>Falck</surname><given-names>J.</given-names></name><name><surname>D’Amours</surname><given-names>D.</given-names></name><name><surname>Rahman</surname><given-names>D.</given-names></name><name><surname>Pappin</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>MDC1 is required for the intra-S-phase DNA damage checkpoint.</article-title>
<source/><italic>Nature</italic>
<volume>421</volume>
<fpage>952</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1038/nature01445</pub-id>
<pub-id pub-id-type="pmid">12607003</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopinathan</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>S. L. W.</given-names></name><name><surname>Padmakumar</surname><given-names>V. C.</given-names></name><name><surname>Coppola</surname><given-names>V.</given-names></name><name><surname>Tessarollo</surname><given-names>L.</given-names></name><name><surname>Kaldis</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>74</volume>
<fpage>3870</fpage>–<lpage>3879</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.can-13-3440</pub-id>
<pub-id pub-id-type="pmid">24802190</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>J. D.</given-names></name><name><surname>Comeau</surname><given-names>L.</given-names></name><name><surname>Rosenfield</surname><given-names>S.</given-names></name><name><surname>Stansel</surname><given-names>R. M.</given-names></name><name><surname>Bianchi</surname><given-names>A.</given-names></name><name><surname>Moss</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Mammalian telomeres end in a large duplex loop.</article-title>
<source/><italic>Cell</italic>
<volume>97</volume>
<fpage>503</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80760-6</pub-id><pub-id pub-id-type="pmid">10338214</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groisman</surname><given-names>R.</given-names></name><name><surname>Kuraoka</surname><given-names>I.</given-names></name><name><surname>Chevallier</surname><given-names>O.</given-names></name><name><surname>Gaye</surname><given-names>N.</given-names></name><name><surname>Magnaldo</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>20</volume>
<fpage>1429</fpage>–<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1101/gad.378206</pub-id>
<pub-id pub-id-type="pmid">16751180</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutteridge</surname><given-names>R. E.</given-names></name><name><surname>Ndiaye</surname><given-names>M. A.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Plk1 inhibitors in cancer therapy: from laboratory to clinic.</article-title>
<source/><italic>Mol. Cancer Ther.</italic>
<volume>15</volume>
<fpage>1427</fpage>–<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1158/1535-7163.Mct-15-0897</pub-id>
<pub-id pub-id-type="pmid">27330107</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname><given-names>A.</given-names></name><name><surname>Bulyk</surname><given-names>M. L.</given-names></name><name><surname>Jambhekar</surname><given-names>A.</given-names></name><name><surname>Lahav</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>The multiple mechanisms that regulate p53 activity and cell fate.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>20</volume>
<fpage>199</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-019-0110-x</pub-id>
<pub-id pub-id-type="pmid">30824861</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y.-H.</given-names></name><name><surname>Fountain</surname><given-names>M. D.</given-names></name><name><surname>Fon Tacer</surname><given-names>K.</given-names></name><name><surname>Xia</surname><given-names>F.</given-names></name><name><surname>Bi</surname><given-names>W.</given-names></name><name><surname>Kang</surname><given-names>S.-H. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>USP7 acts as a molecular rheostat to promote WASH-dependent endosomal protein recycling and is mutated in a human neurodevelopmental disorder.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>59</volume>
<fpage>956</fpage>–<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.07.033</pub-id>
<pub-id pub-id-type="pmid">26365382</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>C. B.</given-names></name><name><surname>Futcher</surname><given-names>A. B.</given-names></name><name><surname>Greider</surname><given-names>C. W.</given-names></name></person-group> (<year>1990</year>). <article-title>Telomeres shorten during ageing of human fibroblasts.</article-title>
<source/><italic>Nature</italic>
<volume>345</volume>
<fpage>458</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1038/345458a0</pub-id>
<pub-id pub-id-type="pmid">2342578</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>J. S.</given-names></name><name><surname>Cornett</surname><given-names>E. M.</given-names></name><name><surname>Goldfarb</surname><given-names>D.</given-names></name><name><surname>DaRosa</surname><given-names>P. A.</given-names></name><name><surname>Li</surname><given-names>Z. M.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Hemi-methylated DNA regulates DNA methylation inheritance through allosteric activation of H3 ubiquitylation by UHRF1.</article-title>
<source/><italic>eLife</italic>
<volume>5</volume>:<issue>e17101</issue>. <pub-id pub-id-type="doi">10.7554/eLife.17101</pub-id>
<pub-id pub-id-type="pmid">27595565</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haupt</surname><given-names>Y.</given-names></name><name><surname>Maya</surname><given-names>R.</given-names></name><name><surname>Kazaz</surname><given-names>A.</given-names></name><name><surname>Oren</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Mdm2 promotes the rapid degradation of p53.</article-title>
<source/><italic>Nature</italic>
<volume>387</volume>
<fpage>296</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1038/387296a0</pub-id>
<pub-id pub-id-type="pmid">9153395</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Wani</surname><given-names>G.</given-names></name><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>27278</fpage>–<lpage>27289</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.589812</pub-id>
<pub-id pub-id-type="pmid">25118285</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname><given-names>A.</given-names></name><name><surname>Goyal</surname><given-names>R.</given-names></name><name><surname>Jeltsch</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>48350</fpage>–<lpage>48359</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M403427200</pub-id>
<pub-id pub-id-type="pmid">15339928</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Carralero</surname><given-names>E.</given-names></name><name><surname>Cabrera</surname><given-names>E.</given-names></name><name><surname>Alonso-de Vega</surname><given-names>I.</given-names></name><name><surname>Hernandez-Perez</surname><given-names>S.</given-names></name><name><surname>Smits</surname><given-names>V. A. J.</given-names></name><name><surname>Freire</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Control of DNA replication initiation by ubiquitin.</article-title>
<source/><italic>Cells</italic>
<volume>7</volume>:<issue>146</issue>. <pub-id pub-id-type="doi">10.3390/cells7100146</pub-id>
<pub-id pub-id-type="pmid">30241373</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández-Pérez</surname><given-names>S.</given-names></name><name><surname>Cabrera</surname><given-names>E.</given-names></name><name><surname>Salido</surname><given-names>E.</given-names></name><name><surname>Lim</surname><given-names>M.</given-names></name><name><surname>Reid</surname><given-names>L.</given-names></name><name><surname>Lakhani</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.</article-title>
<source/><italic>Oncogene</italic>
<volume>36</volume>
<fpage>4802</fpage>–<lpage>4809</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.21</pub-id>
<pub-id pub-id-type="pmid">28288134</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higa</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Stabilization of ultraviolet (UV)-stimulated scaffold protein A by interaction with ubiquitin-specific peptidase 7 is essential for transcription-coupled nucleotide excision repair.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>13771</fpage>–<lpage>13779</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.724658</pub-id>
<pub-id pub-id-type="pmid">27129218</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeijmakers</surname><given-names>J. H. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Genome maintenance mechanisms for preventing cancer.</article-title>
<source/><italic>Nature</italic>
<volume>411</volume>
<fpage>366</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1038/35077232</pub-id>
<pub-id pub-id-type="pmid">11357144</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>R.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>420</volume>
<fpage>25</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(97)01480-4</pub-id><pub-id pub-id-type="pmid">9450543</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Karube</surname><given-names>K.</given-names></name><name><surname>Takebayashi</surname><given-names>K.</given-names></name><name><surname>Yoshino</surname><given-names>H.</given-names></name><name><surname>Yoshioka</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Cyclin A is a reliable proliferation marker in endometrial cancer cell lines.</article-title>
<source/><italic>Oncol. Lett.</italic>
<volume>17</volume>
<fpage>4455</fpage>–<lpage>4462</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2019.10135</pub-id>
<pub-id pub-id-type="pmid">30988814</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Jeffrey</surname><given-names>P. D.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>4</volume>:<issue>e27</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0040027</pub-id>
<pub-id pub-id-type="pmid">16402859</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Yao</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.</article-title>
<source/><italic>Cell Biochem. Biophys.</italic>
<volume>111</volume>
<fpage>1041</fpage>–<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(02)01199-6</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. T.</given-names></name><name><surname>Nijman</surname><given-names>S. M.</given-names></name><name><surname>Mirchandani</surname><given-names>K. D.</given-names></name><name><surname>Galardy</surname><given-names>P. J.</given-names></name><name><surname>Cohn</surname><given-names>M. A.</given-names></name><name><surname>Haas</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Regulation of monoubiquitinated PCNA by DUB autocleavage.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>8</volume>
<fpage>339</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1378</pub-id>
<pub-id pub-id-type="pmid">16531995</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Guryanova</surname><given-names>O. A.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Shou</surname><given-names>W.</given-names></name><name><surname>Rich</surname><given-names>J. N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>13</volume>
<fpage>142</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2153</pub-id>
<pub-id pub-id-type="pmid">21258371</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilves</surname><given-names>I.</given-names></name><name><surname>Petojevic</surname><given-names>T.</given-names></name><name><surname>Pesavento</surname><given-names>J. J.</given-names></name><name><surname>Botchan</surname><given-names>M. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>37</volume>
<fpage>247</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2009.12.030</pub-id>
<pub-id pub-id-type="pmid">20122406</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiyama</surname><given-names>S.</given-names></name><name><surname>Nishiyama</surname><given-names>A.</given-names></name><name><surname>Saeki</surname><given-names>Y.</given-names></name><name><surname>Moritsugu</surname><given-names>K.</given-names></name><name><surname>Morimoto</surname><given-names>D.</given-names></name><name><surname>Yamaguchi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Structure of the Dnmt1 reader module complexed with a unique two-mono-ubiquitin mark on histone H3 reveals the basis for DNA methylation maintenance.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>68</volume>
<fpage>350</fpage>–<lpage>360.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.037</pub-id>
<pub-id pub-id-type="pmid">29053958</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacq</surname><given-names>X.</given-names></name><name><surname>Kemp</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>N. M. B.</given-names></name><name><surname>Jackson</surname><given-names>S. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Deubiquitylating enzymes and DNA damage response pathways.</article-title>
<source/><italic>Cell Biochem. Biophys.</italic>
<volume>67</volume>
<fpage>25</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-013-9635-3</pub-id>
<pub-id pub-id-type="pmid">23712866</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagannathan</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Gallo</surname><given-names>D.</given-names></name><name><surname>Luthra</surname><given-names>N.</given-names></name><name><surname>Brown</surname><given-names>G. W.</given-names></name><name><surname>Saridakis</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A role for USP7 in DNA replication.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>34</volume>
<fpage>132</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00639-13</pub-id>
<pub-id pub-id-type="pmid">24190967</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaqaman</surname><given-names>K.</given-names></name><name><surname>King</surname><given-names>E. M.</given-names></name><name><surname>Amaro</surname><given-names>A. C.</given-names></name><name><surname>Winter</surname><given-names>J. R.</given-names></name><name><surname>Dorn</surname><given-names>J. F.</given-names></name><name><surname>Elliott</surname><given-names>H. L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Kinetochore alignment within the metaphase plate is regulated by centromere stiffness and microtubule depolymerases.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>188</volume>
<fpage>665</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200909005</pub-id>
<pub-id pub-id-type="pmid">20212316</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>Y.</given-names></name><name><surname>Markovtsov</surname><given-names>V.</given-names></name><name><surname>Lang</surname><given-names>W.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Pearsall</surname><given-names>D.</given-names></name><name><surname>Warner</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth.</article-title>
<source/><italic>Mol. Biol. Cell</italic>
<volume>16</volume>
<fpage>5621</fpage>–<lpage>5629</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e05-03-0194</pub-id>
<pub-id pub-id-type="pmid">16195352</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>E.</given-names></name><name><surname>Dixon</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Replicative DNA polymerases.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>5</volume>:<issue>a012799</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a012799</pub-id>
<pub-id pub-id-type="pmid">23732474</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>P. L.</given-names></name><name><surname>Veenstra</surname><given-names>G. J.</given-names></name><name><surname>Wade</surname><given-names>P. A.</given-names></name><name><surname>Vermaak</surname><given-names>D.</given-names></name><name><surname>Kass</surname><given-names>S. U.</given-names></name><name><surname>Landsberger</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>19</volume>
<fpage>187</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1038/561</pub-id>
<pub-id pub-id-type="pmid">9620779</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>M. A.</given-names></name><name><surname>Toso</surname><given-names>R. J.</given-names></name><name><surname>Thrower</surname><given-names>D.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name></person-group> (<year>1993</year>). <article-title>Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>90</volume>
<fpage>9552</fpage>–<lpage>9556</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.20.9552</pub-id>
<pub-id pub-id-type="pmid">8105478</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>Y.-S.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group> (<year>2012</year>). <article-title>DNA polymerase eta is targeted by Mdm2 for polyubiquitination and proteasomal degradation in response to ultraviolet irradiation.</article-title>
<source/><italic>DNA Repair.</italic>
<volume>11</volume>
<fpage>177</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.dnarep.2011.10.017</pub-id>
<pub-id pub-id-type="pmid">22056306</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wong</surname><given-names>J.</given-names></name><name><surname>Fang</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>156</volume>
<fpage>249</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200108016</pub-id>
<pub-id pub-id-type="pmid">11807090</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannouche</surname><given-names>P. L.</given-names></name><name><surname>Wing</surname><given-names>J.</given-names></name><name><surname>Lehmann</surname><given-names>A. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>14</volume>
<fpage>491</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1016/s1097-2765(04)00259-x</pub-id><pub-id pub-id-type="pmid">15149598</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwaba</surname><given-names>S.</given-names></name><name><surname>Kanao</surname><given-names>R.</given-names></name><name><surname>Masuda</surname><given-names>Y.</given-names></name><name><surname>Kusumoto-Matsuo</surname><given-names>R.</given-names></name><name><surname>Hanaoka</surname><given-names>F.</given-names></name><name><surname>Masutani</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>USP7 is a suppressor of PCNA ubiquitination and oxidative-stress-induced mutagenesis in human cells.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>13</volume>
<fpage>2072</fpage>–<lpage>2080</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.11.014</pub-id>
<pub-id pub-id-type="pmid">26673319</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kategaya</surname><given-names>L.</given-names></name><name><surname>Di Lello</surname><given-names>P.</given-names></name><name><surname>Rouge</surname><given-names>L.</given-names></name><name><surname>Pastor</surname><given-names>R.</given-names></name><name><surname>Clark</surname><given-names>K. R.</given-names></name><name><surname>Drummond</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>USP7 small-molecule inhibitors interfere with ubiquitin binding.</article-title>
<source/><italic>Nature</italic>
<volume>550</volume>
<fpage>534</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1038/nature24006</pub-id>
<pub-id pub-id-type="pmid">29045385</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>H.</given-names></name><name><surname>Wiederschain</surname><given-names>D.</given-names></name><name><surname>Kitao</surname><given-names>H.</given-names></name><name><surname>Stuart</surname><given-names>J.</given-names></name><name><surname>Tsai</surname><given-names>K. K.</given-names></name><name><surname>Yuan</surname><given-names>Z. M.</given-names></name></person-group> (<year>2003</year>). <article-title>DNA damage-induced MDMX degradation is mediated by MDM2.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>45946</fpage>–<lpage>45953</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M308295200</pub-id>
<pub-id pub-id-type="pmid">12963717</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelling</surname><given-names>J.</given-names></name><name><surname>Sullivan</surname><given-names>K.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name><name><surname>Jordan</surname><given-names>M. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Suppression of centromere dynamics by Taxol in living osteosarcoma cells.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>63</volume>
<fpage>2794</fpage>–<lpage>2801</lpage>.<pub-id pub-id-type="pmid">12782584</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>K. K.</given-names></name><name><surname>Jackson</surname><given-names>S. P.</given-names></name></person-group> (<year>2001</year>). <article-title>DNA double-strand breaks: signaling, repair and the cancer connection.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>27</volume>
<fpage>247</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1038/85798</pub-id>
<pub-id pub-id-type="pmid">11242102</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>R. Q.</given-names></name><name><surname>Geurink</surname><given-names>P. P.</given-names></name><name><surname>Mulder</surname><given-names>M. P. C.</given-names></name><name><surname>Fish</surname><given-names>A.</given-names></name><name><surname>Ekkebus</surname><given-names>R.</given-names></name><name><surname>El Oualid</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Kinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>10</volume>:<issue>231</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-08231-5</pub-id>
<pub-id pub-id-type="pmid">30651545</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>R. Q.</given-names></name><name><surname>Sixma</surname><given-names>T. K.</given-names></name></person-group> (<year>2017</year>). <article-title>Regulation of USP7: a high incidence of E3 complexes.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>429</volume>
<fpage>3395</fpage>–<lpage>3408</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2017.05.028</pub-id>
<pub-id pub-id-type="pmid">28591556</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>R. Q.</given-names></name><name><surname>van Dijk</surname><given-names>W. J.</given-names></name><name><surname>Sixma</surname><given-names>T. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Structure of USP7 catalytic domain and three Ubl-domains reveals a connector alpha-helix with regulatory role.</article-title>
<source/><italic>J. Struct. Biol.</italic>
<volume>195</volume>
<fpage>11</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsb.2016.05.005</pub-id>
<pub-id pub-id-type="pmid">27183903</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolas</surname><given-names>N. K.</given-names></name><name><surname>Chapman</surname><given-names>J. R.</given-names></name><name><surname>Nakada</surname><given-names>S.</given-names></name><name><surname>Ylanko</surname><given-names>J.</given-names></name><name><surname>Chahwan</surname><given-names>R.</given-names></name><name><surname>Sweeney</surname><given-names>F. D.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.</article-title>
<source/><italic>Science</italic>
<volume>318</volume>
<fpage>1637</fpage>–<lpage>1640</lpage>. <pub-id pub-id-type="doi">10.1126/science.1150034</pub-id>
<pub-id pub-id-type="pmid">18006705</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komander</surname><given-names>D.</given-names></name><name><surname>Clague</surname><given-names>M. J.</given-names></name><name><surname>Urbe</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Breaking the chains: structure and function of the deubiquitinases.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>10</volume>
<fpage>550</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2731</pub-id>
<pub-id pub-id-type="pmid">19626045</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komander</surname><given-names>D.</given-names></name><name><surname>Rape</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>The ubiquitin code.</article-title>
<source/><italic>Annu. Rev. Biochem.</italic>
<volume>81</volume>
<fpage>203</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-060310-170328</pub-id>
<pub-id pub-id-type="pmid">22524316</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kon</surname><given-names>N.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Brooks</surname><given-names>C. L.</given-names></name><name><surname>Ludwig</surname><given-names>T.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Inactivation of HAUSP in vivo modulates p53 function.</article-title>
<source/><italic>Oncogene</italic>
<volume>29</volume>
<fpage>1270</fpage>–<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2009.427</pub-id>
<pub-id pub-id-type="pmid">19946331</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>C. M.</given-names></name><name><surname>Lee</surname><given-names>X. W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2013</year>). <article-title>Telomere shortening in human diseases.</article-title>
<source/><italic>FEBS J.</italic>
<volume>280</volume>
<fpage>3180</fpage>–<lpage>3193</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12326</pub-id>
<pub-id pub-id-type="pmid">23647631</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kracikova</surname><given-names>M.</given-names></name><name><surname>Akiri</surname><given-names>G.</given-names></name><name><surname>George</surname><given-names>A.</given-names></name><name><surname>Sachidanandam</surname><given-names>R.</given-names></name><name><surname>Aaronson</surname><given-names>S. A.</given-names></name></person-group> (<year>2013</year>). <article-title>A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>20</volume>
<fpage>576</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2012.155</pub-id>
<pub-id pub-id-type="pmid">23306555</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubbutat</surname><given-names>M. H.</given-names></name><name><surname>Jones</surname><given-names>S. N.</given-names></name><name><surname>Vousden</surname><given-names>K. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Regulation of p53 stability by Mdm2.</article-title>
<source/><italic>Nature</italic>
<volume>387</volume>
<fpage>299</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1038/387299a0</pub-id>
<pub-id pub-id-type="pmid">9153396</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusakabe</surname><given-names>M.</given-names></name><name><surname>Onishi</surname><given-names>Y.</given-names></name><name><surname>Tada</surname><given-names>H.</given-names></name><name><surname>Kurihara</surname><given-names>F.</given-names></name><name><surname>Kusao</surname><given-names>K.</given-names></name><name><surname>Furukawa</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Mechanism and regulation of DNA damage recognition in nucleotide excision repair.</article-title>
<source/><italic>Genes Environ.</italic>
<volume>41</volume>:<issue>2</issue>. <pub-id pub-id-type="doi">10.1186/s41021-019-0119-6</pub-id>
<pub-id pub-id-type="pmid">30700997</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamberto</surname><given-names>I.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Seo</surname><given-names>H. S.</given-names></name><name><surname>Schauer</surname><given-names>N. J.</given-names></name><name><surname>Iacob</surname><given-names>R. E.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.</article-title>
<source/><italic>Cell Chem. Biol.</italic>
<volume>24</volume>
<fpage>1490</fpage>–<lpage>1500.e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2017.09.003</pub-id>
<pub-id pub-id-type="pmid">29056421</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBron</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Gilkes</surname><given-names>D. M.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.</article-title>
<source/><italic>EMBO J.</italic>
<volume>25</volume>
<fpage>1196</fpage>–<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601032</pub-id>
<pub-id pub-id-type="pmid">16511560</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecona</surname><given-names>E.</given-names></name><name><surname>Rodriguez-Acebes</surname><given-names>S.</given-names></name><name><surname>Specks</surname><given-names>J.</given-names></name><name><surname>Lopez-Contreras</surname><given-names>A. J.</given-names></name><name><surname>Ruppen</surname><given-names>I.</given-names></name><name><surname>Murga</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>USP7 is a SUMO deubiquitinase essential for DNA replication.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>23</volume>
<fpage>270</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3185</pub-id>
<pub-id pub-id-type="pmid">26950370</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leman</surname><given-names>A. R.</given-names></name><name><surname>Noguchi</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>The replication fork: understanding the eukaryotic replication machinery and the challenges to genome duplication.</article-title>
<source/><italic>Genes</italic>
<volume>4</volume>
<fpage>1</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.3390/genes4010001</pub-id>
<pub-id pub-id-type="pmid">23599899</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>L. K.</given-names></name><name><surname>Francisco</surname><given-names>G.</given-names></name><name><surname>Soltys</surname><given-names>D. T.</given-names></name><name><surname>Rocha</surname><given-names>C. R. R.</given-names></name><name><surname>Quinet</surname><given-names>A.</given-names></name><name><surname>Vessoni</surname><given-names>A. T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>45</volume>
<fpage>1270</fpage>–<lpage>1280</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1196</pub-id>
<pub-id pub-id-type="pmid">28180309</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>M. S.</given-names></name><name><surname>Holland</surname><given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>The impact of mitotic errors on cell proliferation and tumorigenesis.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>32</volume>
<fpage>620</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1101/gad.314351.118</pub-id>
<pub-id pub-id-type="pmid">29802124</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Brooks</surname><given-names>C. L.</given-names></name><name><surname>Kon</surname><given-names>N.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name></person-group> (<year>2004</year>). <article-title>A dynamic role of HAUSP in the p53-Mdm2 pathway.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>13</volume>
<fpage>879</fpage>–<lpage>886</lpage>. <pub-id pub-id-type="doi">10.1016/S1097-2765(04)00157-1</pub-id><pub-id pub-id-type="pmid">15053880</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Shiloh</surname><given-names>A.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Nikolaev</surname><given-names>A. Y.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.</article-title>
<source/><italic>Nature</italic>
<volume>416</volume>
<fpage>648</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1038/nature737</pub-id>
<pub-id pub-id-type="pmid">11923872</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>H. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.</article-title>
<source/><italic>Eur. J. Med. Chem.</italic>
<volume>191</volume>:<issue>112107</issue>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112107</pub-id>
<pub-id pub-id-type="pmid">32092586</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>F.</given-names></name><name><surname>Miller</surname><given-names>A. S.</given-names></name><name><surname>Longerich</surname><given-names>S.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Maranon</surname><given-names>D.</given-names></name><name><surname>Williamson</surname><given-names>E. A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>10</volume>:<issue>2849</issue>. <pub-id pub-id-type="doi">10.1038/s41467-019-10408-5</pub-id>
<pub-id pub-id-type="pmid">31253762</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieber</surname><given-names>M. R.</given-names></name></person-group> (<year>2010</year>). <article-title>The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.</article-title>
<source/><italic>Annu. Rev. Biochem.</italic>
<volume>79</volume>
<fpage>181</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.052308.093131</pub-id>
<pub-id pub-id-type="pmid">20192759</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.-J.</given-names></name><name><surname>Dimova</surname><given-names>N. V.</given-names></name><name><surname>Tan</surname><given-names>M.-K. M.</given-names></name><name><surname>Sigoillot</surname><given-names>F. D.</given-names></name><name><surname>King</surname><given-names>R. W.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>33</volume>
<fpage>4166</fpage>–<lpage>4180</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00689-13</pub-id>
<pub-id pub-id-type="pmid">23979597</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linares</surname><given-names>L. K.</given-names></name><name><surname>Hengstermann</surname><given-names>A.</given-names></name><name><surname>Ciechanover</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>S.</given-names></name><name><surname>Scheffner</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>100</volume>
<fpage>12009</fpage>–<lpage>12014</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2030930100</pub-id>
<pub-id pub-id-type="pmid">14507994</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Davydenko</surname><given-names>O.</given-names></name><name><surname>Lampson</surname><given-names>M. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>198</volume>
<fpage>491</fpage>–<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201205090</pub-id>
<pub-id pub-id-type="pmid">22908307</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Tanasa</surname><given-names>B.</given-names></name><name><surname>Tyurina</surname><given-names>O. V.</given-names></name><name><surname>Zhou</surname><given-names>T. Y.</given-names></name><name><surname>Gassmann</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>W. T.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression.</article-title>
<source/><italic>Nature</italic>
<volume>466</volume>
<fpage>508</fpage>–<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1038/nature09272</pub-id>
<pub-id pub-id-type="pmid">20622854</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>4</volume>:<issue>1563</issue>. <pub-id pub-id-type="doi">10.1038/ncomms2562</pub-id>
<pub-id pub-id-type="pmid">23463006</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Contreras</surname><given-names>A. J.</given-names></name><name><surname>Ruppen</surname><given-names>I.</given-names></name><name><surname>Nieto-Soler</surname><given-names>M.</given-names></name><name><surname>Murga</surname><given-names>M.</given-names></name><name><surname>Rodriguez-Acebes</surname><given-names>S.</given-names></name><name><surname>Remeseiro</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A proteomic characterization of factors enriched at nascent DNA molecules.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>3</volume>
<fpage>1105</fpage>–<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.009</pub-id>
<pub-id pub-id-type="pmid">23545495</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>J. D.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Lor</surname><given-names>L. A.</given-names></name><name><surname>Kennedy-Wilson</surname><given-names>K. M.</given-names></name><name><surname>Sinnamon</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.</article-title>
<source/><italic>Arch. Biochem. Biophys.</italic>
<volume>503</volume>
<fpage>207</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2010.08.020</pub-id>
<pub-id pub-id-type="pmid">20816748</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magidson</surname><given-names>V.</given-names></name><name><surname>O’Connell</surname><given-names>C. B.</given-names></name><name><surname>Lončarek</surname><given-names>J.</given-names></name><name><surname>Paul</surname><given-names>R.</given-names></name><name><surname>Mogilner</surname><given-names>A.</given-names></name><name><surname>Khodjakov</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The spatial arrangement of chromosomes during prometaphase facilitates spindle assembly.</article-title>
<source/><italic>Cell</italic>
<volume>146</volume>
<fpage>555</fpage>–<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.07.012</pub-id>
<pub-id pub-id-type="pmid">21854981</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mailand</surname><given-names>N.</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S.</given-names></name><name><surname>Faustrup</surname><given-names>H.</given-names></name><name><surname>Melander</surname><given-names>F.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.</article-title>
<source/><italic>Cell</italic>
<volume>131</volume>
<fpage>887</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.09.040</pub-id>
<pub-id pub-id-type="pmid">18001824</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mailand</surname><given-names>N.</given-names></name><name><surname>Falck</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>C.</given-names></name><name><surname>Syljuåsen</surname><given-names>R. G.</given-names></name><name><surname>Welcker</surname><given-names>M.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Rapid destruction of human Cdc25A in response to DNA damage.</article-title>
<source/><italic>Science</italic>
<volume>288</volume>
<fpage>1425</fpage>–<lpage>1429</lpage>. <pub-id pub-id-type="doi">10.1126/science.288.5470.1425</pub-id>
<pub-id pub-id-type="pmid">10827953</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malumbres</surname><given-names>M.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Cell cycle, CDKs and cancer: a changing paradigm.</article-title>
<source/><italic>Nat. Rev. Cancer</italic>
<volume>9</volume>
<fpage>153</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2602</pub-id>
<pub-id pub-id-type="pmid">19238148</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maréchal</surname><given-names>A.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>DNA damage sensing by the ATM and ATR kinases.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>5</volume>:<issue>a012716</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a012716</pub-id>
<pub-id pub-id-type="pmid">24003211</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>Y.</given-names></name><name><surname>Kanao</surname><given-names>R.</given-names></name><name><surname>Kawai</surname><given-names>H.</given-names></name><name><surname>Kukimoto</surname><given-names>I.</given-names></name><name><surname>Masutani</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>294</volume>
<fpage>4177</fpage>–<lpage>4187</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA118.005167</pub-id>
<pub-id pub-id-type="pmid">30647135</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuya</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Nakashima</surname><given-names>T.</given-names></name><name><surname>Yokomise</surname><given-names>H.</given-names></name><name><surname>Ueno</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.</article-title>
<source/><italic>J. Pathol.</italic>
<volume>208</volume>
<fpage>724</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1002/path.1931</pub-id>
<pub-id pub-id-type="pmid">16450335</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiroli</surname><given-names>F.</given-names></name><name><surname>Vissers</surname><given-names>J. H.</given-names></name><name><surname>van Dijk</surname><given-names>W. J.</given-names></name><name><surname>Ikpa</surname><given-names>P.</given-names></name><name><surname>Citterio</surname><given-names>E.</given-names></name><name><surname>Vermeulen</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling.</article-title>
<source/><italic>Cell</italic>
<volume>150</volume>
<fpage>1182</fpage>–<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.08.005</pub-id>
<pub-id pub-id-type="pmid">22980979</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGarry</surname><given-names>T. J.</given-names></name><name><surname>Kirschner</surname><given-names>M. W.</given-names></name></person-group> (<year>1998</year>). <article-title>Geminin, an inhibitor of DNA replication, is degraded during mitosis.</article-title>
<source/><italic>Cell</italic>
<volume>93</volume>
<fpage>1043</fpage>–<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)81209-x</pub-id><pub-id pub-id-type="pmid">9635433</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>J. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitosis.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>8</volume>:<issue>a023218</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a023218</pub-id>
<pub-id pub-id-type="pmid">27587616</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meulmeester</surname><given-names>E.</given-names></name><name><surname>Maurice</surname><given-names>M. M.</given-names></name><name><surname>Boutell</surname><given-names>C.</given-names></name><name><surname>Teunisse</surname><given-names>A. F. A. S.</given-names></name><name><surname>Ovaa</surname><given-names>H.</given-names></name><name><surname>Abraham</surname><given-names>T. E.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>18</volume>
<fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.04.024</pub-id>
<pub-id pub-id-type="pmid">15916963</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mocciaro</surname><given-names>A.</given-names></name><name><surname>Rape</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>125</volume>(<issue>Pt 2</issue>), <fpage>255</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.091199</pub-id>
<pub-id pub-id-type="pmid">22357967</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>M. E.</given-names></name><name><surname>Morgan</surname><given-names>M. T.</given-names></name><name><surname>Clerici</surname><given-names>M.</given-names></name><name><surname>Growkova</surname><given-names>K.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Komander</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>19</volume>:<issue>e45680</issue>. <pub-id pub-id-type="doi">10.15252/embr.201745680</pub-id>
<pub-id pub-id-type="pmid">30150323</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motegi</surname><given-names>A.</given-names></name><name><surname>Liaw</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>K. Y.</given-names></name><name><surname>Roest</surname><given-names>H. P.</given-names></name><name><surname>Maas</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>12411</fpage>–<lpage>12416</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0805685105</pub-id>
<pub-id pub-id-type="pmid">18719106</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer</surname><given-names>S. E.</given-names></name><name><surname>Lewis</surname><given-names>P. W.</given-names></name><name><surname>Botchan</surname><given-names>M. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>10236</fpage>–<lpage>10241</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0602400103</pub-id>
<pub-id pub-id-type="pmid">16798881</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mungamuri</surname><given-names>S. K.</given-names></name><name><surname>Benson</surname><given-names>E. K.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>S. W.</given-names></name><name><surname>Aaronson</surname><given-names>S. A.</given-names></name></person-group> (<year>2012</year>). <article-title>p53-mediated heterochromatin reorganization regulates its cell fate decisions.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>19</volume>
<fpage>478</fpage>–<lpage>S471</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2271</pub-id>
<pub-id pub-id-type="pmid">22466965</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mungamuri</surname><given-names>S. K.</given-names></name><name><surname>Qiao</surname><given-names>R. F.</given-names></name><name><surname>Yao</surname><given-names>S.</given-names></name><name><surname>Manfredi</surname><given-names>J. J.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Aaronson</surname><given-names>S. A.</given-names></name></person-group> (<year>2016</year>). <article-title>USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>14</volume>
<fpage>2528</fpage>–<lpage>2537</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.049</pub-id>
<pub-id pub-id-type="pmid">26971997</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>S.</given-names></name><name><surname>Briasoulis</surname><given-names>E.</given-names></name><name><surname>Linardou</surname><given-names>H.</given-names></name><name><surname>Bafaloukos</surname><given-names>D.</given-names></name><name><surname>Papadimitriou</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.</article-title>
<source/><italic>Cancer Treat. Rev.</italic>
<volume>38</volume>
<fpage>890</fpage>–<lpage>903</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2012.02.011</pub-id>
<pub-id pub-id-type="pmid">22465195</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musacchio</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>The molecular biology of spindle assembly checkpoint signaling dynamics.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>25</volume>
<fpage>R1002</fpage>–<lpage>R1018</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2015.08.051</pub-id>
<pub-id pub-id-type="pmid">26485365</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musacchio</surname><given-names>A.</given-names></name><name><surname>Salmon</surname><given-names>E. D.</given-names></name></person-group> (<year>2007</year>). <article-title>The spindle-assembly checkpoint in space and time.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>8</volume>
<fpage>379</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2163</pub-id>
<pub-id pub-id-type="pmid">17426725</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>K.</given-names></name><name><surname>Vousden</surname><given-names>K. H.</given-names></name></person-group> (<year>2001</year>). <article-title>PUMA, a novel proapoptotic gene, is induced by p53.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>7</volume>
<fpage>683</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/s1097-2765(01)00214-3</pub-id><pub-id pub-id-type="pmid">11463392</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Jagannathan</surname><given-names>M.</given-names></name><name><surname>Shire</surname><given-names>K.</given-names></name><name><surname>Frappier</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Interactions of the human MCM-BP protein with MCM complex components and Dbf4.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e35931</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0035931</pub-id>
<pub-id pub-id-type="pmid">22540012</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nihira</surname><given-names>N. T.</given-names></name><name><surname>Ogura</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>North</surname><given-names>B. J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.</article-title>
<source/><italic>Sci. Signal.</italic>
<volume>10</volume>:<issue>eaai8026</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.aai8026</pub-id>
<pub-id pub-id-type="pmid">28196907</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijman</surname><given-names>S. M.</given-names></name><name><surname>Luna-Vargas</surname><given-names>M. P.</given-names></name><name><surname>Velds</surname><given-names>A.</given-names></name><name><surname>Brummelkamp</surname><given-names>T. R.</given-names></name><name><surname>Dirac</surname><given-names>A. M.</given-names></name><name><surname>Sixma</surname><given-names>T. K.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>A genomic and functional inventory of deubiquitinating enzymes.</article-title>
<source/><italic>Cell</italic>
<volume>123</volume>
<fpage>773</fpage>–<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.11.007</pub-id>
<pub-id pub-id-type="pmid">16325574</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>A.</given-names></name><name><surname>Frappier</surname><given-names>L.</given-names></name><name><surname>Méchali</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>MCM-BP regulates unloading of the MCM2-7 helicase in late S phase.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>25</volume>
<fpage>165</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1101/gad.614411</pub-id>
<pub-id pub-id-type="pmid">21196493</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>A.</given-names></name><name><surname>Yamaguchi</surname><given-names>L.</given-names></name><name><surname>Sharif</surname><given-names>J.</given-names></name><name><surname>Johmura</surname><given-names>Y.</given-names></name><name><surname>Kawamura</surname><given-names>T.</given-names></name><name><surname>Nakanishi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication.</article-title>
<source/><italic>Nature</italic>
<volume>502</volume>
<fpage>249</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1038/nature12488</pub-id>
<pub-id pub-id-type="pmid">24013172</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novellasdemunt</surname><given-names>L.</given-names></name><name><surname>Foglizzo</surname><given-names>V.</given-names></name><name><surname>Cuadrado</surname><given-names>L.</given-names></name><name><surname>Antas</surname><given-names>P.</given-names></name><name><surname>Kucharska</surname><given-names>A.</given-names></name><name><surname>Encheva</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>USP7 is a tumor-specific WNT activator for APC-mutated colorectal cancer by mediating beta-catenin deubiquitination.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>21</volume>
<fpage>612</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.072</pub-id>
<pub-id pub-id-type="pmid">29045831</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowsheen</surname><given-names>S.</given-names></name><name><surname>Aziz</surname><given-names>K.</given-names></name><name><surname>Aziz</surname><given-names>A.</given-names></name><name><surname>Deng</surname><given-names>M.</given-names></name><name><surname>Qin</surname><given-names>B.</given-names></name><name><surname>Luo</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>20</volume>
<fpage>455</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1038/s41556-018-0071-x</pub-id>
<pub-id pub-id-type="pmid">29581593</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Dowd</surname><given-names>C. R.</given-names></name><name><surname>Helm</surname><given-names>M. D.</given-names></name><name><surname>Rountree</surname><given-names>J. S. S.</given-names></name><name><surname>Flasz</surname><given-names>J. T.</given-names></name><name><surname>Arkoudis</surname><given-names>E.</given-names></name><name><surname>Miel</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Identification and structure-guided development of pyrimidinone based USP7 inhibitors</article-title>. <source/><italic>ACS Med. Chem. Lett.</italic>
<volume>9</volume>, <fpage>238</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1021/acsmedchemlett.7b00512</pub-id>
<pub-id pub-id-type="pmid">29541367</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oestergaard</surname><given-names>V. H.</given-names></name><name><surname>Langevin</surname><given-names>F.</given-names></name><name><surname>Kuiken</surname><given-names>H. J.</given-names></name><name><surname>Pace</surname><given-names>P.</given-names></name><name><surname>Niedzwiedz</surname><given-names>W.</given-names></name><name><surname>Simpson</surname><given-names>L. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Deubiquitination of FANCD2 is required for DNA crosslink repair.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>28</volume>
<fpage>798</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.09.020</pub-id>
<pub-id pub-id-type="pmid">18082605</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>Y. M.</given-names></name><name><surname>Yoo</surname><given-names>S. J.</given-names></name><name><surname>Seol</surname><given-names>J. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>357</volume>
<fpage>615</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.03.193</pub-id>
<pub-id pub-id-type="pmid">17442268</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterwald</surname><given-names>S.</given-names></name><name><surname>Deeg</surname><given-names>K. I.</given-names></name><name><surname>Chung</surname><given-names>I.</given-names></name><name><surname>Parisotto</surname><given-names>D.</given-names></name><name><surname>Wörz</surname><given-names>S.</given-names></name><name><surname>Rohr</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>128</volume>
<fpage>1887</fpage>–<lpage>1900</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.148296</pub-id>
<pub-id pub-id-type="pmid">25908860</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Sullivan</surname><given-names>R. J.</given-names></name><name><surname>Karlseder</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Telomeres: protecting chromosomes against genome instability.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>11</volume>
<fpage>171</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2848</pub-id>
<pub-id pub-id-type="pmid">20125188</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozen</surname><given-names>A.</given-names></name><name><surname>Rouge</surname><given-names>L.</given-names></name><name><surname>Bashore</surname><given-names>C.</given-names></name><name><surname>Hearn</surname><given-names>B. R.</given-names></name><name><surname>Skelton</surname><given-names>N. J.</given-names></name><name><surname>Dueber</surname><given-names>E. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Selectively modulating conformational states of USP7 catalytic domain for activation.</article-title>
<source/><italic>Structure</italic>
<volume>26</volume>
<fpage>72</fpage>–<lpage>84.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2017.11.010</pub-id>
<pub-id pub-id-type="pmid">29249604</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paek</surname><given-names>A. L.</given-names></name><name><surname>Liu</surname><given-names>J. C.</given-names></name><name><surname>Loewer</surname><given-names>A.</given-names></name><name><surname>Forrester</surname><given-names>W. C.</given-names></name><name><surname>Lahav</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Cell-to-cell variation in p53 dynamics leads to fractional killing.</article-title>
<source/><italic>Cell</italic>
<volume>165</volume>
<fpage>631</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.03.025</pub-id>
<pub-id pub-id-type="pmid">27062928</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>MDM2 promotes ubiquitination and degradation of MDMX.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>23</volume>
<fpage>5113</fpage>–<lpage>5121</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.23.15.5113-5121.2003</pub-id>
<pub-id pub-id-type="pmid">12860999</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panier</surname><given-names>S.</given-names></name><name><surname>Ichijima</surname><given-names>Y.</given-names></name><name><surname>Fradet-Turcotte</surname><given-names>A.</given-names></name><name><surname>Leung</surname><given-names>C. C.</given-names></name><name><surname>Kaustov</surname><given-names>L.</given-names></name><name><surname>Arrowsmith</surname><given-names>C. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Tandem protein interaction modules organize the ubiquitin-dependent response to DNA double-strand breaks.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>47</volume>
<fpage>383</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.045</pub-id>
<pub-id pub-id-type="pmid">22742833</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>J. L.</given-names></name><name><surname>Dianova</surname><given-names>I. I.</given-names></name><name><surname>Khoronenkova</surname><given-names>S. V.</given-names></name><name><surname>Edelmann</surname><given-names>M. J.</given-names></name><name><surname>Kessler</surname><given-names>B. M.</given-names></name><name><surname>Dianov</surname><given-names>G. L.</given-names></name></person-group> (<year>2011</year>). <article-title>USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase β.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>41</volume>
<fpage>609</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.02.016</pub-id>
<pub-id pub-id-type="pmid">21362556</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>USP7 is a novel deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.</article-title>
<source/><italic>J. Exp. Clin. Cancer Res.</italic>
<volume>38</volume>:<issue>468</issue>. <pub-id pub-id-type="doi">10.1186/s13046-019-1457-8</pub-id>
<pub-id pub-id-type="pmid">31730000</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereg</surname><given-names>Y.</given-names></name><name><surname>Lam</surname><given-names>S.</given-names></name><name><surname>Teunisse</surname><given-names>A.</given-names></name><name><surname>Biton</surname><given-names>S.</given-names></name><name><surname>Meulmeester</surname><given-names>E.</given-names></name><name><surname>Mittelman</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>26</volume>
<fpage>6819</fpage>–<lpage>6831</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00562-06</pub-id>
<pub-id pub-id-type="pmid">16943424</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereg</surname><given-names>Y.</given-names></name><name><surname>Shkedy</surname><given-names>D.</given-names></name><name><surname>de Graaf</surname><given-names>P.</given-names></name><name><surname>Meulmeester</surname><given-names>E.</given-names></name><name><surname>Edelson-Averbukh</surname><given-names>M.</given-names></name><name><surname>Salek</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>102</volume>
<fpage>5056</fpage>–<lpage>5061</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0408595102</pub-id>
<pub-id pub-id-type="pmid">15788536</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfoh</surname><given-names>R.</given-names></name><name><surname>Lacdao</surname><given-names>I. K.</given-names></name><name><surname>Georges</surname><given-names>A. A.</given-names></name><name><surname>Capar</surname><given-names>A.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Frappier</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Crystal structure of USP7 ubiquitin-like domains with an ICP0 peptide reveals a novel mechanism used by viral and cellular proteins to target USP7.</article-title>
<source/><italic>PLoS Pathog.</italic>
<volume>11</volume>:<issue>e1004950</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004950</pub-id>
<pub-id pub-id-type="pmid">26046769</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickart</surname><given-names>C. M.</given-names></name><name><surname>Eddins</surname><given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Ubiquitin: structures, functions, mechanisms.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1695</volume>
<fpage>55</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2004.09.019</pub-id>
<pub-id pub-id-type="pmid">15571809</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polo</surname><given-names>S. E.</given-names></name><name><surname>Jackson</surname><given-names>S. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>25</volume>
<fpage>409</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1101/gad.2021311</pub-id>
<pub-id pub-id-type="pmid">21363960</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>M.</given-names></name><name><surname>Lukas</surname><given-names>C.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S.</given-names></name><name><surname>Mailand</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>197</volume>
<fpage>189</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201109100</pub-id>
<pub-id pub-id-type="pmid">22492721</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozhidaeva</surname><given-names>A.</given-names></name><name><surname>Valles</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Sterner</surname><given-names>D. E.</given-names></name><name><surname>Nguyen</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>USP7-specific inhibitors target and modify the enzyme’s active site via distinct chemical mechanisms.</article-title>
<source/><italic>Cell Chem. Biol.</italic>
<volume>24</volume>
<fpage>1501</fpage>–<lpage>1512.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2017.09.004</pub-id>
<pub-id pub-id-type="pmid">29056420</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Pentz</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Srivastava</surname><given-names>A. K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability.</article-title>
<source/><italic>Oncogene</italic>
<volume>34</volume>
<fpage>4791</fpage>–<lpage>4796</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2014.394</pub-id>
<pub-id pub-id-type="pmid">25435364</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Leonhardt</surname><given-names>H.</given-names></name><name><surname>Spada</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>USP7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1.</article-title>
<source/><italic>J. Cell. Biochem.</italic>
<volume>112</volume>
<fpage>439</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.22998</pub-id>
<pub-id pub-id-type="pmid">21268065</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qing</surname><given-names>P.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Bin</surname><given-names>L.</given-names></name><name><surname>Yan</surname><given-names>L.</given-names></name><name><surname>Ping</surname><given-names>W. X.</given-names></name></person-group> (<year>2011</year>). <article-title>USP7 regulates the stability and function of HLTF through deubiquitination.</article-title>
<source/><italic>J. Cell. Biochem.</italic>
<volume>112</volume>
<fpage>3856</fpage>–<lpage>3862</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.23317</pub-id>
<pub-id pub-id-type="pmid">21845734</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>J. M.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Lok</surname><given-names>G. T.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Huen</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The E3 ubiquitin ligase Rnf8 stabilizes Tpp1 to promote telomere end protection.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>18</volume>
<fpage>1400</fpage>–<lpage>1407</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2172</pub-id>
<pub-id pub-id-type="pmid">22101936</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>S. M.</given-names></name><name><surname>Quelle</surname><given-names>D. E.</given-names></name></person-group> (<year>2014</year>). <article-title>p53 acetylation: regulation and consequences.</article-title>
<source/><italic>Cancers</italic>
<volume>7</volume>
<fpage>30</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.3390/cancers7010030</pub-id>
<pub-id pub-id-type="pmid">25545885</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remus</surname><given-names>D.</given-names></name><name><surname>Beuron</surname><given-names>F.</given-names></name><name><surname>Tolun</surname><given-names>G.</given-names></name><name><surname>Griffith</surname><given-names>J. D.</given-names></name><name><surname>Morris</surname><given-names>E. P.</given-names></name><name><surname>Diffley</surname><given-names>J. F. X.</given-names></name></person-group> (<year>2009</year>). <article-title>Concerted loading of Mcm2-7 double hexamers around DNA during DNA replication origin licensing.</article-title>
<source/><italic>Cell</italic>
<volume>139</volume>
<fpage>719</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.10.015</pub-id>
<pub-id pub-id-type="pmid">19896182</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reverdy</surname><given-names>C.</given-names></name><name><surname>Conrath</surname><given-names>S.</given-names></name><name><surname>Lopez</surname><given-names>R.</given-names></name><name><surname>Planquette</surname><given-names>C.</given-names></name><name><surname>Atmanene</surname><given-names>C.</given-names></name><name><surname>Collura</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.</article-title>
<source/><italic>Chem. Biol.</italic>
<volume>19</volume>
<fpage>467</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.02.007</pub-id>
<pub-id pub-id-type="pmid">22520753</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes-Turcu</surname><given-names>F. E.</given-names></name><name><surname>Ventii</surname><given-names>K. H.</given-names></name><name><surname>Wilkinson</surname><given-names>K. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.</article-title>
<source/><italic>Annu. Rev. Biochem.</italic>
<volume>78</volume>
<fpage>363</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.78.082307.091526</pub-id>
<pub-id pub-id-type="pmid">19489724</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>C. L.</given-names></name><name><surname>Maiato</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>7</volume>
<fpage>637</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2004.09.002</pub-id>
<pub-id pub-id-type="pmid">15525526</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roschke</surname><given-names>A. V.</given-names></name><name><surname>Tonon</surname><given-names>G.</given-names></name><name><surname>Gehlhaus</surname><given-names>K. S.</given-names></name><name><surname>McTyre</surname><given-names>N.</given-names></name><name><surname>Bussey</surname><given-names>K. J.</given-names></name><name><surname>Lababidi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Karyotypic complexity of the NCI-60 drug-screening panel.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>63</volume>
<fpage>8634</fpage>–<lpage>8647</lpage>.<pub-id pub-id-type="pmid">14695175</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>K. E.</given-names></name><name><surname>Cohen-Fix</surname><given-names>O.</given-names></name></person-group> (<year>2002</year>). <article-title>Separase: a conserved protease separating more than just sisters.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>12</volume>
<fpage>1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/S0962-8924(01)02202-4</pub-id><pub-id pub-id-type="pmid">11853993</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouge</surname><given-names>L.</given-names></name><name><surname>Bainbridge</surname><given-names>T. W.</given-names></name><name><surname>Kwok</surname><given-names>M.</given-names></name><name><surname>Tong</surname><given-names>R.</given-names></name><name><surname>Di Lello</surname><given-names>P.</given-names></name><name><surname>Wertz</surname><given-names>I. E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Molecular understanding of USP7 substrate recognition and c-terminal activation.</article-title>
<source/><italic>Structure</italic>
<volume>24</volume>
<fpage>1335</fpage>–<lpage>1345</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2016.05.020</pub-id>
<pub-id pub-id-type="pmid">27452404</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>J.</given-names></name><name><surname>Schlüter</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>17</volume>:<issue>102</issue>. <pub-id pub-id-type="doi">10.1186/s12974-020-01783-8</pub-id>
<pub-id pub-id-type="pmid">32248814</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saintigny</surname><given-names>Y.</given-names></name><name><surname>Delacôte</surname><given-names>F.</given-names></name><name><surname>Varès</surname><given-names>G.</given-names></name><name><surname>Petitot</surname><given-names>F.</given-names></name><name><surname>Lambert</surname><given-names>S.</given-names></name><name><surname>Averbeck</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Characterization of homologous recombination induced by replication inhibition in mammalian cells.</article-title>
<source/><italic>EMBO J.</italic>
<volume>20</volume>
<fpage>3861</fpage>–<lpage>3870</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/20.14.3861</pub-id>
<pub-id pub-id-type="pmid">11447127</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sale</surname><given-names>J. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Competition, collaboration and coordination – determining how cells bypass DNA damage.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>125</volume>
<fpage>1633</fpage>–<lpage>1643</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.094748</pub-id>
<pub-id pub-id-type="pmid">22499669</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sale</surname><given-names>J. E.</given-names></name><name><surname>Lehmann</surname><given-names>A. R.</given-names></name><name><surname>Woodgate</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Y-family DNA polymerases and their role in tolerance of cellular DNA damage.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>13</volume>
<fpage>141</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3289</pub-id>
<pub-id pub-id-type="pmid">22358330</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sales Gil</surname><given-names>R.</given-names></name><name><surname>Vagnarelli</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Ki-67: more hidden behind a ‘classic proliferation marker’.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>43</volume>
<fpage>747</fpage>–<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2018.08.004</pub-id>
<pub-id pub-id-type="pmid">30131191</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampath</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Targeting deubiquitinases in CLL.</article-title>
<source/><italic>Blood</italic>
<volume>130</volume>
<fpage>100</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2017-06-786236</pub-id>
<pub-id pub-id-type="pmid">28705854</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarasin</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>UVSSA and USP7: new players regulating transcription-coupled nucleotide excision repair in human cells.</article-title>
<source/><italic>Genome Med.</italic>
<volume>4</volume>
<fpage>44</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1186/gm343</pub-id>
<pub-id pub-id-type="pmid">22621766</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saridakis</surname><given-names>V.</given-names></name><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Sarkari</surname><given-names>F.</given-names></name><name><surname>Holowaty</surname><given-names>M. N.</given-names></name><name><surname>Shire</surname><given-names>K.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>18</volume>
<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.02.029</pub-id>
<pub-id pub-id-type="pmid">15808506</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkari</surname><given-names>F.</given-names></name><name><surname>La Delfa</surname><given-names>A.</given-names></name><name><surname>Arrowsmith</surname><given-names>C. H.</given-names></name><name><surname>Frappier</surname><given-names>L.</given-names></name><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Saridakis</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>402</volume>
<fpage>825</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2010.08.017</pub-id>
<pub-id pub-id-type="pmid">20713061</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkari</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Frappier</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e16598</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016598</pub-id>
<pub-id pub-id-type="pmid">21305000</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>J. B.</given-names></name><name><surname>Morgan</surname><given-names>D. O.</given-names></name></person-group> (<year>2011</year>). <article-title>Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>45186</fpage>–<lpage>45196</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.310094</pub-id>
<pub-id pub-id-type="pmid">22072716</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schärer</surname><given-names>O. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Nucleotide excision repair in eukaryotes.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>5</volume>:<issue>a012609</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a012609</pub-id>
<pub-id pub-id-type="pmid">24086042</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schauer</surname><given-names>N. J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Magin</surname><given-names>R. S.</given-names></name><name><surname>Doherty</surname><given-names>L. M.</given-names></name><name><surname>Chan</surname><given-names>W. C.</given-names></name><name><surname>Ficarro</surname><given-names>S. B.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>10</volume>:<issue>5324</issue>. <pub-id pub-id-type="doi">10.1038/s41598-020-62076-x</pub-id>
<pub-id pub-id-type="pmid">32210275</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schermelleh</surname><given-names>L.</given-names></name><name><surname>Haemmer</surname><given-names>A.</given-names></name><name><surname>Spada</surname><given-names>F.</given-names></name><name><surname>Rösing</surname><given-names>N.</given-names></name><name><surname>Meilinger</surname><given-names>D.</given-names></name><name><surname>Rothbauer</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>35</volume>
<fpage>4301</fpage>–<lpage>4312</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm432</pub-id>
<pub-id pub-id-type="pmid">17576694</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwertman</surname><given-names>P.</given-names></name><name><surname>Lagarou</surname><given-names>A.</given-names></name><name><surname>Dekkers</surname><given-names>D. H. W.</given-names></name><name><surname>Raams</surname><given-names>A.</given-names></name><name><surname>van der Hoek</surname><given-names>A. C.</given-names></name><name><surname>Laffeber</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>598</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2230</pub-id>
<pub-id pub-id-type="pmid">22466611</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.</article-title>
<source/><italic>Signal Transduct. Target. Ther.</italic>
<volume>3</volume>:<issue>29</issue>. <pub-id pub-id-type="doi">10.1038/s41392-018-0028-3</pub-id>
<pub-id pub-id-type="pmid">30370059</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Saridakis</surname><given-names>V.</given-names></name><name><surname>Sarkari</surname><given-names>F.</given-names></name><name><surname>Duan</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Arrowsmith</surname><given-names>C. H.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Molecular recognition of p53 and MDM2 by USP7/HAUSP.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>13</volume>
<fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb1067</pub-id>
<pub-id pub-id-type="pmid">16474402</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shieh</surname><given-names>S. Y.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name><name><surname>Tamai</surname><given-names>K.</given-names></name><name><surname>Taya</surname><given-names>Y.</given-names></name><name><surname>Prives</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>14</volume>
<fpage>289</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">10673501</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>A.</given-names></name><name><surname>Le Guen</surname><given-names>T.</given-names></name><name><surname>Lopez</surname><given-names>B. S.</given-names></name><name><surname>Guirouilh-Barbat</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Genomic rearrangements induced by unscheduled DNA double strand breaks in somatic mammalian cells.</article-title>
<source/><italic>FEBS J.</italic>
<volume>284</volume>
<fpage>2324</fpage>–<lpage>2344</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14053</pub-id>
<pub-id pub-id-type="pmid">28244221</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobhian</surname><given-names>B.</given-names></name><name><surname>Shao</surname><given-names>G.</given-names></name><name><surname>Lilli</surname><given-names>D. R.</given-names></name><name><surname>Culhane</surname><given-names>A. C.</given-names></name><name><surname>Moreau</surname><given-names>L. A.</given-names></name><name><surname>Xia</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.</article-title>
<source/><italic>Science</italic>
<volume>316</volume>
<fpage>1198</fpage>–<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1126/science.1139516</pub-id>
<pub-id pub-id-type="pmid">17525341</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M. S.</given-names></name><name><surname>Salmena</surname><given-names>L.</given-names></name><name><surname>Carracedo</surname><given-names>A.</given-names></name><name><surname>Egia</surname><given-names>A.</given-names></name><name><surname>Lo-Coco</surname><given-names>F.</given-names></name><name><surname>Teruya-Feldstein</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008a</year>). <article-title>The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.</article-title>
<source/><italic>Nature</italic>
<volume>455</volume>
<fpage>813</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1038/nature07290</pub-id>
<pub-id pub-id-type="pmid">18716620</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M. S.</given-names></name><name><surname>Song</surname><given-names>S. J.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Oh</surname><given-names>H. J.</given-names></name><name><surname>Lim</surname><given-names>D.-S.</given-names></name></person-group> (<year>2008b</year>). <article-title>The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.</article-title>
<source/><italic>EMBO J.</italic>
<volume>27</volume>
<fpage>1863</fpage>–<lpage>1874</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2008.115</pub-id>
<pub-id pub-id-type="pmid">18566590</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>N.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Long</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>USP7 deubiquitinates and stabilizes SIRT1.</article-title>
<source/><italic>Anat. Rec.</italic>
<volume>303</volume>
<fpage>1337</fpage>–<lpage>1345</lpage>. <pub-id pub-id-type="doi">10.1002/ar.24252</pub-id>
<pub-id pub-id-type="pmid">31502386</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spada</surname><given-names>F.</given-names></name><name><surname>Haemmer</surname><given-names>A.</given-names></name><name><surname>Kuch</surname><given-names>D.</given-names></name><name><surname>Rothbauer</surname><given-names>U.</given-names></name><name><surname>Schermelleh</surname><given-names>L.</given-names></name><name><surname>Kremmer</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>176</volume>
<fpage>565</fpage>–<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200610062</pub-id>
<pub-id pub-id-type="pmid">17312023</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spit</surname><given-names>M.</given-names></name><name><surname>Rieser</surname><given-names>E.</given-names></name><name><surname>Walczak</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Linear ubiquitination at a glance.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>132</volume>:<issue>jcs208512</issue>. <pub-id pub-id-type="doi">10.1242/jcs.208512</pub-id>
<pub-id pub-id-type="pmid">30659056</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stad</surname><given-names>R.</given-names></name><name><surname>Little</surname><given-names>N. A.</given-names></name><name><surname>Xirodimas</surname><given-names>D. P.</given-names></name><name><surname>Frenk</surname><given-names>R.</given-names></name><name><surname>van der Eb</surname><given-names>A. J.</given-names></name><name><surname>Lane</surname><given-names>D. P.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>2</volume>
<fpage>1029</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1093/embo-reports/kve227</pub-id>
<pub-id pub-id-type="pmid">11606419</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>G. S.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Bignell</surname><given-names>C. R.</given-names></name><name><surname>Taylor</surname><given-names>A. M.</given-names></name><name><surname>Elledge</surname><given-names>S. J.</given-names></name></person-group> (<year>2003</year>). <article-title>MDC1 is a mediator of the mammalian DNA damage checkpoint.</article-title>
<source/><italic>Nature</italic>
<volume>421</volume>
<fpage>961</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1038/nature01446</pub-id>
<pub-id pub-id-type="pmid">12607005</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stommel</surname><given-names>J. M.</given-names></name><name><surname>Wahl</surname><given-names>G. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.</article-title>
<source/><italic>EMBO J.</italic>
<volume>23</volume>
<fpage>1547</fpage>–<lpage>1556</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600145</pub-id>
<pub-id pub-id-type="pmid">15029243</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>D.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>128</volume>
<fpage>4280</fpage>–<lpage>4296</lpage>. <pub-id pub-id-type="doi">10.1172/jci120518</pub-id>
<pub-id pub-id-type="pmid">30179224</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugasawa</surname><given-names>K.</given-names></name><name><surname>Okuda</surname><given-names>Y.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Nishi</surname><given-names>R.</given-names></name><name><surname>Matsuda</surname><given-names>N.</given-names></name><name><surname>Chu</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex.</article-title>
<source/><italic>Cell</italic>
<volume>121</volume>
<fpage>387</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.02.035</pub-id>
<pub-id pub-id-type="pmid">15882621</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Kaufman</surname><given-names>P. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Ki-67: more than a proliferation marker.</article-title>
<source/><italic>Chromosoma</italic>
<volume>127</volume>
<fpage>175</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1007/s00412-018-0659-8</pub-id>
<pub-id pub-id-type="pmid">29322240</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundara Rajan</surname><given-names>S.</given-names></name><name><surname>Hanby</surname><given-names>A. M.</given-names></name><name><surname>Horgan</surname><given-names>K.</given-names></name><name><surname>Thygesen</surname><given-names>H. H.</given-names></name><name><surname>Speirs</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>The potential utility of geminin as a predictive biomarker in breast cancer.</article-title>
<source/><italic>Breast Cancer Res. Treat.</italic>
<volume>143</volume>
<fpage>91</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-013-2786-5</pub-id>
<pub-id pub-id-type="pmid">24292956</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sykes</surname><given-names>S. M.</given-names></name><name><surname>Mellert</surname><given-names>H. S.</given-names></name><name><surname>Holbert</surname><given-names>M. A.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Marmorstein</surname><given-names>R.</given-names></name><name><surname>Lane</surname><given-names>W. S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Acetylation of the p53 DNA-binding domain regulates apoptosis induction.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>24</volume>
<fpage>841</fpage>–<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2006.11.026</pub-id>
<pub-id pub-id-type="pmid">17189187</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Agrawal</surname><given-names>T.</given-names></name><name><surname>Cheng</surname><given-names>Q.</given-names></name><name><surname>Qu</surname><given-names>L.</given-names></name><name><surname>Brewer</surname><given-names>M. D.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e55813</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0055813</pub-id>
<pub-id pub-id-type="pmid">23405218</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Qu</surname><given-names>L. K.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Michaelson</surname><given-names>J. S.</given-names></name><name><surname>Degenhardt</surname><given-names>Y. Y.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Critical role for Daxx in regulating Mdm2.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>8</volume>
<fpage>855</fpage>–<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1442</pub-id>
<pub-id pub-id-type="pmid">16845383</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>). <article-title>Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>24</volume>
<fpage>827</fpage>–<lpage>839</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2006.11.021</pub-id>
<pub-id pub-id-type="pmid">17189186</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Isamiddinova</surname><given-names>N. S.</given-names></name><name><surname>Peroutka</surname><given-names>R. J.</given-names></name><name><surname>Goldenberg</surname><given-names>S. J.</given-names></name><name><surname>Mattern</surname><given-names>M. R.</given-names></name><name><surname>Nicholson</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.</article-title>
<source/><italic>Assay Drug Dev. Technol.</italic>
<volume>9</volume>
<fpage>165</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1089/adt.2010.0317</pub-id>
<pub-id pub-id-type="pmid">21133675</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>L. N.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>Prevention of DNA re-replication in eukaryotic cells.</article-title>
<source/><italic>J. Mol. Cell Biol.</italic>
<volume>3</volume>
<fpage>13</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/jmcb/mjq052</pub-id>
<pub-id pub-id-type="pmid">21278447</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>A. P.</given-names></name><name><surname>Ioannidis</surname><given-names>S.</given-names></name><name><surname>Krajewski</surname><given-names>W. W.</given-names></name><name><surname>Pinto-Fernandez</surname><given-names>A.</given-names></name><name><surname>Heride</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>A. C. L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Molecular basis of USP7 inhibition by selective small-molecule inhibitors.</article-title>
<source/><italic>Nature</italic>
<volume>550</volume>
<fpage>481</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1038/nature24451</pub-id>
<pub-id pub-id-type="pmid">29045389</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unk</surname><given-names>I.</given-names></name><name><surname>Hajdú</surname><given-names>I.</given-names></name><name><surname>Fátyol</surname><given-names>K.</given-names></name><name><surname>Hurwitz</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>J. H.</given-names></name><name><surname>Prakash</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>3768</fpage>–<lpage>3773</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0800563105</pub-id>
<pub-id pub-id-type="pmid">18316726</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uto</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>D.</given-names></name><name><surname>Shimuta</surname><given-names>K.</given-names></name><name><surname>Nakajo</surname><given-names>N.</given-names></name><name><surname>Sagata</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.</article-title>
<source/><italic>EMBO J.</italic>
<volume>23</volume>
<fpage>3386</fpage>–<lpage>3396</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600328</pub-id>
<pub-id pub-id-type="pmid">15272308</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Horst</surname><given-names>A.</given-names></name><name><surname>de Vries-Smits</surname><given-names>A. M.</given-names></name><name><surname>Brenkman</surname><given-names>A. B.</given-names></name><name><surname>van Triest</surname><given-names>M. H.</given-names></name><name><surname>van den Broek</surname><given-names>N.</given-names></name><name><surname>Colland</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>8</volume>
<fpage>1064</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1469</pub-id>
<pub-id pub-id-type="pmid">16964248</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquero</surname><given-names>A.</given-names></name><name><surname>Scher</surname><given-names>M.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Serrano</surname><given-names>L.</given-names></name><name><surname>Reinberg</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.</article-title>
<source/><italic>Nature</italic>
<volume>450</volume>
<fpage>440</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1038/nature06268</pub-id>
<pub-id pub-id-type="pmid">18004385</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquero</surname><given-names>A.</given-names></name><name><surname>Scher</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>D.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Reinberg</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>16</volume>
<fpage>93</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2004.08.031</pub-id>
<pub-id pub-id-type="pmid">15469825</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujanovic</surname><given-names>M.</given-names></name><name><surname>Krietsch</surname><given-names>J.</given-names></name><name><surname>Raso</surname><given-names>M. C.</given-names></name><name><surname>Terraneo</surname><given-names>N.</given-names></name><name><surname>Zellweger</surname><given-names>R.</given-names></name><name><surname>Schmid</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Replication fork slowing and reversal upon DNA damage require PCNA polyubiquitination and ZRANB3 DNA translocase activity.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>67</volume>
<fpage>882</fpage>–<lpage>890.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.08.010</pub-id>
<pub-id pub-id-type="pmid">28886337</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Podell</surname><given-names>E. R.</given-names></name><name><surname>Zaug</surname><given-names>A. J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Baciu</surname><given-names>P.</given-names></name><name><surname>Cech</surname><given-names>T. R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>The POT1-TPP1 telomere complex is a telomerase processivity factor.</article-title>
<source/><italic>Nature</italic>
<volume>445</volume>
<fpage>506</fpage>–<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1038/nature05454</pub-id>
<pub-id pub-id-type="pmid">17237768</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The USP7 inhibitor P5091 induces cell death in ovarian cancers with different p53 status.</article-title>
<source/><italic>Cell. Physiol. Biochem.</italic>
<volume>43</volume>
<fpage>1755</fpage>–<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1159/000484062</pub-id>
<pub-id pub-id-type="pmid">29049989</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>126</volume>
<fpage>2205</fpage>–<lpage>2220</lpage>. <pub-id pub-id-type="doi">10.1172/JCI85747</pub-id>
<pub-id pub-id-type="pmid">27183383</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.-E.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Wani</surname><given-names>G.</given-names></name><name><surname>El-Mahdy</surname><given-names>M. A.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wani</surname><given-names>A. A.</given-names></name></person-group> (<year>2005</year>). <article-title>DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>33</volume>
<fpage>4023</fpage>–<lpage>4034</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki684</pub-id>
<pub-id pub-id-type="pmid">16030353</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Tateishi</surname><given-names>S.</given-names></name><name><surname>Kawasuji</surname><given-names>M.</given-names></name><name><surname>Tsurimoto</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Yamaizumi</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Rad18 guides pol eta to replication stalling sites through physical interaction and PCNA monoubiquitination.</article-title>
<source/><italic>EMBO J.</italic>
<volume>23</volume>
<fpage>3886</fpage>–<lpage>3896</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600383</pub-id>
<pub-id pub-id-type="pmid">15359278</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Lan</surname><given-names>L.</given-names></name><name><surname>Yasui</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Matsuzawa</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>BRCA1 contributes to transcription-coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein.</article-title>
<source/><italic>Cancer Sci.</italic>
<volume>102</volume>
<fpage>1840</fpage>–<lpage>1847</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2011.02037.x</pub-id>
<pub-id pub-id-type="pmid">21756275</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Borcherds</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E2558</fpage>–<lpage>E2563</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1603838113</pub-id>
<pub-id pub-id-type="pmid">27114532</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstock</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Kingsbury</surname><given-names>W. D.</given-names></name><name><surname>McDermott</surname><given-names>J. L.</given-names></name><name><surname>Kodrasov</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47.</article-title>
<source/><italic>ACS Med. Chem. Lett.</italic>
<volume>3</volume>
<fpage>789</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1021/ml200276j</pub-id>
<pub-id pub-id-type="pmid">24900381</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>D. R.</given-names></name><name><surname>Lee</surname><given-names>W. T. C.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Ofri</surname><given-names>D. M.</given-names></name><name><surname>Bermudez-Hernandez</surname><given-names>K.</given-names></name><name><surname>Keegan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>3882</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-06435-3</pub-id>
<pub-id pub-id-type="pmid">30250272</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohlschlegel</surname><given-names>J. A.</given-names></name><name><surname>Dwyer</surname><given-names>B. T.</given-names></name><name><surname>Dhar</surname><given-names>S. K.</given-names></name><name><surname>Cvetic</surname><given-names>C.</given-names></name><name><surname>Walter</surname><given-names>J. C.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Inhibition of eukaryotic DNA replication by geminin binding to Cdt1.</article-title>
<source/><italic>Science</italic>
<volume>290</volume>
<fpage>2309</fpage>–<lpage>2312</lpage>. <pub-id pub-id-type="doi">10.1126/science.290.5500.2309</pub-id>
<pub-id pub-id-type="pmid">11125146</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Gunasekera</surname><given-names>A. H.</given-names></name><name><surname>Sowin</surname><given-names>T. J.</given-names></name><name><surname>Rosenberg</surname><given-names>S. H.</given-names></name><name><surname>Fesik</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>21767</fpage>–<lpage>21773</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M300229200</pub-id>
<pub-id pub-id-type="pmid">12676925</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Kiselar</surname><given-names>J.</given-names></name><name><surname>Whited</surname><given-names>T. L.</given-names></name><name><surname>Hernandez-Sanchez</surname><given-names>W.</given-names></name><name><surname>Taylor</surname><given-names>D. J.</given-names></name></person-group> (<year>2019</year>). <article-title>POT1-TPP1 differentially regulates telomerase via POT1 His266 and as a function of single-stranded telomere DNA length.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>116</volume>
<fpage>23527</fpage>–<lpage>23533</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1905381116</pub-id>
<pub-id pub-id-type="pmid">31685617</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>L.</given-names></name><name><surname>Nishiyama</surname><given-names>A.</given-names></name><name><surname>Misaki</surname><given-names>T.</given-names></name><name><surname>Johmura</surname><given-names>Y.</given-names></name><name><surname>Ueda</surname><given-names>J.</given-names></name><name><surname>Arita</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>USP7-dependent histone H3 deubiquitylation regulates maintenance of DNA methylation.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>55</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-00136-5</pub-id>
<pub-id pub-id-type="pmid">28246399</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Damage repair DNA polymerases Y.</article-title>
<source/><italic>Curr. Opin. Struct. Biol.</italic>
<volume>13</volume>
<fpage>23</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/s0959-440x(02)00003-9</pub-id><pub-id pub-id-type="pmid">12581656</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarychkivska</surname><given-names>O.</given-names></name><name><surname>Tavana</surname><given-names>O.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Bestor</surname><given-names>T. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Independent functions of DNMT1 and USP7 at replication foci.</article-title>
<source/><italic>Epigenetics Chromatin</italic>
<volume>11</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1186/s13072-018-0179-z</pub-id>
<pub-id pub-id-type="pmid">29482658</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.</article-title>
<source/><italic>Oncol. Rep.</italic>
<volume>36</volume>
<fpage>2935</fpage>–<lpage>2945</lpage>. <pub-id pub-id-type="doi">10.3892/or.2016.5099</pub-id>
<pub-id pub-id-type="pmid">27632941</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>M.-J.</given-names></name><name><surname>Hsu</surname><given-names>K.-C.</given-names></name><name><surname>Lin</surname><given-names>T. E.</given-names></name><name><surname>Chang</surname><given-names>W.-C.</given-names></name><name><surname>Hung</surname><given-names>J.-J.</given-names></name></person-group> (<year>2019</year>). <article-title>The role of ubiquitin-specific peptidases in cancer progression.</article-title>
<source/><italic>J. Biomed. Sci.</italic>
<volume>26</volume>:<issue>42</issue>. <pub-id pub-id-type="doi">10.1186/s12929-019-0522-0</pub-id>
<pub-id pub-id-type="pmid">31133011</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>T.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><name><surname>Ying</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>9</volume>:<issue>1080</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2018.01080</pub-id>
<pub-id pub-id-type="pmid">30319415</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapata</surname><given-names>J. M.</given-names></name><name><surname>Pawlowski</surname><given-names>K.</given-names></name><name><surname>Haas</surname><given-names>E.</given-names></name><name><surname>Ware</surname><given-names>C. F.</given-names></name><name><surname>Godzik</surname><given-names>A.</given-names></name><name><surname>Reed</surname><given-names>J. C.</given-names></name></person-group> (<year>2001</year>). <article-title>A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>24242</fpage>–<lpage>24252</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M100354200</pub-id>
<pub-id pub-id-type="pmid">11279055</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemp</surname><given-names>I.</given-names></name><name><surname>Lingner</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>28595</fpage>–<lpage>28606</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.596056</pub-id>
<pub-id pub-id-type="pmid">25172512</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Q. W.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>J. H.</given-names></name><name><surname>Liu</surname><given-names>S. L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells.</article-title>
<source/><italic>Int. J. Biochem. Cell Biol.</italic>
<volume>79</volume>
<fpage>209</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2016.08.025</pub-id>
<pub-id pub-id-type="pmid">27590858</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Zhan</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>5059</issue>. <pub-id pub-id-type="doi">10.1038/ncomms6059</pub-id>
<pub-id pub-id-type="pmid">25283148</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Debeb</surname><given-names>B. G.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>16</volume>
<fpage>864</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3013</pub-id>
<pub-id pub-id-type="pmid">25086746</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Bian</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance.</article-title>
<source/><italic>Cancer Cell Int.</italic>
<volume>20</volume>:<issue>28</issue>. <pub-id pub-id-type="doi">10.1186/s12935-020-1109-2</pub-id>
<pub-id pub-id-type="pmid">32002017</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Horibata</surname><given-names>K.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Ishigami</surname><given-names>C.</given-names></name><name><surname>Ukai</surname><given-names>A.</given-names></name><name><surname>Kanno</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>593</fpage>–<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2228</pub-id>
<pub-id pub-id-type="pmid">22466612</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z. M.</given-names></name><name><surname>Rothbart</surname><given-names>S. B.</given-names></name><name><surname>Allison</surname><given-names>D. F.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Harrison</surname><given-names>J. S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>An allosteric interaction links USP7 to deubiquitination and chromatin targeting of UHRF1.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>12</volume>
<fpage>1400</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.046</pub-id>
<pub-id pub-id-type="pmid">26299963</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhivotovsky</surname><given-names>B.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Apoptosis and genomic instability.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>5</volume>
<fpage>752</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1443</pub-id>
<pub-id pub-id-type="pmid">15340382</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Caron</surname><given-names>P.</given-names></name><name><surname>Legube</surname><given-names>G.</given-names></name><name><surname>Paull</surname><given-names>T. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Quantitation of DNA double-strand break resection intermediates in human cells.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>42</volume>:<issue>e19</issue>. <pub-id pub-id-type="doi">10.1093/nar/gkt1309</pub-id>
<pub-id pub-id-type="pmid">24362840</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Ding</surname><given-names>N.</given-names></name><name><surname>Wei</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Wani</surname><given-names>G.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>USP7-mediated deubiquitination differentially regulates CSB but not UVSSA upon UV radiation-induced DNA damage.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>19</volume>
<fpage>124</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2019.1695996</pub-id>
<pub-id pub-id-type="pmid">31775559</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Wani</surname><given-names>G.</given-names></name><name><surname>Wani</surname><given-names>A. A.</given-names></name></person-group> (<year>2015</year>). <article-title>USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>14</volume>
<fpage>1413</fpage>–<lpage>1425</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2015.1007785</pub-id>
<pub-id pub-id-type="pmid">25894431</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlatanou</surname><given-names>A.</given-names></name><name><surname>Sabbioneda</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>E. S.</given-names></name><name><surname>Greenwalt</surname><given-names>A.</given-names></name><name><surname>Aggathanggelou</surname><given-names>A.</given-names></name><name><surname>Maurice</surname><given-names>M. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>USP7 is essential for maintaining Rad18 stability and DNA damage tolerance.</article-title>
<source/><italic>Oncogene</italic>
<volume>35</volume>
<fpage>965</fpage>–<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2015.149</pub-id>
<pub-id pub-id-type="pmid">25961918</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlatanou</surname><given-names>A.</given-names></name><name><surname>Stewart</surname><given-names>G. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Damaged replication forks tolerate USP7 to maintain genome stability.</article-title>
<source/><italic>Mol. Cell Oncol.</italic>
<volume>3</volume>:<issue>e1063571</issue>. <pub-id pub-id-type="doi">10.1080/23723556.2015.1063571</pub-id>
<pub-id pub-id-type="pmid">27308573</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>